Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
138a534c2d7ec63bb7d7009f530ce302a9706497301ebde93ae4af9e8e2b4d59.png
complex
<table><tr><td rowspan="2"> </td><td rowspan="2">Study population</td><td rowspan="2">Non-pregnant group</td><td rowspan="2">Pregnant group</td><td><i>p-</i>Value</td></tr><tr><td>Difference between groups</td></tr><tr><td> </td><td>N = 728</td><td>N = 235</td><td>N = 493</td><td> </td></tr><tr><td>Age, Mean (SD) years</td><td>32.5 (4.7)</td><td>32.8 (4.2)</td><td>32.4 (4.9)</td><td>0.27<sup>1</sup></td></tr><tr><td>Marital status, n (%)</td><td>N = 722</td><td>N = 234</td><td>N = 487</td><td> </td></tr><tr><td>Married/co-habiting</td><td>699 (96.8%)</td><td>230 (98.3%)</td><td>469 (96.1%)</td><td> </td></tr><tr><td>Other</td><td>23 (3.2%)</td><td>4 (1.7%)</td><td>19 (3.9%)</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>0.12<sup>2</sup></td></tr><tr><td>Basic education, n (%)</td><td>N = 720</td><td>N = 234</td><td>N = 486</td><td> </td></tr><tr><td>Elementary school</td><td>165 (22.9%)</td><td>42 (17.9%)</td><td>123 (25.3%)</td><td> </td></tr><tr><td>Part of high school</td><td>31 (4.3%)</td><td>15 (6.4%)</td><td>16 (3.3%)</td><td> </td></tr><tr><td>High school diploma</td><td>514 (71.4%)</td><td>173 (73.9%)</td><td>341 (70.2%)</td><td> </td></tr><tr><td>Other</td><td>10 (1.4%)</td><td>4 (1.7%)</td><td>6 (1.2%)</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>0.049<sup>2</sup></td></tr><tr><td>Vocational education, n (%)</td><td>N = 718</td><td>N = 232</td><td>N = 486</td><td> </td></tr><tr><td>No professional education/ diploma/degree</td><td>76 (10.6%)</td><td>25 (10.8%)</td><td>51 (10.5%)</td><td> </td></tr><tr><td>Vocational course/school or apprenticeship</td><td>236 (32.9%)</td><td>70 (30.2%)</td><td>166 (34.2%)</td><td> </td></tr><tr><td>Vocational diploma/degree</td><td>174 (24.2%)</td><td>54 (23.3%)</td><td>120 (24.7%)</td><td> </td></tr><tr><td>Academic degree</td><td>228 (31.8%)</td><td>83 (35.8%)</td><td>145 (29.8%)</td><td> </td></tr><tr><td>Other</td><td>4 (0.6%)</td><td>0 (0.0%)</td><td>4 (0.8%)</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>0.34<sup>2</sup></td></tr><tr><td>Current work situation, n (%)</td><td>N = 722</td><td>N = 234</td><td>N = 488</td><td> </td></tr><tr><td>Full-time work</td><td>368 (51.0%)</td><td>75 (32.1%)</td><td>293 (60.0%)</td><td> </td></tr><tr><td>Part-time work</td><td>70 (9.7%)</td><td>25 (10.7%)</td><td>45 (9.2%)</td><td> </td></tr><tr><td>Housewife</td><td>191 (26.5%)</td><td>87 (37.2%)</td><td>104 (21.3%)</td><td> </td></tr><tr><td>Unemployed</td><td>16 (2.2%)</td><td>4 (1.7%)</td><td>12 (2.5%)</td><td> </td></tr><tr><td>Maternity leave</td><td>36 (5.0%)</td><td>29 (12.4%)</td><td>7 (1.4%)</td><td> </td></tr><tr><td>Other</td><td>41 (5.7%)</td><td>14 (6.0%)</td><td>27 (5.5%)</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>&lt;0.001<sup>2</sup></td></tr><tr><td>Annual household income, n (%)</td><td>N = 689</td><td>N = 226</td><td>N = 463</td><td> </td></tr><tr><td>&lt;20 000 euro/year</td><td>33 (4.8%)</td><td>9 (4.0%)</td><td>24 (5.2%)</td><td> </td></tr><tr><td>20 001-50 000</td><td>251 (36.4%)</td><td>83 (36.7%)</td><td>168 (36.3%)</td><td> </td></tr><tr><td>50 001-100 000</td><td>366 (53.1%)</td><td>116 (51.3%)</td><td>250 (54.0%)</td><td> </td></tr><tr><td>&gt;100 000</td><td>39 (5.7%)</td><td>18 (8.0%)</td><td>21 (4.5%)</td><td> </td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>0.28<sup>2</sup></td></tr></table>
dd65b2c332a980a8408e09c76c2b30464bec241f79a3569e422798019a8f70a9.png
complex
<table><tr><td></td><td colspan="6">EC<sub>50</sub> (&#956;M) [conf. int.]*</td></tr><tr><td></td><td>Control Glutamate</td><td>EU1794-27 Glutamate</td><td>Fold Difference</td><td>Control Glycine</td><td>EU1794-27 Glycine</td><td>Fold Difference</td></tr><tr><td>GluN2A</td><td>2.9 [2.2, 4.0]</td><td>1.1 [0.88, 2.1]</td><td>2.3<sup>&#8224;</sup></td><td>0.57 [0.34, 0.96]</td><td>0.38 [0.23, 0.64]</td><td>1.6</td></tr><tr><td>GluN2B</td><td>1.2 [1.1, 1.3]</td><td>0.65 [0.49, 0.85]</td><td>2.0<sup>&#8224;</sup></td><td>0.28 [0.22, 0.36]</td><td>0.14 [0.08, 0.24]</td><td>2.9<sup>&#8224;</sup></td></tr><tr><td>GluN2C</td><td>0.67 [0.61, 0.73]</td><td>0.22 [0.16, 0.31]</td><td>3.3<sup>&#8224;</sup></td><td>0.23 [0.13, 0.40]</td><td>0.10 [0.07, 0.15]</td><td>2.4</td></tr><tr><td>GluN2D</td><td>0.21 [0.17,0.27]</td><td>0.054 [0.028, 0.11]</td><td>5.3<sup>&#8224;</sup></td><td>0.086 [0.077, 0.095]</td><td>0.020 [0.013, 0.029]</td><td>4.9<sup>&#8224;</sup></td></tr></table>
ecbb1f0ec251bb97c166d8277f06bb8f7323bc0f84e12535c63358be8ceaa82d.png
simple
<table><tr><td></td><td>2003</td><td>2004</td><td>2005</td><td>2006</td><td>2007</td><td>Total</td></tr><tr><td>Number of complicated induced abortions </td><td>23</td><td>13</td><td>11</td><td>18</td><td>46</td><td>111</td></tr><tr><td>Number of admission into gynaecological ward</td><td>757</td><td>716</td><td>471</td><td>785</td><td>818</td><td>3547</td></tr><tr><td>Number of live births</td><td>1543</td><td>1479</td><td>1512</td><td>1756</td><td>2101</td><td>8391</td></tr><tr><td>Percentage of gynaecological admission </td><td>3.0</td><td>1.8</td><td>2.3</td><td>2.3</td><td>5.6</td><td>3.1%</td></tr><tr><td>Ratio of complicated induced abortion per 1000 live births </td><td>14.9</td><td>8.8</td><td>7.3</td><td>10.3</td><td>21.9</td><td>13.2/1000</td></tr></table>
154507d66b38187314873c4d45a0b6855384f71e996d8010cbfb6975c684e4eb.png
simple
<table><tr><td>Year</td><td>Journal</td><td>Title of the paper</td><td>First author; volume number; page numbers</td></tr><tr><td>2013</td><td>Public health action</td><td>The burden and outcomes of childhood tuberculosis in Cotonou, Benin<sup>a</sup></td><td>Ade S; vol 314; no 1; 15&#8211;19</td></tr><tr><td>2013</td><td>Public health action</td><td>MDR-TB treatment needs in patients previously treated for TB in Cotonou, Benin<sup>b</sup></td><td>Ade S; vol 3; no 2; 160&#8211;165</td></tr><tr><td>2013</td><td>Transactions of the royal society of tropical medicine and hygiene</td><td>National profile and treatment outcomes of adult smear-negative pulmonary TB patients in Benin<sup>b</sup></td><td>Ade S; 10.1093/trstmh/trt092</td></tr><tr><td>2014</td><td>PLoS One</td><td>National profile and treatment outcomes of patients with extrapulmonary tuberculosis in Benin<sup>a</sup></td><td>Ade S; vol 9; no 4; e95603</td></tr><tr><td>2015</td><td>Public health action</td><td>Low prevalence of diabetes mellitus in patients with tuberculosis in Cotonou, Benin<sup>b</sup></td><td>Ade S; vol 5; no 2; 147&#8211;149</td></tr><tr><td>2016</td><td>BMC health services research</td><td>Follow-up and tracing of tuberculosis patients who fail to attend their scheduled appointments in Cotonou, Benin: a retrospective cohort study<sup>a</sup></td><td>Ade S; vol 5; no 2; 7 pages; 10.1186/s12913-015-1219-z</td></tr><tr><td>2016</td><td>Tuberculosis research and treatment</td><td>Characteristics and treatment outcomes of retreatment tuberculosis patients in Benin<sup>b</sup></td><td>Ade S; vol 2016, Article ID 1468631, 7 pages http://dx.doi.org/10.1155/2016/1468631</td></tr><tr><td>2016</td><td>Tuberculosis research and treatment</td><td>Tuberculosis case finding in Benin, 2000&#8211;2014 and beyond: a retrospective cohort and Time Series Study<sup>b</sup></td><td>Ade S; volume 2016, Article ID 3205843, 9 pages http://dx.doi.org/10.1155/2016/3205843</td></tr></table>
b28f3ed80995e05f7fa062ca503a03e70457bdb4f8a4ad639c95f3b7cc0f2c0b.png
simple
<table><tr><td>Factor</td><td><i>B</i></td><td>S.E.</td><td>Wald</td><td><i>P</i></td><td>OR</td><td>95% CI</td></tr><tr><td>SDF-1&#945;</td><td>1.083</td><td>0.444</td><td>5.958</td><td>0.015</td><td>2.952</td><td>1.238&#8211;7.042</td></tr><tr><td>CXCR4</td><td>0.546</td><td>0.634</td><td>4.742</td><td>0.039</td><td>1.726</td><td>1.499&#8211;5.973</td></tr><tr><td>EBV-IgG status</td><td>0.720</td><td>0.334</td><td>3.006</td><td>0.036</td><td>1.027</td><td>1.534&#8211;1.976</td></tr><tr><td>T staging</td><td>0.572</td><td>0.222</td><td>2.008</td><td>0.036</td><td>1.080</td><td>1.034&#8211;1.515</td></tr><tr><td>N staging</td><td>0.617</td><td>0.223</td><td>7.640</td><td>0.006</td><td>1.853</td><td>1.197&#8211;2.869</td></tr><tr><td>TNM staging</td><td>1.485</td><td>0.192</td><td>6.394</td><td>0.011</td><td>1.624</td><td>1.115&#8211;2.364</td></tr><tr><td>Skull base invasion</td><td>1.643</td><td>1.181</td><td>1.934</td><td>0.043</td><td>1.193</td><td>1.019&#8211;1.959</td></tr><tr><td>Cervical lymph node metastasis</td><td>0.915</td><td>1.099</td><td>2.693</td><td>0.045</td><td>2.496</td><td>1.290&#8211;2.497</td></tr></table>
801970c62eab26b5ea1b37d82832fdaa122d62aa901e76e08bdbe2fb783d1a68.png
complex
<table><tr><td rowspan="2">Treatment [Reference]</td><td rowspan="2">Annual exacerbation rate</td><td rowspan="2">Comparator</td><td rowspan="2">Annual exacerbation rate</td><td rowspan="2">Reduction in exacerbations</td><td rowspan="2">Exacerbation endpoint</td><td colspan="2">Patient population</td></tr><tr><td>Exacerbation entry criteria (No./year)</td><td>FEV<sub>1</sub> % predicted</td></tr><tr><td colspan="8">ICS</td></tr><tr><td> FP [131]</td><td>0.93</td><td>Placebo</td><td>0.73</td><td>NS</td><td>Primary</td><td>NA</td><td>&lt;90 % (post-BD)</td></tr><tr><td> FP [13]</td><td>0.93</td><td>Placebo</td><td>1.13</td><td>18 %</td><td>Secondary (moderate or severe)</td><td>NA</td><td>&lt;60 % (pre-BD)</td></tr><tr><td> FP [65]</td><td>1.05</td><td>Placebo</td><td>1.30</td><td>19 %</td><td>Secondary (any)</td><td>&#8805;1</td><td>25&#8211;70 % (pre-BD)</td></tr><tr><td> FP [132]</td><td>0.99</td><td>Placebo</td><td>1.32</td><td>25 %</td><td>Secondary (any)</td><td>NA</td><td>&lt;85 % (post-BD)</td></tr><tr><td colspan="8">LABA/ICS</td></tr><tr><td> SFC [133]</td><td>0.44</td><td>Salmeterol</td><td>0.48</td><td>NS</td><td>Primary (severe)</td><td>&#8805;1 (last 14 days)</td><td>&lt;70 % (pre-BD)</td></tr><tr><td> SFC [134]</td><td>1.10</td><td>Salmeterol</td><td>1.59</td><td>30.4 %</td><td>Primary (moderate or severe)</td><td>&#8805;1</td><td>&lt;50 %</td></tr><tr><td> SFC [13]</td><td>0.85</td><td>PlaceboSalmeterolFP</td><td>1.130.970.93</td><td>25 %12 %9 %</td><td>Secondary (moderate or severe)</td><td>NA</td><td>&lt;60 % (pre-BD)</td></tr><tr><td> SFC [65]</td><td>0.97</td><td>Placebo</td><td>1.30</td><td>25 %</td><td>Secondary (moderate)</td><td>&#8805;1</td><td>25&#8211;70 % (pre-BD)</td></tr><tr><td> SFC [135]</td><td>1.06</td><td>Salmeterol</td><td>1.53</td><td>30.5 %</td><td>Primary</td><td>&#8805;1</td><td>&lt;50 %</td></tr><tr><td> SFC [61, 136]</td><td>1.28</td><td>Tiotropium</td><td>1.32</td><td>NS</td><td>Primary (moderate or severe)</td><td>NA</td><td>&lt;50 % (post-BD)</td></tr><tr><td> SFC [137]</td><td>0.92</td><td>Salmeterol</td><td>1.4</td><td>35 %</td><td>Primary (moderate or severe)</td><td>&#8805;2</td><td>&lt;50 % (post-BD)</td></tr><tr><td> Bud/Form [80]</td><td>1.38</td><td>PlaceboFormeterolBudesonide</td><td>1.801.851.60</td><td>23.6 %NSNS</td><td>Primary (all)</td><td>&#8805;1</td><td>&lt;50 % (pre-BD)</td></tr><tr><td> Bud/Form [81]</td><td>1.42</td><td>PlaceboFormoterolBudesonide</td><td>1.871.841.59</td><td>24 %23 %NS</td><td>Primary (severe)</td><td>&#8805;1</td><td>&lt;50 %</td></tr><tr><td> Bud/Form [138]</td><td>0.70 (320/9 &#956;g)0.79 (160/9 &#956;g)</td><td>Formoterol</td><td>1.07</td><td>34.6 %25.9 %</td><td>Primary (moderate or severe)</td><td>&#8805;1</td><td>&#8804;50 % (pre-BD)</td></tr><tr><td> Bud/Form [139]</td><td>NR</td><td>Formoterol</td><td>NR</td><td>36 %</td><td>Secondary (any)</td><td>&#8805;1</td><td>&#8804;50 % (pre-BD)</td></tr><tr><td> FF/VI [79]</td><td>0.81</td><td>Vilanterol</td><td>1.11</td><td>30 %(Pooled data)</td><td>Primary (moderate or severe)</td><td>&#8805;1</td><td>&lt;70 % (post-BD)</td></tr><tr><td> BDP/FOR [140]</td><td>0.80</td><td>Formoterol</td><td>1.12</td><td>28 %</td><td>Primary (moderate or severe)</td><td>&#8805;1</td><td>&lt;50 %</td></tr><tr><td> BDP/FOR [141]</td><td>0.41</td><td>Bud/Form Formoterol</td><td>0.420.43</td><td>NS</td><td>Primary</td><td>&#8805;1</td><td>30&#8211;50 % (post-BD)</td></tr><tr><td colspan="8">Triple therapy</td></tr><tr><td> Tiotropium + salmeterol + FP [64]</td><td>1.37</td><td>Tiotropium</td><td>1.61</td><td>NS</td><td>Secondary (any)</td><td>&#8805;1</td><td>&lt;65 % (post-BD)</td></tr></table>
aa36920de5d74ed0f6c97945437f69056a638cb92091e99672efdbf0fb1bc8f1.png
complex
<table><tr><td rowspan="2">Identified phenolic compounds</td><td colspan="3"><i>P. veris</i></td><td colspan="3"><i>P. elatior</i></td></tr><tr><td>Mean</td><td>&#177;sd</td><td>CV (%)</td><td>Mean</td><td>&#177;sd</td><td>CV (%)</td></tr><tr><td>(+)-Catechin</td><td>312.11</td><td>&#177;90.91<sup><i>&#8727;&#8727;</i></sup></td><td>29.13</td><td>171.75</td><td>&#177;57.26</td><td>33.34</td></tr><tr><td>Orientin</td><td>204.23</td><td>&#177;78.03 ns</td><td>38.21</td><td>149.13</td><td>&#177;57.16</td><td>38.33</td></tr><tr><td>Rutoside</td><td>630.83</td><td>&#177;199.15</td><td>31.57</td><td>1025.96</td><td>&#177;237.21<sup><i>&#8727;&#8727;</i></sup></td><td>23.12</td></tr><tr><td>Hyperoside</td><td>nd</td><td> </td><td> </td><td>265.30</td><td>&#177;122.80</td><td>46.29</td></tr><tr><td>Isorhamnetin-3-O-rutinoside</td><td>740.24</td><td>&#177;337.09</td><td>45.54</td><td>1142.75</td><td>&#177;401.76<sup><i>&#8727;&#8727;</i></sup></td><td>35.16</td></tr><tr><td>Isorhamnetin-3-O-glucoside</td><td>448.45</td><td>&#177;143.39<sup><i>&#8727;&#8727;</i></sup></td><td>31.97</td><td>124.73</td><td>&#177;54.02</td><td>43.31</td></tr><tr><td>Astragalin</td><td>185.07</td><td>&#177;38.79<sup><i>&#8727;&#8727;</i></sup></td><td>20.96</td><td>117.27</td><td>&#177;34.81</td><td>29.68</td></tr><tr><td>Chlorogenic acid</td><td>72.84</td><td>&#177;22.81 ns</td><td>31.31</td><td>55.38</td><td>&#177;21.04</td><td>37.99</td></tr></table>
415515fc1ae9569bb8241512c39f0b96567255d5dfa9de7199c79e84add3b252.png
complex
<table><tr><td rowspan="3">Item</td><td rowspan="3"></td><td>Group 1: feedback report (<i>n</i> = 9)</td><td>Group 2: feedback report with appendix (<i>n</i> = 11)</td><td rowspan="3"><i>P</i>-value</td></tr><tr><td>Mean (CI)</td><td>Mean (CI)</td></tr><tr><td>Scale 1&#8211;10</td><td>Scale 1&#8211;10</td></tr><tr><td>1<sup>a</sup></td><td>I think that the patient safety culture feedback report is....</td><td></td><td></td><td></td></tr><tr><td></td><td> Understandable</td><td>6.1 (4.8&#8211;7.5)</td><td>7.3 (6.0&#8211;8.6)</td><td>0.04*</td></tr><tr><td></td><td> Interesting</td><td>7.6 (7.0&#8211;8.1)</td><td>7.6 (6.7&#8211;8.6)</td><td>0.53</td></tr><tr><td></td><td> Useful</td><td>6.8 (3.0&#8211;7.5)</td><td>7.2 (5.8&#8211;8.6)</td><td>0.10</td></tr><tr><td></td><td> Relevant</td><td>7.3 (6.8&#8211;7.9)</td><td>7.8 (7.3&#8211;8.3)</td><td>0.20</td></tr><tr><td></td><td> Well-ordered</td><td>6.7 (5.9&#8211;7.4)</td><td>7.5 (6.4&#8211;8.5)</td><td>0.12</td></tr><tr><td></td><td> Complete</td><td>6.9 (6.2&#8211;7.6)</td><td>7.4 (6.6&#8211;8.2)</td><td>0.45</td></tr><tr><td></td><td> Attractive (lay-out)</td><td>6.8 (6.3&#8211;7.3)</td><td>7.6 (7.0&#8211;8.3)</td><td>0.04*</td></tr><tr><td></td><td></td><td><i>N</i> (%)</td><td><i>N</i> (%)</td><td></td></tr><tr><td rowspan="2">2<sup>b</sup></td><td>Do you miss any results in this report?</td><td>5 (56 %)</td><td>7 (64 %)</td><td></td></tr><tr><td> Yes</td><td></td><td></td><td>1.000</td></tr><tr><td rowspan="4">3<sup>b</sup></td><td>Which statement reflects the patient safety culture report best:</td><td>6 (67 %)</td><td>5 (46 %)</td><td>0.49</td></tr><tr><td> we now see suggestions to improve patient safety culture</td><td>1 (11 %)</td><td>4 (36 %)</td><td></td></tr><tr><td> we now have insight, but we do not know how to improve</td><td>2 (22 %)</td><td>1 (9 %)</td><td></td></tr><tr><td> this report has brought us little new information different statements</td><td>-</td><td>1 (9 %)</td><td></td></tr></table>
e4228dfb71bd50f58418de1b35580b05535bf512845d97fd686b04e9495fa225.png
complex
<table><tr><td></td><td></td><td>Aguie</td><td>Guidan Roumdji</td><td>Maradi CU</td><td>Madarounfa</td><td>Total</td></tr><tr><td colspan="2">Total population</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="2">Number of households/respondents</td><td>735</td><td>735</td><td>735</td><td>735</td><td>2940</td></tr><tr><td colspan="2">Number of children under 5 yo</td><td>1550</td><td>2011</td><td>1736</td><td>1644</td><td>6941</td></tr><tr><td colspan="2">Number (%) of households with</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>1 to 2 children &lt; 5 yo</td><td>535 (72.8)</td><td>463 (63.0)</td><td>492 (66.9)</td><td>518 (70.5)</td><td>2008 (68.3)</td></tr><tr><td></td><td>3 to 5 children &lt; 5 yo</td><td>192 (26.1)</td><td>211 (28.7)</td><td>209 (28.5)</td><td>200 (27.3)</td><td>812 (27.7)</td></tr><tr><td></td><td>more than 5 children &lt; 5 yo</td><td>8 (1.1)</td><td>61 (8.3)</td><td>34 (4.6)</td><td>17 (2.3)</td><td>120 (4.1)</td></tr><tr><td colspan="2">Number (%) of respondents with</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>0 years of education</td><td>680 (92.5)</td><td>669 (91.0)</td><td>534 (72.7)</td><td>665 (90.5)</td><td>2548 (86.7)</td></tr><tr><td></td><td>1 to 6 years of education</td><td>35 (4.8)</td><td>38 (5.2)</td><td>72 (9.8)</td><td>39 (5.3)</td><td>184 (6.3)</td></tr><tr><td></td><td>more than 6 years of education</td><td>20 (2.7)</td><td>28 (3.8)</td><td>129 (17.6)</td><td>31 (4/2)</td><td>208 (7.1)</td></tr><tr><td colspan="2">Selected population</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="2">Selected children</td><td>735</td><td>735</td><td>735</td><td>735</td><td>2940</td></tr><tr><td colspan="2">Sex ratio M/F</td><td>0.96</td><td>0.94</td><td>1.03</td><td>1.15</td><td>1.01</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>median (month) (IQR)</td><td>23 (12-35)</td><td>23 (13-35)</td><td>23 (12-36)</td><td>25 (14-38)</td><td>24 (13-36)</td></tr><tr><td></td><td>&lt; 1 year (%)</td><td>214 (29.1)</td><td>175 (23.9)</td><td>184 (25.2)</td><td>153 (20.9)</td><td>726 (24.8)</td></tr><tr><td></td><td>1 - 2 years (%)</td><td>202 (27.5)</td><td>212 (29.0)</td><td>203 (27.8)</td><td>201 (27.5)</td><td>818 (28.0)</td></tr><tr><td></td><td>2 - 3 years (%)</td><td>163 (22.2)</td><td>185 (25.3)</td><td>169 (23.2)</td><td>186 (25.4)</td><td>703 (24.0)</td></tr><tr><td></td><td>3 - 4 years (%)</td><td>106 (14.4)</td><td>110 (15.1)</td><td>104 (14.2)</td><td>117 (16.0)</td><td>437 (14.9)</td></tr><tr><td></td><td>4 - 5 years (%)</td><td>49 (6.7)</td><td>49 (6.7)</td><td>70 (9.6)</td><td>75 (10.2)</td><td>243 (8.3)</td></tr></table>
4b13a75c58c363a7cc134e705dcddccdf380bf587d7d1f0033358e93aed9c982.png
simple
<table><tr><td>Land-cover type</td><td>Proportion of area of suitable habitat (%) <sup>1</sup></td><td>Mean habitat suitability (%)</td></tr><tr><td>Madrean Encinal</td><td>6.3</td><td>47.1</td></tr><tr><td>Madrean Pinyon-Juniper Woodland</td><td>12.6</td><td>40.7</td></tr><tr><td>Mogollon Chaparral</td><td>2.5</td><td>38.8</td></tr><tr><td>Chihuahuan Mixed Salt Desert Scrub</td><td>2.5</td><td>34.7</td></tr><tr><td>Madrean Lower Montane Pine-Oak Forest and Woodland</td><td>1.4</td><td>34.6</td></tr><tr><td>Apacherian-Chihuahuan Mesquite Upland Scrub</td><td>10.6</td><td>22.6</td></tr><tr><td>Apacherian-Chihuahuan Semi-Desert Grassland and Steppe</td><td>28.2</td><td>18.9</td></tr><tr><td>Chihuahuan Creosote, Mixed Desert and Thorn Scrub</td><td>10.4</td><td>16.7</td></tr><tr><td>Southern Rocky Mountain Ponderosa Pine Woodland</td><td>8.5</td><td>14.6</td></tr><tr><td>Colorado Plateau Pinyon-Juniper Woodland</td><td>5.1</td><td>13.9</td></tr><tr><td>Chihuahuan Stabilized Coppice Dune and Sand Flat Scrub</td><td>1.2</td><td>8.3</td></tr><tr><td>Sonoran Paloverde-Mixed Cacti Desert Scrub</td><td>2.8</td><td>5.9</td></tr></table>
c7bd607fed238368e7947de2fa7b7e11f3f57a7369aa5b2c26a5d53f077179f5.png
simple
<table><tr><td>Request</td><td>Time for the injury prevention request to be responded (ms)</td></tr><tr><td>Average</td><td>8702.68164</td></tr><tr><td>Median</td><td>11257</td></tr></table>
fe970b77dd089bd5ba220b05a6b4d07ca3f82bec34000d42ed65f59255969c2a.png
simple
<table><tr><td>Cww [g l<sup>-1</sup>]</td><td>c<sub>valencene </sub>[mg l<sup>-1</sup>]</td><td>Conversion [%]<sup>b</sup></td><td>Yield [mg g<sup>-1 </sup>cdw]</td><td>Yield [mg l<sup>-1</sup>]</td></tr><tr><td>70</td><td>409</td><td>15.1</td><td>3.35</td><td>61.6</td></tr><tr><td>70</td><td>613</td><td>13.2</td><td>4.40</td><td>80.9</td></tr><tr><td>70</td><td>818</td><td>11.8</td><td>5.22</td><td>96.0</td></tr><tr><td>140</td><td>409</td><td>21.8</td><td>2.42</td><td>89.1</td></tr><tr><td>280</td><td>409</td><td>23.0</td><td>1.28</td><td>94.2</td></tr><tr><td>140</td><td>818</td><td>14.1</td><td>3.14</td><td>118.5</td></tr></table>
a0da87ceb598ffd77443720d826d0aaf44597bc1726572d33b19d08ee1e8f3d4.png
simple
<table><tr><td>Rank</td><td>Topic</td><td>Mean</td><td>Median</td></tr><tr><td>1</td><td>Newborn circumcision</td><td>1.36</td><td>1</td></tr><tr><td>2</td><td>Reduce paraphimosis</td><td>1.36</td><td>0</td></tr><tr><td>3</td><td>Vasectomy</td><td>1.18</td><td>0</td></tr><tr><td>4</td><td>Drain hydrocoele</td><td>1.00</td><td>0</td></tr><tr><td>5</td><td>Bladder catheterization</td><td>0.91</td><td>1</td></tr><tr><td>6</td><td>Intracavernosal injections</td><td>0.82</td><td>0</td></tr><tr><td>7</td><td>Adult circumcision</td><td>0</td><td>0</td></tr><tr><td>8</td><td>Prostate biopsy</td><td>0</td><td>0</td></tr></table>
a97b676dc6acbd8aaf4c2909c14234e211f045a96b261ed4901b988945c9d28d.png
simple
<table><tr><td> </td><td>Baseline</td><td>Routine clinic visits<sup>a</sup></td></tr><tr><td>Fasting plasma glucose</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Fasting insulin</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Glycated haemoglobin A1c</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Serum triglycerides</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Cholesterol</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>High-density lipoprotein</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Low-density lipoprotein</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Apolipoprotein B/apolipoprotein A1</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Serum sodium</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Serum potassium</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Serum renin</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Serum osteocalcin</td><td>&#8730;</td><td>&#8730;</td></tr><tr><td>Serum procollagen I <i>N</i>-terminal propeptide</td><td>&#8730;</td><td>&#8730;</td></tr></table>
c356b661491b72eccd267d5b6efa97258f03b24d2d1adc75ae274ea5b1d0ab49.png
complex
<table><tr><td>Variables</td><td>Sample distribution</td><td>OIDP = 0</td><td>OIDP = 1</td><td>OIDP &#8805; 2</td></tr><tr><td></td><td>n (%)</td><td colspan="3">n (%)</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>182(53.7)</td><td>76(41.8)</td><td>54(29.7)</td><td>52(28.5)</td></tr><tr><td>Female</td><td>157(46.3)</td><td>66(42.0)</td><td>48(30.6)</td><td>43(27.4)</td></tr><tr><td>Skin color</td><td></td><td></td><td></td><td></td></tr><tr><td>White</td><td>270(79.7)</td><td>113(41.9)</td><td>83(30.7)</td><td>74(27.4)</td></tr><tr><td>Blacks</td><td>69(20.3)</td><td>29(42.1)</td><td>19(27.5)</td><td>21(30.4)</td></tr><tr><td>Family income at child birth*</td><td></td><td></td><td></td><td></td></tr><tr><td>&gt; 6</td><td>45(13.3)</td><td>21(46.6)</td><td>17(37.9)</td><td>7(15.5)</td></tr><tr><td>1.1-6</td><td>232(68.6)</td><td>94(40.5)</td><td>66(28.5)</td><td>72(31.0)</td></tr><tr><td>&#8804; 1</td><td>61(18.1)</td><td>27(44.3)</td><td>18(29.5)</td><td>16(26.2)</td></tr><tr><td>Maternal schooling at child birth</td><td></td><td></td><td></td><td></td></tr><tr><td>&#8805; 9 yr</td><td>78(23.1)</td><td>32(41.0)</td><td>27(34.6)</td><td>19(24.4)</td></tr><tr><td>5 - 8 yr</td><td>164(48.5)</td><td>76(46.3)</td><td>42(25.6)</td><td>46(28.1)</td></tr><tr><td>&#8804; 4</td><td>96(28.4)</td><td>34(35.4)</td><td>32(33.3)</td><td>30(31.3)</td></tr><tr><td>Mother employment status at child aged 6 month</td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>230(68.1)</td><td>110(47.8)</td><td>67(29.1)</td><td>53(23.1)</td></tr><tr><td>Yes</td><td>108(31.9)</td><td>32(29.6)</td><td>34(31.5)</td><td>42(38.9)</td></tr><tr><td>Untreated dental caries at age 6</td><td></td><td></td><td></td><td></td></tr><tr><td>0</td><td>124(36.7)</td><td>54(43.5)</td><td>40(32.3)</td><td>30(24.2)</td></tr><tr><td>1-3</td><td>92(27.2)</td><td>38(41.3)</td><td>25(27.2)</td><td>29(31.5)</td></tr><tr><td>4-19</td><td>122(36.1)</td><td>50(41.0)</td><td>36(29.5)</td><td>36(29.5)</td></tr><tr><td>Open bite at age 6 yr</td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>173(52.2)</td><td>73(42.2)</td><td>49(28.3)</td><td>51(29.5)</td></tr><tr><td>Yes</td><td>165(48.8)</td><td>69(41.8)</td><td>52(31.5)</td><td>44(26.7)</td></tr><tr><td>Cross bite at age 6 yr</td><td></td><td></td><td></td><td></td></tr><tr><td>No</td><td>277(81.9)</td><td>120(43.3)</td><td>85(30.7)</td><td>72(26.0)</td></tr><tr><td>Yes</td><td>61(18.1)</td><td>22(36.1)</td><td>16(26.2)</td><td>23(37.7)</td></tr></table>
75569c4331bbc520c02872bc3c083f2e5a8989d120e47ed39a9c6c411b3db8f8.png
simple
<table><tr><td></td><td><i>Vmax</i> (mM&#183;min<sup>&#8722;1</sup>)</td><td><i>Km</i> (&#956;M)</td></tr><tr><td>Al(III) (&#956;M)</td><td></td><td></td></tr><tr><td>0</td><td>28.1</td><td>23.8</td></tr><tr><td>30</td><td>30.3</td><td>16.1</td></tr><tr><td>Nano-Al<sub>13</sub> (&#956;M)</td><td></td><td></td></tr><tr><td>0</td><td>28.3</td><td>23.5</td></tr><tr><td>30</td><td>28.5</td><td>13.6</td></tr></table>
d7a5b572bf606d8c6deeae875ee5cc10e8b1b42f7fe80525016405468e15db3e.png
complex
<table><tr><td rowspan="2"></td><td>Recreational</td><td>High school</td><td>University</td><td>Overall</td></tr><tr><td><i>n</i> = 56 (%)</td><td><i>n</i> = 32 (%)</td><td><i>n</i> = 52 (%)</td><td><i>n</i> = 140 (%)</td></tr><tr><td>Males (%)</td><td>56 (100)</td><td>19 (59.3)</td><td>19 (36.53)</td><td>94 (67.1)</td></tr><tr><td>Age (years) (mean &#177; SD)</td><td>14.9 &#177; 2.0</td><td>16.1 &#177; 1.7</td><td>20.6 &#177; 2.0</td><td>17.3 &#177; 3.3</td></tr><tr><td>Use ASD (%)</td><td>8 (14.3)</td><td>7 (21.9)</td><td>31 (59.6) *</td><td>46 (32.9)</td></tr><tr><td>Previous ankle injury (%)</td><td>41 (73.2)</td><td>28 (87.5)</td><td>45 (86.5)</td><td>114 (81.4)</td></tr><tr><td>Coach enforcement of ASD (%)</td><td>4 (7.1)</td><td>4 (12.5)</td><td>24 (46.2) *</td><td>32 (22.9)</td></tr></table>
490cedc952f2a084a0afaffe59f1b6165ae79b4a1f25a240e10bc106aa33aec0.png
simple
<table><tr><td> </td><td>Group &lt;70 yrs (<i>n</i>)</td><td>Group &#8805;70 yrs (<i>n</i>)</td></tr><tr><td>Pulmonary embolism</td><td>2</td><td>4</td></tr><tr><td>Hypertension</td><td>6</td><td>8</td></tr><tr><td>Atrial fibrillation</td><td>5</td><td>5</td></tr><tr><td>Pneumonia</td><td>1</td><td>2</td></tr><tr><td>Leucopenia</td><td>4</td><td>7</td></tr><tr><td>Prolonged ileus</td><td>8</td><td>10</td></tr><tr><td>Urinary tract infections</td><td>4</td><td>6</td></tr><tr><td>Drainage of intra-abdominal collection</td><td>2</td><td>4</td></tr><tr><td>Reoperation</td><td>5</td><td>3</td></tr><tr><td> Pancreatic fistula</td><td>1</td><td>1</td></tr><tr><td> Hemorrhage</td><td>3</td><td>1</td></tr><tr><td> Peritonitis</td><td>1</td><td>1</td></tr></table>
b4e81e558653e169bbf4212a3d73b7e557d0508829b92ccbb893f6b1d32fbea6.png
complex
<table><tr><td>Variable</td><td></td><td>N (%)</td><td>Mean &#177; SD</td><td><i>p</i>-value</td></tr><tr><td rowspan="2">Gender</td><td>Men</td><td>768 (79.8)</td><td>26.25 &#177; 7.65</td><td>&lt; 0.01</td></tr><tr><td>Women</td><td>194 (20.2)</td><td>22.61 &#177; 7.15</td><td></td></tr><tr><td rowspan="2">Marriage</td><td>Single</td><td>530 (53.5)</td><td>24.59 &#177; 7.39</td><td>0.01</td></tr><tr><td>Married</td><td>461 (46.5)</td><td>26.25 &#177; 7.97</td><td></td></tr><tr><td rowspan="5">Age (years)</td><td>&lt;20</td><td>17 (1.7)</td><td>22.77 &#177; 8.59</td><td>0.01</td></tr><tr><td>20&#8211;29</td><td>299 (30.5)</td><td>24.74 &#177; 7.82</td><td></td></tr><tr><td>30&#8211;39</td><td>420 (42.9)</td><td>25.23 &#177; 8.04</td><td></td></tr><tr><td>40&#8211;49</td><td>190 (19.4)</td><td>27.10 &#177; 6.85</td><td></td></tr><tr><td>50&#8211;59</td><td>49 (5.0)</td><td>26.69 &#177; 6.47</td><td></td></tr><tr><td rowspan="3">Education</td><td>Less than high school</td><td>413 (42.2)</td><td>24.91 &#177; 8.05</td><td>0.04</td></tr><tr><td>College</td><td>308 (31.5)</td><td>24.44 &#177; 7.28</td><td></td></tr><tr><td>University</td><td>258 (26.4)</td><td>26.47 &#177; 7.47</td><td></td></tr><tr><td rowspan="3">Salary (US dollar/month)</td><td>&lt;2000</td><td>345 (38.4)</td><td>23.78 &#177; 8.14</td><td>&lt; 0.01</td></tr><tr><td>2000&#8211;3000</td><td>371 (41.3)</td><td>26.06 &#177; 7.13</td><td></td></tr><tr><td>&#8805; 3000</td><td>183 (20.4)</td><td>26.70 &#177; 7.24</td><td></td></tr></table>
eca18558d4d3313a9a1c409820f7fa46454d5b49a70444f129b47344facb0f2b.png
simple
<table><tr><td>Variable</td><td>0 min</td><td>30 min</td><td>60 min</td><td>90 min</td></tr><tr><td>Heart rate (bpm)<i>Meltdown<sup>&#174;</sup></i></td><td>59 &#177; 3</td><td>63 &#177; 2</td><td>62 &#177; 2</td><td>63 &#177; 2</td></tr><tr><td>Heart rate (bpm)<i>Placebo</i></td><td>59 &#177; 3</td><td>60 &#177; 3</td><td>62 &#177; 3</td><td>60 &#177; 3</td></tr><tr><td>Systolic Blood Pressure (mmHg)<i>Meltdown<sup>&#174; </sup>*</i></td><td>117 &#177; 2</td><td>122 &#177; 3</td><td>123 &#177; 2</td><td>122 &#177; 3</td></tr><tr><td>Systolic Blood Pressure (mmHg)<i>Placebo</i></td><td>118 &#177; 2</td><td>118 &#177; 2</td><td>117 &#177; 1</td><td>116 &#177; 1</td></tr><tr><td>Diastolic Blood Pressure (mmHg)<i>Meltdown<sup>&#174;</sup></i></td><td>72 &#177; 1</td><td>71 &#177; 2</td><td>72 &#177; 2</td><td>70 &#177; 2</td></tr><tr><td>Diastolic Blood Pressure (mmHg)<i>Placebo</i></td><td>72 &#177; 1</td><td>72 &#177; 2</td><td>71 &#177; 1</td><td>71 &#177; 1</td></tr></table>
e044a7fda573b54b142b32d7a4db636ab47fee127cc06c2d8c89ab027f96a6ab.png
complex
<table><tr><td rowspan="2">Missed appointment</td><td colspan="2">Missed doses</td><td>Total</td></tr><tr><td>No</td><td>Yes</td></tr><tr><td>No</td><td>694 (94.3)</td><td>42 (5.7)</td><td>736</td></tr><tr><td>Yes</td><td>17 (70.8)</td><td>7 (29.2)</td><td>24</td></tr></table>
ba7bbaf097841de8562ca3c376831608f4b0ac5e6909cb7bbe0af93be0ed39cb.png
simple
<table><tr><td>Tag sequence</td><td>Tags</td><td>TPM<sup><i>a</i></sup></td><td>UniGene ID</td><td>Gene</td><td>Cluster name</td><td>Biological Function<sup><i>b</i></sup></td></tr><tr><td>TACCTGCAGA</td><td>515</td><td>16930</td><td>Hs.416073</td><td><i>S100A8</i></td><td>S100 calgranulin A</td><td>Regulation of cell cycle progression and differentiation.</td></tr><tr><td>TAGGTTGTCT</td><td>356</td><td>11703</td><td>Hs.374596</td><td><i>TPT1</i></td><td>Tumor protein, translationally-controlled 1</td><td>Unknown</td></tr><tr><td>TTTCCTGCTC</td><td>276</td><td>9073</td><td>Hs.139322</td><td><i>SPRR3</i></td><td>Small proline-rich protein 3</td><td>Cross-linked envelope protein of keratinocytes</td></tr><tr><td>GAGGGAGTTT</td><td>201</td><td>6607</td><td>Hs.523463</td><td><i>RPL27A</i></td><td>Ribosomal protein L27a</td><td>Component of the ribosomal 60S subunit</td></tr><tr><td>GTGACCACGG</td><td>188</td><td>6180</td><td>Hs.436980</td><td><i>GRIN2C</i></td><td>Glutamate receptor, N-methyl D-aspartate 2C</td><td>Ionotropic glutamate receptor</td></tr><tr><td>GTGGCCACGG</td><td>184</td><td>6049</td><td>Hs.112405</td><td><i>S100A9</i></td><td>S100 calcium binding protein A9 (calgranulin B)</td><td>Regulation of cell cycle progression and differentiation.</td></tr><tr><td>GGGCTGGGGT</td><td>173</td><td>5687</td><td>Hs.425125; Hs.90436</td><td><i>RPL29; SPAG7</i></td><td>Ribosomal protein L29; Sperm associated antigen 7</td><td>Component of the ribosomal 60S subunit.</td></tr><tr><td>GCATAATAGG</td><td>168</td><td>5523</td><td>Hs.381123</td><td><i>RPL21</i></td><td>Ribosomal protein L21</td><td>Component of the ribosomal 60S subunit.</td></tr><tr><td>TCAGATCTTT</td><td>161</td><td>5292</td><td>Hs.446628</td><td><i>RPS4X</i></td><td>Ribosomal protein S4, X-linked</td><td>Component of the ribosomal 40S subunit.</td></tr><tr><td>GTTGTGGTTA</td><td>155</td><td>5095</td><td>Hs.99785</td><td></td><td>FLJ21245</td><td>Unknown</td></tr><tr><td>GGATTTGGCC</td><td>151</td><td>4964</td><td>Hs.437594</td><td><i>RPLP2</i></td><td>Ribosomal protein, large P2</td><td>Component of the ribosomal 60S subunit.</td></tr><tr><td>TTGGGGTTTC</td><td>143</td><td>4701</td><td>Hs.448738</td><td><i>FTH1</i></td><td>Ferritin, heavy polypeptide 1</td><td>Important for iron homeostasis, stores iron in a soluble, nontoxic, readily available form.</td></tr><tr><td>TTGGTCCTCT</td><td>138</td><td>4536</td><td>Hs.381172</td><td><i>RPL41</i></td><td>Rribosomal protein L41</td><td>Component of the ribosomal 60S subunit.</td></tr><tr><td>TGCACGTTTT</td><td>130</td><td>4273</td><td>Hs.265174</td><td><i>RPL32</i></td><td>Ribosomal protein L32</td><td>Component of the ribosomal 60S subunit.</td></tr><tr><td>ACAAAGCATT</td><td>128</td><td>4208</td><td>Hs.369982</td><td><i>IGFBP5</i></td><td>Insulin-like growth factor binding protein 5</td><td>IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGF on cell culture.</td></tr><tr><td>AGGGCTTCCA</td><td>122</td><td>4010</td><td>Hs.401929</td><td><i>RPL10</i></td><td>Ribosomal protein L10</td><td>Component of the ribosomal 60S subunit.</td></tr><tr><td>CCACTGCACT</td><td>114</td><td>3747</td><td>Hs.107003</td><td><i>CCNB1IP1</i></td><td>Cyclin B1 interacting protein 1</td><td>Functions in progression of the cell cycle through G(2)/M.</td></tr><tr><td>GGCAAGCCCC</td><td>107</td><td>3517</td><td>Hs.148340</td><td><i>RPL10A</i></td><td>ribosomal protein L10a</td><td>Component of the ribosomal 60S subunit.</td></tr><tr><td>CTGGGTTAAT</td><td>105</td><td>3451</td><td>Hs.334534</td><td><i>GNS</i></td><td>Glucosamine (N-acetyl)-6-sulfatase</td><td>Lysosomal enzyme found in all cells. It is involved in the catabolism of heparin, heparan sulphate, and keratan sulphate.</td></tr><tr><td>TGCACTTCAA</td><td>103</td><td>3386</td><td>Hs.62886</td><td><i>SPARCL1</i></td><td>SPARC-like 1 (mast9, hevin)</td><td>Calcium ion binding</td></tr></table>
323e8caede273813b18fc4a21ec3110dafcbc7332cfb85fe48e121f7e43dc05c.png
complex
<table><tr><td rowspan="2">IL-10 variants</td><td rowspan="2">Cancer type</td><td rowspan="2">Studies</td><td colspan="2">Allele contrast</td><td colspan="2">Ht vs. WT Ho</td><td colspan="2">VR Ho vs. WT Ho</td><td colspan="2">Dominant model</td><td colspan="2">Recessive model</td></tr><tr><td>OR [95%CI]</td><td><i>P<sub>h</sub></i>/I<sup>2</sup></td><td>OR [95%CI]</td><td><i>P<sub>h</sub></i>/I<sup>2</sup></td><td>OR [95%CI]</td><td><i>P<sub>h</sub></i>/I<sup>2</sup></td><td>OR [95%CI]</td><td><i>P<sub>h</sub></i>/I<sup>2</sup></td><td>OR [95%CI]</td><td><i>P<sub>h</sub></i>/I<sup>2</sup></td></tr><tr><td rowspan="5">&#8722;1082G&gt;A</td><td>overall</td><td>10</td><td>1.07 [0.98, 1.18]</td><td>0.27/19%</td><td>1.09 [0.76, 1.57]</td><td>&lt;0.001/76%</td><td>1.17 [0.89, 1.54]</td><td>0.07/44%</td><td>1.12 [0.82, 1.52]</td><td>0.0004/70%</td><td>1.10 [0.95, 1.28]</td><td>0.11/37%</td></tr><tr><td>melanoma</td><td>5</td><td>1.09 [0.94, 1.27]</td><td>0.94/0%</td><td>0.98 [0.75, 1.28]</td><td>0.55/0%</td><td>1.20 [0.88, 1.64]</td><td>0.94/0%</td><td>1.05 [0.81, 1.35]</td><td>0.87/0%</td><td>1.21 [0.95, 1.54]</td><td>0.35/11%</td></tr><tr><td>NMC</td><td>5</td><td>1.05 [0.85, 1.29]</td><td>0.04/61%</td><td>1.22 [0.61, 2.41]</td><td>&lt;0.001/88%</td><td>1.17 [0.70, 1.97]</td><td>0.005/73%</td><td>1.22 [0.68, 2.22]</td><td>&lt;0.001/86%</td><td>1.00 [0.73, 1.37]</td><td>0.06/56%</td></tr><tr><td>BCC</td><td>4</td><td>1.07 [0.86, 1.33]</td><td>0.06/59%</td><td>1.54 [0.67, 3.52]</td><td>&lt;0.001/90%</td><td>1.31 [0.70, 2.46]</td><td>0.006/76%</td><td>1.47 [0.70, 3.10]</td><td>&lt;0.001/89%</td><td>1.00 [0.81, 1.24]</td><td>0.39/1%</td></tr><tr><td>SCC</td><td>2</td><td>1.03 [0.76, 1.40]</td><td>0.16/49%</td><td>0.66 [0.38, 1.14]</td><td>0.33/0%</td><td>0.62 [0.15, 2.58]</td><td>0.05/75%</td><td>0.76 [0.46, 1.26]</td><td>0.80/0%</td><td>0.73 [0.12, 4.41]</td><td>0.002/89%</td></tr><tr><td rowspan="5">&#8722;819C&gt;T</td><td>overall</td><td>7</td><td>0.86 [0.67, 1.11]</td><td>0.02/61%</td><td>0.82 [0.67, 1.00]</td><td>0.43/0%</td><td>0.83 [0.42, 1.64]</td><td>0.02/59%</td><td>0.84 [0.69, 1.01]</td><td>0.19/31%</td><td>0.89 [0.45, 1.74]</td><td>0.02/60%</td></tr><tr><td>melanoma</td><td>4</td><td>0.93 [0.76, 1.14]</td><td>0.64/0%</td><td>0.95 [0.73, 1.23]</td><td>0.53/0%</td><td>0.84 [0.48, 1.47]</td><td>0.40/0%</td><td>0.93 [0.72, 1.19]</td><td>0.64/0%</td><td>0.84 [0.49, 1.46]</td><td>0.34/11%</td></tr><tr><td>NMC</td><td>3</td><td>0.77 [0.41, 1.45]</td><td>0.001/85%</td><td>0.67 [0.50, 0.91]</td><td>0.60/0%</td><td>0.74 [0.16, 3.41]</td><td>0.004/82%</td><td>0.70 [0.43, 1.16]</td><td>0.06/64%</td><td>0.87 [0.20, 3.75]</td><td>0.005/81%</td></tr><tr><td>BCC</td><td>2</td><td>0.72 [0.54, 0.97]</td><td>0.60/0%</td><td>0.71 [0.48, 1.03]</td><td>0.74/0%</td><td>0.58 [0.28, 1.22]</td><td>0.29/12%</td><td>0.68 [0.48, 0.98]</td><td>0.94/0%</td><td>0.66 [0.32, 1.36]</td><td>0.26/20%</td></tr><tr><td>SCC</td><td>2</td><td>0.74 [0.19, 2.83]</td><td>0.001/90%</td><td>0.68 [0.43, 1.09]</td><td>0.36/0%</td><td>0.57 [0.01, 26.7]</td><td>0.01/85%</td><td>0.68 [0.24, 1.94]</td><td>0.03/78%</td><td>0.68 [0.02, 26.5]</td><td>0.01/83%</td></tr><tr><td rowspan="5">&#8722;592C&gt;A</td><td>overall</td><td>9</td><td>0.90 [0.68, 1.19]</td><td>&lt;0.001/79%</td><td>0.80 [0.55, 1.16]</td><td>&lt;0.001/80%</td><td>0.95 [0.54, 1.66]</td><td>0.006/62%</td><td>0.83 [0.57, 1.20]</td><td>&lt;0.001/82%</td><td>1.10 [0.68, 1.77]</td><td>0.04/51%</td></tr><tr><td>melanoma</td><td>5</td><td>1.08 [0.90, 1.28]</td><td>0.62/0%</td><td>1.06 [0.84, 1.32]</td><td>0.99/0%</td><td>1.15 [0.73, 1.80]</td><td>0.24/27%</td><td>1.09 [0.88, 1.35]</td><td>0.94/0%</td><td>1.11 [0.71, 1.72]</td><td>0.21/32%</td></tr><tr><td>NMC</td><td>4</td><td>0.73 [0.41, 1.30]</td><td>&lt;0.001/90%</td><td>0.55 [0.26, 1.17]</td><td>&lt;0.001/89%</td><td>0.77 [0.26, 2.29]</td><td>&lt;0.001/81%</td><td>0.59 [0.27, 1.27]</td><td>&lt;0.001/91%</td><td>1.09 [0.46, 2.60]</td><td>0.02/71%</td></tr><tr><td>BCC</td><td>3</td><td>0.67 [0.37, 1.24]</td><td>&lt;0.001/87%</td><td>0.56 [0.20, 1.63]</td><td>&lt;0.001/93%</td><td>0.60 [0.24, 1.51]</td><td>0.09/59%</td><td>0.55 [0.20, 1.52]</td><td>&lt;0.001/93%</td><td>0.92 [0.56, 1.49]</td><td>0.34/7%</td></tr><tr><td>SCC</td><td>2</td><td>0.74 [0.19, 2.83]</td><td>0.001/90%</td><td>0.68 [0.43, 1.09]</td><td>0.36/0%</td><td>0.57 [0.01, 26.7]</td><td>0.01/85%</td><td>0.68 [0.24, 1.94]</td><td>0.03/78%</td><td>0.68 [0.02, 26.5]</td><td>0.01/83%</td></tr></table>
4b6fbf4d0332925fe5e5b24332c1e22ffc99f5631eddba31d0a7a17020946755.png
complex
<table><tr><td></td><td colspan="2">Presence/absence of IgG in oral fluid at six months</td><td colspan="2">Presence/absence of IgG in oral fluid before measles vaccination at nine months</td><td colspan="2">Presence/absence of IgM &amp; IgG in oral fluid after measles vaccination</td></tr><tr><td>Variable</td><td><i>OR</i></td><td><i>95% CI</i></td><td><i>OR</i></td><td><i>95% CI</i></td><td><i>OR</i></td><td><i>95% CI</i></td></tr><tr><td>Gender (F, M)</td><td>1.1</td><td>0.74&#8211;1.61</td><td>1.1</td><td>0.78&#8211;1.55</td><td>0.66</td><td>0.32&#8211;1.37</td></tr><tr><td>Breast feeding (Yes, No)</td><td>1.02</td><td>1&#8211;1.04</td><td>0.88</td><td>0.39&#8211;1.95</td><td>2.73</td><td>0.62&#8211;1.20</td></tr><tr><td>Measles history (Yes, No)</td><td>1.39</td><td>0.17&#8211;11.43</td><td>0.78</td><td>0.14&#8211;4.28</td><td>0.22</td><td>0.01&#8211;3.70</td></tr><tr><td>Type of birth (Normal, Caesarean)</td><td>0.94</td><td>0.81&#8211;1.83</td><td>1.18</td><td>0.58&#8211;2.39</td><td>0.54</td><td>0.12&#8211;2.51</td></tr><tr><td>Low-birth-weight (Yes, No)</td><td>1.03</td><td>0.25&#8211;4.21</td><td>0.78</td><td>0.44&#8211;1.36</td><td>0.36</td><td>0.13&#8211;1.94</td></tr><tr><td>Prematurity (Yes, No)</td><td>1.02</td><td>0.7&#8211;1.48</td><td>0.57</td><td>0.31&#8211;1.05</td><td>1.70</td><td>0.54&#8211;3.35</td></tr><tr><td>Weight for height cat (&#8805; -2, &lt;-2)</td><td>-</td><td>-</td><td>0.78</td><td>0.32&#8211;1.87</td><td>1.18</td><td>0.12&#8211;1.01</td></tr><tr><td>Weight for age cat (&#8805; -2, &lt;-2)</td><td>0.59</td><td>0.1&#8211;3.58</td><td>2.16</td><td>0.75&#8211;6.19</td><td>0.75</td><td>0.15&#8211;3.54</td></tr><tr><td>Height for age cat (&#8805; -2, &lt;-2)</td><td>1.26</td><td>0.46&#8211;3.46</td><td>0.79</td><td>0.55&#8211;1.13</td><td>0.50</td><td>0.18&#8211;1.39</td></tr><tr><td>Mother's IgG (Pos, Neg*)</td><td>1.96</td><td>0.62&#8211;6.17</td><td>1.57</td><td>0.86&#8211;2.87</td><td>1.62</td><td>0.59&#8211;3.48</td></tr><tr><td>Mother's age &#8804; 28 y, &#8805; 29 y</td><td>0.81</td><td>0.29&#8211;2.32</td><td>1.15</td><td>0.61&#8211;2.19</td><td>1.08</td><td>0.67&#8211;1.75</td></tr></table>
04c9977d451b98a59be87f99156c357bcf1d1b653129a978817d2896afafef91.png
simple
<table><tr><td>Variable</td><td>Frequency</td><td>(%)</td></tr><tr><td>Sex</td><td></td><td></td></tr><tr><td>Male</td><td>241</td><td>54.7 %</td></tr><tr><td>Female</td><td>199</td><td>45.3 %</td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td>15-24</td><td>89</td><td>20.2 %</td></tr><tr><td>25-34</td><td>112</td><td>25.5 %</td></tr><tr><td>35-44</td><td>85</td><td>19.3 %</td></tr><tr><td>45-54</td><td>65</td><td>14.8 %</td></tr><tr><td>55-64</td><td>49</td><td>11.1 %</td></tr><tr><td>&gt;64</td><td>40</td><td>9.1 %</td></tr><tr><td>Ethnicity</td><td></td><td></td></tr><tr><td>Oromo</td><td>306</td><td>69.5 %</td></tr><tr><td>Amhara</td><td>50</td><td>11.5 %</td></tr><tr><td>Dawro</td><td>43</td><td>9.8 %</td></tr><tr><td>Others<sup>a</sup></td><td>41</td><td>9.3 %</td></tr><tr><td>Religion</td><td></td><td></td></tr><tr><td>Muslim</td><td>332</td><td>75.5 %</td></tr><tr><td>Orthodox</td><td>78</td><td>17.7 %</td></tr><tr><td>Protestant</td><td>30</td><td>6.8 %</td></tr><tr><td>Educational status</td><td></td><td></td></tr><tr><td>Illiterate</td><td>221</td><td>50.2 %</td></tr><tr><td>Read and write</td><td>73</td><td>16.6 %</td></tr><tr><td>Elementary</td><td>113</td><td>25.7 %</td></tr><tr><td>Secondary education</td><td>33</td><td>7.5 %</td></tr><tr><td>&amp; above</td><td></td><td></td></tr><tr><td>Occupations</td><td></td><td></td></tr><tr><td>Farmers</td><td>260</td><td>59.1 %</td></tr><tr><td>House wives</td><td>83</td><td>18.9 %</td></tr><tr><td>Students</td><td>74</td><td>16.8 %</td></tr><tr><td>Others<sup>b</sup></td><td>23</td><td>5.2 %</td></tr></table>
2bc32205e5f9d8706c289fd51f809d0cf75ba953ea92c93e2f0e292c876a44a0.png
complex
<table><tr><td>Gestation</td><td colspan="2">Study cohort</td><td colspan="2">Previous study cohort</td></tr><tr><td> </td><td>N*</td><td>%</td><td>N**</td><td>%</td></tr><tr><td>14&#8211;17 weeks</td><td>147</td><td>4</td><td>0</td><td>0</td></tr><tr><td>18&#8211;22 weeks</td><td>578</td><td>16</td><td>0</td><td>0</td></tr><tr><td>23&#8211;27 weeks</td><td>561</td><td>16</td><td>76</td><td>0</td></tr><tr><td>28&#8211;32 weeks</td><td>550</td><td>16</td><td>258</td><td>0</td></tr><tr><td>33&#8211;39 weeks</td><td>1,251</td><td>35</td><td>35,575</td><td>57</td></tr><tr><td>40&#8211;42 weeks</td><td>452</td><td>13</td><td>26,837</td><td>43</td></tr><tr><td>Total</td><td>3,539</td><td> </td><td>62,746</td><td> </td></tr></table>
802b7db5d77890f6de6b4ca8c7a1a1044de6860ca0fabfd3ff85dc79292e621c.png
simple
<table><tr><td>gliomas</td><td>Number of cases (tissue cores)</td></tr><tr><td>Glioblastoma (GBM, WHO Grade IV)</td><td>128 (256)</td></tr><tr><td>Anaplastic astrocytoma (AA, WHO Grade III)</td><td>27 (54)</td></tr><tr><td>Diffuse astrocytoma (LGA, WHO Grade II)</td><td>33 (66)</td></tr><tr><td>Anaplastic oligodendroglioma (AO, WHO Grade III)</td><td>16 (32)</td></tr><tr><td>Oligodendroglioma (ODG, WHO Grade II)</td><td>26 (52)</td></tr><tr><td>Anaplastic mixed oligoastrocytoma (AMOA, WHO Grade III)</td><td>30 (60)</td></tr><tr><td>Oligoastrocytoma (MOA, WHO Grade II)</td><td>32 (64)</td></tr><tr><td>non neoplastic brain tissue(NB)</td><td>13 (26)</td></tr></table>
eb9ba27730bff83b51aa9c3d74da04ff7c01937c3be869a03e4ad85b57e0aabe.png
simple
<table><tr><td></td><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td></tr><tr><td>1</td><td>PTSD &#8211; Re-experiencing</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>2</td><td>PTSD &#8211; Avoidance</td><td>0.48**</td><td></td><td></td><td></td><td></td></tr><tr><td>3</td><td>PTSD &#8211; Arousal</td><td>0.48**</td><td>0.49**</td><td></td><td></td><td></td></tr><tr><td>4</td><td>DSO &#8211; Affect Dysregulation</td><td>0.37**</td><td>0.40**</td><td>0.48**</td><td></td><td></td></tr><tr><td>5</td><td>DSO &#8211; Disturbances in Self-Concept</td><td>0.36**</td><td>0.45**</td><td>0.46**</td><td>0.50**</td><td></td></tr><tr><td>6</td><td>DSO &#8211; Difficulties in Interpersonal Relationships</td><td>0.27**</td><td>0.24**</td><td>0.30**</td><td>0.47**</td><td>0.21*</td></tr></table>
b14fa62c5027c187e08c77d93e0449bbe63cd98ddfb2cebcf648e1edb3dd7571.png
complex
<table><tr><td>SOFIT activity category</td><td colspan="2">Control PE lessons (<i>N</i> = 97)</td><td colspan="2">Intervention PE lessons (<i>N</i> = 96)</td><td></td></tr><tr><td></td><td>Mdn</td><td>IQR</td><td>Mdn</td><td>IQR</td><td><i>p</i></td></tr><tr><td colspan="6">Lesson Time</td></tr><tr><td> Minutes<sup>a</sup></td><td>35.6</td><td>9.7</td><td>47.1</td><td>10.6</td><td>0001</td></tr><tr><td colspan="6">Sitting</td></tr><tr><td> Minutes per lesson</td><td>3.3</td><td>(0.3,9.0)</td><td>7.9</td><td>(4.4,12.0)</td><td>0.006</td></tr><tr><td> Percentage of time per lesson</td><td>12.3</td><td>(2.7,44.1))</td><td>19.7</td><td>(11.5,29.3)</td><td>0.049</td></tr><tr><td colspan="6">Standing</td></tr><tr><td> Minutes per lesson</td><td>11.3</td><td>(7.8,16.2)</td><td>18.9</td><td>(12.7,24.2)</td><td>0.002</td></tr><tr><td> Percentage of time per lesson</td><td>44.4</td><td>(32.1,56.7)</td><td>43.6</td><td>(31.7,52.2)</td><td>0.448</td></tr><tr><td colspan="6">Walking</td></tr><tr><td> Minutes per lesson</td><td>4.3</td><td>(2.4,6.6)</td><td>9.2</td><td>(5.7,12.5)</td><td>0.004</td></tr><tr><td> Percentage of time per lesson</td><td>15.5</td><td>(8.5,22.2)</td><td>20.6</td><td>(14.3,25.1)</td><td>0.077</td></tr><tr><td colspan="6">Very Active</td></tr><tr><td> Minutes per lesson</td><td>5.6</td><td>(2.7,6.6)</td><td>6.4</td><td>(4.7,9.1)</td><td>0.006</td></tr><tr><td> Percentage of time per lesson</td><td>21.5</td><td>(10.2,33.9)</td><td>14.6</td><td>(10.7,20.2)</td><td>0.04</td></tr><tr><td colspan="6">MVPA (Walking plus Very Active)</td></tr><tr><td> Minutes per lesson</td><td>10.2</td><td>(7.8,12.8)</td><td>16.9</td><td>(11.6,20.2)</td><td>0.004</td></tr><tr><td> Percentage of time per lesson</td><td>33.6</td><td>(27.8,42.2)</td><td>35.4</td><td>(28.1,43.2)</td><td>0.09</td></tr></table>
8cd7ca9e305e9d208bc63e9e053de3d31c85dfe1a13265783da1df48f0f17a13.png
complex
<table><tr><td></td><td>Test (<i>n</i> = 16)</td><td>Control (<i>n</i> = 17)</td></tr><tr><td>Age, years</td><td>74.7 (4.8)</td><td>72.7 (8.2)</td></tr><tr><td>Male sex, <i>n</i> (%)</td><td>7 (44%)</td><td>7 (41%)</td></tr><tr><td>MMSE score</td><td>23.0 (2.1)</td><td>23.2 (1.8)</td></tr><tr><td>Time since diagnosis, months</td><td>1.7 [0.4-15.3]</td><td>1.4 [0.2-10.2]</td></tr><tr><td>BMI, kg/m<sup>2</sup></td><td>24.2 (3.8)</td><td>26.7 (3.3)</td></tr><tr><td colspan="3">Educational level, <i>n</i> (%)</td></tr><tr><td> Low</td><td>6 (37.5%)</td><td>4 (23.5%)</td></tr><tr><td> Medium</td><td>8 (50.0%)</td><td>9 (52.9%)</td></tr><tr><td> High</td><td>2 (12.5%)</td><td>4 (23.5%)</td></tr><tr><td>Study product compliance</td><td>96.4% (4.8)</td><td>99.0% (1.6)</td></tr></table>
858dcd101c01c685dcea546c391a982b57d7af50cd3d0fae0df0e7b58f7d7fd7.png
simple
<table><tr><td>Complication</td><td>Number of complications (%)</td></tr><tr><td>Bleeding</td><td>10 (3.8)</td></tr><tr><td>Aspiration</td><td>2 (0.7)</td></tr><tr><td>Fistula</td><td>2 (0.7)</td></tr><tr><td>Wound healing disorders</td><td>1 (0.7)</td></tr><tr><td>Nerve lesions</td><td>3 (1.1)</td></tr><tr><td>Other complications</td><td>2 (0.7)</td></tr></table>
3b24494bcc4c0f9c82aa8e2073e4433dd6162079cfce56b78e1b707ecae7b394.png
complex
<table><tr><td>Subjects<sup>b</sup></td><td colspan="2">Vbeta</td><td>CDR3</td><td colspan="2">BJ</td><td>Ratio<sup>c</sup></td></tr><tr><td>J24 (CD4+)</td><td>BV24</td><td>AAMYLCATS</td><td>SDRVSPL</td><td>HFGNGTRLTVTED</td><td>1.6</td><td>22/25</td></tr><tr><td>J23</td><td>BV20</td><td>SGFYLCAWS</td><td>VQVGWGETQ</td><td>YFGPGTRLLVLED</td><td>2.5</td><td>12/21</td></tr><tr><td>J24 (CD4+)</td><td>BV20</td><td>SGFYLCAWS</td><td>TGTGHSPL</td><td>HFGNGTRLTVTED</td><td>1.6</td><td>21/25</td></tr><tr><td>J28 (CD8+)</td><td>BV20</td><td>SGFYLCAWS</td><td>TGTGHSPL</td><td>HFGNGTRLTVTED</td><td>1.6</td><td>20/24</td></tr><tr><td>J38</td><td>BV20</td><td>SGFYLCAWS</td><td>TGTGHSPL</td><td>HFGNGTRLTVTED</td><td>1.6</td><td>22/25</td></tr><tr><td>J32 (CD4+)</td><td>BV14</td><td>SLYFCASS</td><td>PGTTQETQ</td><td>YFGSGTRLLVLED</td><td>2.5</td><td>18/23</td></tr><tr><td>J25</td><td>BV14</td><td>SLYFCASS</td><td>PGTTQETQ</td><td>YFGPGTRLTVLED</td><td>2.5</td><td>15/23</td></tr><tr><td>J28 (CD8+)</td><td>BV14</td><td>SLYFCASS</td><td>RHTGGTEA</td><td>FFGQGTRLTVVED</td><td>1.1</td><td>19/30</td></tr><tr><td>J29</td><td>BV13.2</td><td>TSVYFCASS</td><td>YDENEQ</td><td>FFGPGTRLTVLED</td><td>2.1</td><td>16/22</td></tr><tr><td>J31 (CD4+)</td><td>BV13.2</td><td>TSVYFCASK</td><td>TKPVGEQ</td><td>FFGPGTRLTVLED</td><td>2.1</td><td>15/23</td></tr><tr><td>J42</td><td>BV13.1</td><td>TSVYFCASS</td><td>YSAGGPNEQ</td><td>FFGPGTRLTVLED</td><td>2.1</td><td>18/25</td></tr><tr><td>J34 (CD4+)</td><td>BV12</td><td>TSVYFCAIR</td><td>KQGDSYEQ</td><td>YFGPGTRLTVTED</td><td>2.7</td><td>17/23</td></tr><tr><td>J35</td><td>BV12</td><td>TSVYFCASR</td><td>VRLITNYGY</td><td>TFGSGTRLTVVED</td><td>1.2</td><td>24/24</td></tr><tr><td>J39 (CD4+)</td><td>BV12</td><td>TSVYFCATA</td><td>GGAPGQPQ</td><td>HFGDGTRLSILED</td><td>1.5</td><td>16/24</td></tr><tr><td>J23</td><td>BJ5.1</td><td>SALYLCASS</td><td>LDYSGNTI</td><td>YFGEGSWLTVVED</td><td>1.3</td><td>22/27</td></tr><tr><td>J25 (CD8+)</td><td>BJ5.1</td><td>SALYLCASS</td><td>LDYSGNTI</td><td>YFGEGSWLTVVED</td><td>1.3</td><td>22/27</td></tr><tr><td>J30</td><td>BJ5.1</td><td>SALYLCASS</td><td>LDYSGNTI</td><td>YFGEGSWLTVVED</td><td>1.3</td><td>22/25</td></tr><tr><td>J24</td><td>BV3</td><td>SMYLCASG</td><td>PNYYEQ</td><td>YFGPGTRLTVTED</td><td>2.7</td><td>23/25</td></tr></table>
314c0c83c75587432c55d01e02f027b68460aa466d0e19dbdab7e50b12054ea3.png
simple
<table><tr><td>Activity category</td><td>Observed activity</td><td>Definition</td></tr><tr><td>(1) Nil physical activity</td><td>Lying in bed sleeping, talking, reading, eating, watching TV, or doing nothing in particular</td><td>Sedentary</td></tr><tr><td>(2) Minimal physical activity</td><td>Sitting supported out of bed while talking, reading, eating, or doing nothing</td><td>Sedentary</td></tr><tr><td>(3) Light physical activity</td><td>Rolling to sit up, sitting unsupported, or transferring with feet on floor</td><td>Physically active</td></tr><tr><td>(4) Moderate physical activity</td><td>Standing, walking, or climbing stairs</td><td>Physically active</td></tr></table>
161994475ec70f1d42c66e5804515b8c36f7dee4aa41d3c3dd63d61003a2449d.png
complex
<table><tr><td rowspan="2">AH</td><td rowspan="2">Position<sup>a</sup></td><td rowspan="2">Length<sup>b</sup></td><td rowspan="2">Hydr. mom<sup>c</sup></td><td colspan="3">Fract of residues<sup>d</sup></td><td rowspan="2">Lipid-binding properties</td><td rowspan="2">Ref</td></tr><tr><td>Hdr</td><td>LH</td><td>Ch</td></tr><tr><td>Hel 13-5</td><td>n.a.<sup>e</sup></td><td>18</td><td>0.69</td><td>0.72</td><td>0.06</td><td>0.28</td><td>Tubulates liposomes</td><td><sup>73</sup></td></tr><tr><td>GMAP210</td><td>1&#8211;38 (1979)</td><td>38</td><td>0.48</td><td>0.37</td><td>0.05</td><td>0.05</td><td>Golgi vesicles/abundant packing defects</td><td><sup>14, 25</sup></td></tr><tr><td>Nup133</td><td>247&#8211;267 (1156)</td><td>21</td><td>0.44</td><td>0.38</td><td>0.05</td><td>0.10</td><td>Nuclear pore membrane</td><td><sup>67</sup></td></tr><tr><td>CIDEA</td><td>163&#8211;180 (219)</td><td>18</td><td>0.53</td><td>0.5</td><td>0.11</td><td>0.17</td><td>LDs<sup>f</sup></td><td><sup>28</sup></td></tr><tr><td>CCT&#945;</td><td>236&#8211;294 (368)</td><td>59</td><td>0.48*</td><td>0.32</td><td>0.10</td><td>0.49</td><td>Nuclear envelope/ER and LDs/liposomes</td><td><sup>6, 16</sup><sup>,</sup><sup>64</sup></td></tr><tr><td>Apolipoprotein-AI</td><td>74&#8211;267 (267)</td><td>186 (7 P)<sup>g</sup></td><td>0.39*</td><td>0.40</td><td>0.065</td><td>0.35</td><td>Lipoprotein particles</td><td><sup>48</sup></td></tr><tr><td>&#945;-Synuclein</td><td>1&#8211;89 (144)</td><td>89</td><td>0.30*</td><td>0.47</td><td>0.02</td><td>0.24</td><td>Synaptic vesicles/neg. charged small liposomes</td><td><sup>44</sup></td></tr><tr><td>Plin3</td><td>114&#8211;204 (434)</td><td>90</td><td>0.35*</td><td>0.37</td><td>0.01</td><td>0.23</td><td>LDs and cytosol</td><td><sup>11</sup></td></tr><tr><td>Plin4</td><td>70&#8211;1037 (1357)</td><td>968</td><td>(0.257)*</td><td>0.35</td><td>0.002</td><td>0.15</td><td>This study</td><td></td></tr></table>
98ed9c81c8ffb5720fecac74ca18f3ae5df120f58bdaa2b94c327a3c51283594.png
simple
<table><tr><td>Links between mutant GBA and PD</td><td>References</td></tr><tr><td>Subset of GD patients develop parkinsonism</td><td>Bembi et al. (2003), Neudorfer et al. (1996), Tayebi et al. (2001)</td></tr><tr><td>Genetic multi-centre study reporting statistically significant association between <i>GBA</i> mutations and PD</td><td>Sidransky et al. (2009)</td></tr><tr><td>Lewy bodies similar in PD brains with and without <i>GBA</i> mutations</td><td>Neumann et al. (2009), Parkkinen et al. (2011)</td></tr><tr><td>Accumulation and impaired turnover of &#945;-synuclein in animal and cell models of GCase deficiency</td><td>Cullen et al. (2011), Fishbein et al. (2014), Manning-Bog&#774; et al. (2009), Mazzulli et al. (2011), Osellame et al. (2013), Sardi et al. (2011), Scho&#776;ndorf et al. (2014)</td></tr><tr><td>GCase activity decreased in sporadic PD</td><td>Gegg et al. (2012), Murphy et al. (2014)</td></tr><tr><td>&#945;-synuclein affects GCase function</td><td>Gegg et al. (2012), Mazzulli et al. (2011), Sardi et al. (2013), Yap et al. (2011)</td></tr></table>
bb2bbdf1a6da58e72c71bd79b2652c9e6c0d87678225cbf3c94caca2cfef47fe.png
complex
<table><tr><td>Type of atresia</td><td colspan="2">Location</td><td colspan="2">Survival</td></tr><tr><td></td><td>Jejunal(n = 11)</td><td>Ileal(n = 17)</td><td>Survivors(n = 20)</td><td>Non-survivors(n = 8)</td></tr><tr><td>I</td><td>1</td><td>1</td><td>2</td><td>0</td></tr><tr><td>II</td><td>1</td><td>1</td><td>0</td><td>2</td></tr><tr><td>IIIa</td><td>2</td><td>12</td><td>14</td><td>0</td></tr><tr><td>IIIb</td><td>4</td><td>1</td><td>2</td><td>3</td></tr><tr><td>IV</td><td>3</td><td>2</td><td>2</td><td>3</td></tr><tr><td>Total</td><td>11</td><td>17</td><td>20</td><td>8</td></tr></table>
baaf0fcb3d963b4e4e8095104f785cb23f669b4e4685cf1ce81c2ca486c42674.png
complex
<table><tr><td>Locality/region</td><td><i>N</i></td><td colspan="2">Tick-infested dogs</td><td colspan="2">Tick-free dogs</td><td>Odds ratio (95% CI)</td><td><i>P</i></td></tr><tr><td></td><td></td><td>positive</td><td>negative</td><td>positive</td><td>negative</td><td></td><td></td></tr><tr><td>Putignano (C)</td><td>80</td><td>6</td><td>24</td><td>4</td><td>46</td><td>2.9 (0.7-11.2)</td><td>0.1640</td></tr><tr><td>Basilicata (D)</td><td>50</td><td>5</td><td>13</td><td>1</td><td>31</td><td>11.9 (1.3-112.3)</td><td>0.0184</td></tr><tr><td>Sicilia (E)</td><td>113</td><td>13</td><td>28</td><td>2</td><td>70</td><td>16.2 (3.4-76.7)</td><td>&lt; 0.0001</td></tr><tr><td>Madrigal de la Vera (F)</td><td>51</td><td>9</td><td>32</td><td>2</td><td>8</td><td>1.1 (0.2-6.3)</td><td>1.000</td></tr><tr><td>Xanthi (G)</td><td>23</td><td>1</td><td>8</td><td>0</td><td>14</td><td>5.1 (0.2-14.4)</td><td>0.3913</td></tr></table>
55ce92e02c337c7272188e4ce6f041a0f159295881966eac25134a94f818f113.png
complex
<table><tr><td>Functional group</td><td colspan="2">Agricultural matrix(mean &#177; SD)</td><td colspan="2">Mining matrix (mean &#177; SD)</td><td colspan="3"><i>F</i>- statistics</td></tr><tr><td></td><td>Edge</td><td>Interior</td><td>Edge</td><td>Interior</td><td>Dist.edge</td><td>Matrix</td><td>Interaction</td></tr><tr><td>Terrestrial insectivores</td><td>0.74 (0.08)</td><td>0.79 (0.04)</td><td>0.48 (0.30)</td><td>0.69 (0.10)</td><td>5.23*</td><td>9.87**</td><td>2.11*</td></tr><tr><td>All lower strata birds</td><td>0.77 (0.12)</td><td>0.71 (0.08)</td><td>0.59 (0.14)</td><td>0.55 (0.15)</td><td>1.42</td><td>14.16***</td><td>0.05</td></tr><tr><td>All upper strata birds</td><td>0.53 (0.19)</td><td>0.43 (0.10)</td><td>0.36 (0.12)</td><td>0.37 (0.15)</td><td>0.68</td><td>4.78*</td><td>0.96</td></tr><tr><td>Obligate frugivores</td><td>0.67 (0.16)</td><td>0.61 (0.12)</td><td>0.44 (0.31)</td><td>0.34 (0.29)</td><td>0.90</td><td>8.37**</td><td>0.10</td></tr><tr><td>Partial fruigivores</td><td>0.72 (0.12)</td><td>0.67 (0.06)</td><td>0.66 (0.13)</td><td>0.72 (0.07)</td><td>0.07</td><td>0.00</td><td>2.03</td></tr><tr><td>Salliers</td><td>0.19 (0.12)</td><td>0.18 (0.12)</td><td>0.22 (0.19)</td><td>0.18 (0.18)</td><td>0.17</td><td>0.08</td><td>0.05</td></tr><tr><td>Upper strata bark gleaners</td><td>0.59 (0.40)</td><td>0.48 (0.39)</td><td>0.75 (0.37)</td><td>0.60 (0.31)</td><td>1.04</td><td>1.23</td><td>0.03</td></tr><tr><td>Upper strata foliage gleaners</td><td>0.26 (0.18)</td><td>0.27 (0.05)</td><td>0.17 (0.12)</td><td>0.27 (0.11)</td><td>1.84</td><td>1.16</td><td>0.93</td></tr><tr><td>All bark gleaning insectivores</td><td>0.59 (0.40)</td><td>0.40 (0.40)</td><td>0.83 (0.36)</td><td>0.60 (0.31)</td><td>2.06</td><td>2.31</td><td>0.13</td></tr><tr><td>Lower strata bark gleaners</td><td>0.89 (0.02)</td><td>0.99 (0.01)</td><td>0.70 (0.43)</td><td>0.64 (0.42)</td><td>0.08</td><td>9.78**</td><td>0.08</td></tr><tr><td>Lower strata foliage gleaners</td><td>0.30 (0.12)</td><td>0.38 (0.06)</td><td>0.27 (0.10)</td><td>0.34 (0.14)</td><td>3.59</td><td>0.84</td><td>0.01</td></tr><tr><td>Canopy insectivores</td><td>0.41 (0.40)</td><td>0.10 (0.07)</td><td>0.27 (0.16)</td><td>0.30 (0.32)</td><td>2.06</td><td>0.07</td><td>3.05</td></tr><tr><td>Raptors</td><td>0.41 (0.30)</td><td>0.74 (0.38)</td><td>0.50 (0.41)</td><td>0.81 (0.35)</td><td>6.15*</td><td>0.38</td><td>&lt; 0.01</td></tr><tr><td>Granivores</td><td>0.61 (0.45)</td><td>0.67 (0.39)</td><td>0.13 (0.20)</td><td>0.13 (0.07)</td><td>0.08</td><td>21.18***</td><td>0.06</td></tr><tr><td>Omnivores</td><td>0.20 (0.11)</td><td>0.24 (0.11)</td><td>0.18 (0.12)</td><td>0.20 (0.10)</td><td>0.49</td><td>0.42</td><td>0.04</td></tr><tr><td>Nectarivores</td><td>0.79 (0.32)</td><td>0.75 (0.36)</td><td>0.92 (0.22)</td><td>0.90 (0.19)</td><td>0.11</td><td>2.00</td><td>&lt; 0.01</td></tr><tr><td>All insectivores</td><td>0.42 (0.11)</td><td>0.46 (0.06)</td><td>0.42 (0.04)</td><td>0.39 (0.13)</td><td>0.04</td><td>1.21</td><td>1.11</td></tr><tr><td>Lower strata aerial sweepers</td><td>0.19 (0.12)</td><td>0.42 (0.27)</td><td>0.10 (0.15)</td><td>0.35 (0.32)</td><td>5.29*</td><td>0.19</td><td>0.24</td></tr><tr><td>Upper strata aerial sweepers</td><td>0.19 (0.18)</td><td>0.14 (0.09)</td><td>0.13 (0.06)</td><td>0.35 (0.41)</td><td>0.94</td><td>0.90</td><td>2.69</td></tr><tr><td>All aerial sweepers</td><td>0.34 (0.08)</td><td>0.21 (0.21)</td><td>0.29 (0.10)</td><td>0.31 (0.13)</td><td>1.26</td><td>0.33</td><td>2.39</td></tr></table>
f3d23edde2f2453e90275772751758e45394892777cd88097fc0764f713c08c0.png
complex
<table><tr><td>Mediterranean Diet</td><td colspan="2">Paleo Diet</td></tr><tr><td>Lipids</td><td>Moderate Fat 40% of daily calories</td><td>Moderate-Low Fat 35% of daily calories</td></tr><tr><td>Proteins</td><td>Reduce processed and red meat. Increased plant-based protein, fish and poultry</td><td>Reduce processed and red meat. Increased plant-based protein, and meat from marine and game animals </td></tr><tr><td>Carbohydrates</td><td>Low Carbohydrate &#8804;40% of daily calories Fruits, vegetables, sugar, and grains</td><td>Moderate Carbohydrates &#8804;45&#8211;65% of daily calories Fruits and vegetables Decreased grains</td></tr></table>
0ef5e1230da84e64bc95021176ded9c1e3bdd725d2c90477d7fece19b8f8e991.png
complex
<table><tr><td rowspan="2">BSS algorithm</td><td colspan="3">Amari indices</td></tr><tr><td>Experiment 1:static uncoupled oscillators</td><td>Experiment 2: static coupled sources</td><td>Experiment 3: dynamic coupled oscillators</td></tr><tr><td>AMICA</td><td>0.31</td><td>0.37</td><td>0.25</td></tr><tr><td>Extended Infomax</td><td>0.31</td><td>0.38</td><td>0.25</td></tr><tr><td>FastICA</td><td>0.32</td><td>0.30</td><td>0.26</td></tr><tr><td>PWC-ICA (1)</td><td>0.35</td><td>0.29</td><td>0.28</td></tr><tr><td>PWC-ICA (2)</td><td>0.34</td><td>0.41</td><td>0.26</td></tr><tr><td>PWC-ICA (4)</td><td>0.35</td><td>0.41</td><td>0.24</td></tr><tr><td>PWC-ICA (8)</td><td>0.30</td><td>0.41</td><td> 0.23 (<i>p</i> &lt; 2.3<i>E</i> &#8722; 3)</td></tr><tr><td>PWC-ICA (1) Haar</td><td>0.30</td><td>0.32</td><td>0.25</td></tr><tr><td>PWC-ICA (2) Haar</td><td> 0.21 (<i>p</i> &lt; 1.5<i>E</i> &#8722; 11)</td><td>0.35</td><td> 0.23 (<i>p</i> &lt; 4.5<i>E</i> &#8722; 4)</td></tr><tr><td>PWC-ICA (4) Haar</td><td> 0.21 (<i>p</i> &lt; 1.5<i>E</i> &#8722; 10)</td><td>0.40</td><td> 0.23 (<i>p</i> &lt; 4.4<i>E</i> &#8722; 2)</td></tr><tr><td>PWC-ICA (8) Haar</td><td> 0.27 (<i>p</i> &lt; 1.5<i>E</i> &#8722; 5)</td><td>0.38</td><td>0.24</td></tr><tr><td>Hilbert complex</td><td> 0.28 (<i>p</i> &lt; 1.5<i>E</i> &#8722; 4)</td><td>0.38</td><td> 0.23 (<i>p</i> &lt; 6.7<i>E</i> &#8722; 3)</td></tr><tr><td>Average baseline</td><td>0.36</td><td>0.42</td><td>0.36</td></tr></table>
a8e7f5a43174244c689b4c8046389ad6534b6e44e4303a5e1db226f4479be8a0.png
simple
<table><tr><td><i>RGT2</i> mutant designation</td><td>Causative constitutive mutation<sup>2</sup></td><td>Location in Rgt2</td><td>Other (likely irrelevant) mutations<sup>2</sup></td></tr><tr><td>87</td><td>F113L</td><td>TM1</td><td></td></tr><tr><td>93</td><td>F113L</td><td>TM1</td><td></td></tr><tr><td>58</td><td>F113L</td><td>TM1</td><td>H517R</td></tr><tr><td>71</td><td>F113L</td><td>TM1</td><td>T130A, L161S</td></tr><tr><td><underline>82</underline></td><td>D116V</td><td>TM1</td><td>F562L</td></tr><tr><td>68</td><td>D116V</td><td>TM1</td><td>D619G</td></tr><tr><td>57</td><td>D116G</td><td>TM1</td><td>I398V, F527L, S754G</td></tr><tr><td>100</td><td>D116N</td><td>TM1</td><td>A226T, Y330C</td></tr><tr><td>111</td><td>D116G, L552S</td><td>TM1, ICH5</td><td>I111M, V324I, K570R</td></tr><tr><td>83</td><td>Q222P</td><td>TM4</td><td></td></tr><tr><td>112</td><td>Q222R</td><td>TM4</td><td></td></tr><tr><td><i>RGT2-1</i><sup>1</sup></td><td>R231K</td><td>TM5</td><td></td></tr><tr><td>98</td><td>R231G</td><td>TM5</td><td>D698G</td></tr><tr><td>50</td><td>R231G</td><td>TM5</td><td>M58R</td></tr><tr><td>103</td><td>G232S</td><td>TM5</td><td>V537A</td></tr><tr><td><underline>59</underline></td><td>G232S</td><td>TM5</td><td>F465Y, S733L</td></tr><tr><td>86</td><td>S236P</td><td>TM5</td><td>F465Y, G471S</td></tr><tr><td><underline>81</underline></td><td>S236P</td><td>TM5</td><td>K488R</td></tr><tr><td><underline>49<sup>3</sup></underline></td><td>S253P, S443P</td><td>TM5, TM9</td><td></td></tr><tr><td>47</td><td>D415N</td><td>TM8</td><td></td></tr><tr><td>60</td><td>W474R</td><td>TM10</td><td></td></tr><tr><td>95</td><td>V475M</td><td>TM10</td><td></td></tr><tr><td><underline>52</underline></td><td>L552S</td><td>ICH5</td><td>N723I</td></tr><tr><td>85</td><td>L552S</td><td>ICH5</td><td>V404G</td></tr><tr><td>108<sup>4</sup></td><td>V473G?</td><td></td><td>V473G, D611G, I626V</td></tr><tr><td>92<sup>4</sup></td><td>?</td><td></td><td>G103S, F111L</td></tr></table>
07dd2cd97291cc7ad54d3736312233cd13eff3d2ceda17c0c5b180c9e733d1f4.png
simple
<table><tr><td></td><td></td><td>Humanities and social sciences</td><td>%</td><td>Natural and formal sciences</td><td>%</td><td>Applied sciences and professions</td><td>%</td><td>Total</td><td>%</td></tr><tr><td>University category</td><td>Highest research</td><td>149</td><td>50</td><td>75</td><td>47</td><td>112</td><td>33</td><td>336</td><td>42</td></tr><tr><td></td><td>Higher research</td><td>113</td><td>38</td><td>54</td><td>34</td><td>146</td><td>42</td><td>313</td><td>39</td></tr><tr><td></td><td>Moderate research</td><td>37</td><td>12</td><td>31</td><td>19</td><td>86</td><td>25</td><td>154</td><td>19</td></tr><tr><td></td><td>Total</td><td>299</td><td>100</td><td>160</td><td>100</td><td>344</td><td>100</td><td>803</td><td>100</td></tr><tr><td>Tenure</td><td>Yes</td><td>215</td><td>72</td><td>108</td><td>68</td><td>244</td><td>71</td><td>567</td><td>71</td></tr><tr><td></td><td>No</td><td>69</td><td>23</td><td>42</td><td>26</td><td>76</td><td>22</td><td>187</td><td>23</td></tr><tr><td></td><td>N/A</td><td>15</td><td>5</td><td>10</td><td>6</td><td>24</td><td>7</td><td>49</td><td>6</td></tr><tr><td></td><td>Total</td><td>299</td><td>100</td><td>160</td><td>100</td><td>344</td><td>100</td><td>803</td><td>100</td></tr><tr><td>Rank</td><td>Lecturer</td><td>6</td><td>2</td><td>4</td><td>3</td><td>8</td><td>2</td><td>18</td><td>2</td></tr><tr><td></td><td>Adjunct</td><td>2</td><td>1</td><td>1</td><td>1</td><td>4</td><td>1</td><td>7</td><td>1</td></tr><tr><td></td><td>Assistant</td><td>57</td><td>19</td><td>33</td><td>21</td><td>60</td><td>17</td><td>150</td><td>19</td></tr><tr><td></td><td>Associate</td><td>100</td><td>33</td><td>37</td><td>23</td><td>92</td><td>27</td><td>229</td><td>29</td></tr><tr><td></td><td>Full</td><td>92</td><td>31</td><td>66</td><td>41</td><td>147</td><td>43</td><td>305</td><td>38</td></tr><tr><td></td><td>University</td><td>12</td><td>4</td><td>6</td><td>4</td><td>6</td><td>2</td><td>24</td><td>3</td></tr><tr><td></td><td>Emeritus</td><td>18</td><td>6</td><td>4</td><td>3</td><td>12</td><td>3</td><td>34</td><td>4</td></tr><tr><td></td><td>Other</td><td>12</td><td>4</td><td>9</td><td>6</td><td>15</td><td>4</td><td>36</td><td>4</td></tr><tr><td></td><td>Total</td><td>299</td><td>100</td><td>160</td><td>100</td><td>344</td><td>100</td><td>803</td><td>100</td></tr><tr><td>Gender</td><td>Male</td><td>156</td><td>52</td><td>114</td><td>71</td><td>177</td><td>51</td><td>447</td><td>56</td></tr><tr><td></td><td>Female</td><td>143</td><td>48</td><td>46</td><td>29</td><td>167</td><td>49</td><td>356</td><td>44</td></tr><tr><td></td><td>Total</td><td>299</td><td>100</td><td>160</td><td>100</td><td>344</td><td>100</td><td>803</td><td>100</td></tr></table>
aafd61a1d092ce16f2d98d4029d3925b34a3afa089ebef0a57749478227d2bbb.png
complex
<table><tr><td></td><td colspan="2">H2-Db</td><td colspan="2">H2-Kb</td><td colspan="2">H2-Kk</td></tr><tr><td></td><td>Additive Method</td><td>SVRMHC Method</td><td>Additive Method</td><td>SVRMHC Method</td><td>Additive Method</td><td>SVRMHC Method</td></tr><tr><td>Numbers of outliers</td><td>6</td><td>3</td><td>7</td><td>6</td><td>2</td><td>0</td></tr><tr><td><i>r</i><sup>2 </sup>(self-consistency, outliers removed)</td><td>0.946</td><td>0.983</td><td>0.989</td><td>0.97</td><td>0.933</td><td>0.973</td></tr><tr><td><i>r</i><sup>2 </sup>(self-consistency, entire dataset)</td><td>0.602</td><td>0.749</td><td>0.37</td><td>0.568</td><td>0.849</td><td>0.973</td></tr><tr><td>Average Residual (entire dataset)</td><td>0.403</td><td>0.17</td><td>0.443</td><td>0.382</td><td>0.178</td><td>0.039</td></tr><tr><td>Average Residual (outliers removed)</td><td>0.187</td><td>0.043</td><td>0.095</td><td>0.13</td><td>0.151</td><td>0.039</td></tr><tr><td><i>q</i><sup>2 </sup>(LOO_CV) (outliers removed)</td><td>0.401</td><td>0.456</td><td>0.454</td><td>0.486</td><td>0.456</td><td>0.721</td></tr></table>
6aa74008df29f125879d5c5dc344d95b653020d1b5b14cb94713758150255905.png
complex
<table><tr><td rowspan="2">Striatal region</td><td colspan="2">Reward scan</td><td colspan="2">Expectation scan</td><td colspan="2">No-drug scan</td></tr><tr><td>Early</td><td>Late</td><td>Early</td><td>Late</td><td>Early</td><td>Late</td></tr><tr><td>Sensorimotor</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Left</td><td>2.44 &#177; 0.33</td><td>2.45 &#177; 0.28</td><td>2.47 &#177; 0.26</td><td>2.48 &#177; 0.27</td><td>2.57 &#177; 0.31</td><td>2.54 &#177; 0.36</td></tr><tr><td> Right</td><td>2.32 &#177; 0.38</td><td>2.34 &#177; 0.33</td><td>2.44 &#177; 0.30</td><td>2.44 &#177; 0.30</td><td>2.58 &#177; 0.36</td><td>2.56 &#177; 0.39</td></tr><tr><td>Associative</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Left</td><td>1.97 &#177; 0.33</td><td>1.96 &#177; 0.29</td><td>2.02 &#177; 0.30</td><td>1.99 &#177; 0.27</td><td>2.19 &#177; 0.32</td><td>2.11 &#177; 0.33</td></tr><tr><td> Right</td><td>2.19 &#177; 0.31</td><td>2.21 &#177; 0.29</td><td>2.25 &#177; 0.29</td><td>2.22 &#177; 0.28</td><td>2.37 &#177; 0.33</td><td>2.31 &#177; 0.35</td></tr><tr><td>Limbic</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Left</td><td>1.95 &#177; 0.31</td><td>1.96 &#177; 0.26</td><td>2.10 &#177; 0.20</td><td>2.11 &#177; 0.20</td><td>2.26 &#177; 0.37</td><td>2.18 &#177; 0.36</td></tr><tr><td> Right</td><td>1.91 &#177; 0.29</td><td>1.90 &#177; 0.22</td><td>1.90 &#177; 0.26</td><td>1.90 &#177; 0.28</td><td>1.99 &#177; 0.32</td><td>2.01 &#177; 0.25</td></tr></table>
aa70ece08a632bd4aa20864ed5dd18686ed5acb5948efc0cbaf971e5ed83bccf.png
complex
<table><tr><td rowspan="2">Strain<sup>1</sup></td><td rowspan="2">Genbank accession #</td><td rowspan="2">Experiment location</td><td rowspan="2">Strawberry tissue</td><td colspan="7">Closest sequence relatives</td></tr><tr><td>Strain(s)</td><td>Genbank accession #</td><td>Homology %</td></tr><tr><td>G1</td><td>JN636809</td><td>greenhouse</td><td>leaf</td><td><i>Candida</i> sp. GA1S07</td><td>FJ527144</td><td>98</td></tr><tr><td>G2*</td><td>JN636810</td><td>greenhouse</td><td>leaf</td><td><i>Cryptococcus</i> sp. VTT C-04547</td><td>DQ377668</td><td>100</td></tr><tr><td>G3</td><td>JN636811</td><td>greenhouse</td><td>leaf</td><td><i>Sakaguchia dacryoidea</i> CBS 6353</td><td>AF189973</td><td>94</td></tr><tr><td>G4</td><td>JN636812</td><td>greenhouse</td><td>leaf</td><td><i>Cryptococcus</i> sp. KCTC 17100</td><td>AF459675</td><td>100</td></tr><tr><td>G5*</td><td>JN636813</td><td>greenhouse</td><td>leaf</td><td><i>Sporobolomyces</i> sp. KCTC 17098</td><td>AF459715</td><td>95</td></tr><tr><td>F1*</td><td>JN636806</td><td>field</td><td>leaf</td><td><i>Cryptococcus</i> sp. HB 982</td><td>FM242574</td><td>99</td></tr><tr><td>F2</td><td>JN636807</td><td>field</td><td>leaf</td><td><i>Cryptococcus heveanensis</i> YFL1.1</td><td>HQ629577</td><td>99</td></tr><tr><td>F3</td><td>JN636808</td><td>field</td><td>ripe fruit</td><td><i>Rhodotorula graminis</i> WP1</td><td>EU563930</td><td>99</td></tr><tr><td>F4*</td><td>JN636804</td><td>field</td><td>unripe fruit</td><td><i>Pichia guilliermondii</i> SYHZS-1</td><td>EU809436</td><td>100</td></tr><tr><td>F5*</td><td>JN636805</td><td>field</td><td>unripe fruit</td><td><i>Metschnikowia pulcherrima</i> Afen</td><td>EU272042</td><td>95</td></tr></table>
d4b3ec149b807aa75efc980a50c055f22933e977cd9eb55a74ebed502224c1ed.png
simple
<table><tr><td></td><td>PlaneDimers</td><td>TransComp1</td></tr><tr><td>INSPiRE</td><td>0.681</td><td>0.529</td></tr><tr><td>SPPIDER [21]</td><td>0.330</td><td>0.150</td></tr><tr><td>PresCont [5]</td><td>0.330</td><td>0.170</td></tr><tr><td>MetaPPISP [22]</td><td>0.040</td><td>0.311</td></tr></table>
c9ac5d94ef95f081ddb39dbe2146d9d9a95919cc9b8703dd9cb4b476266fa271.png
simple
<table><tr><td>Watermelon source</td><td>Cultivar</td><td>(Glucose)(%, w/v)</td><td>(Fructose)(%, w/v)</td><td>(Sucrose)(%, w/v)</td><td>(Amino N)&#956;mol/ml)</td><td>(Citrulline)&#956;mol/ml)</td></tr><tr><td>2007 Hinton, OK, USA</td><td>Crunchy Red</td><td>1.4</td><td>2.8</td><td>3.0</td><td>16.3</td><td>6.3</td></tr><tr><td>2007 Terral, OK, USA</td><td>Unknown</td><td>2.0</td><td>3.6</td><td>2.0</td><td>33.6</td><td>15.4</td></tr><tr><td>2008 Louisiana, USA</td><td>Summer Flavor 800</td><td>1.9</td><td>3.5</td><td>2.8</td><td>33.9</td><td>12.6</td></tr><tr><td>2008 Lane, OK, USA</td><td>Sangria</td><td>1.9</td><td>3.6</td><td>2.8</td><td>17.7</td><td>5.8</td></tr><tr><td>2008 Lane, OK, USA</td><td>Dixie Lee</td><td>1.7</td><td>3.1</td><td>1.8</td><td>19.9</td><td>3.7</td></tr></table>
6052fb69077e358d6a0f060d9203261bb0c10f7cc25b8c7c1d6077e207c1f586.png
complex
<table><tr><td>Oxidative Stress Genes</td><td colspan="2">Average &#916;C<sub>t</sub></td><td colspan="2">2 ^ -&#916; Ct</td><td>Fold Expression</td></tr><tr><td></td><td>+DOX</td><td>&#8722;DOX</td><td>+DOX</td><td>&#8722;DOX</td><td>+DOX/&#8722; DOX</td></tr><tr><td>glutathioneperoxidase2 (GPX2)</td><td>8.68</td><td>7.06</td><td>2.4E-03</td><td>7.5E-03</td><td>&#8722;3.07</td></tr><tr><td>peroxidasin (PXDNL)</td><td>12.48</td><td>10.16</td><td>1.8E-04</td><td>8.7E-04</td><td>&#8722;4.99</td></tr><tr><td>sulfiredoxin (SRXN1)</td><td>6.08</td><td>5.06</td><td>1.5E-02</td><td>3.0E-02</td><td>&#8722;2.03</td></tr><tr><td>peroxiredoxin 2 (PRDX2)</td><td>1.68</td><td>0.96</td><td>3.1E-01</td><td>5.1E-01</td><td>&#8722;1.65</td></tr><tr><td>COX2</td><td>4.78</td><td>4.06</td><td>3.6E-02</td><td>6.0E-02</td><td>&#8722;1.65</td></tr><tr><td>arachidonate 12-lipoxygenase (12-LOX)</td><td>10.08</td><td>9.36</td><td>9.2E-04</td><td>1.5E-03</td><td>&#8722;1.65</td></tr><tr><td>superoxide dismutase 2 (SOD2)</td><td>1.08</td><td>0.56</td><td>4.7E-01</td><td>6.8E-01</td><td>&#8722;1.43*</td></tr><tr><td>superoxide dismutase 3 (SOD3)</td><td>4.68</td><td>4.16</td><td>3.9E-02</td><td>5.6E-02</td><td>&#8722;1.43*</td></tr></table>
c390f86c303fff098ab7c9ef056764cef6bac1e9fad6e82f3094c585067c54a1.png
complex
<table><tr><td>Study</td><td>Input number</td><td>Baseline (%)</td><td>FNN</td><td colspan="2">Accuracy (%)</td><td colspan="2">number of subject</td><td colspan="2">Input characteristic</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>multiple linear regression</td><td>multiple logistic regression</td><td>Case</td><td>Healthy control</td><td>1 input</td><td>2 inputs</td></tr><tr><td>Original Study</td><td>1 input</td><td>63.46</td><td>73.88</td><td>69.23</td><td>73.72</td><td>57</td><td>99</td><td>&#947;-GTP (IU/L)</td><td>&#8722;</td></tr><tr><td> </td><td>2 inputs</td><td>63.71</td><td>77.43</td><td>75.81</td><td>75.81</td><td>45</td><td>79</td><td>&#947;-GTP (IU/L)</td><td>WBC (cells/&#956;L)</td></tr><tr><td>Replication Study</td><td>1 input</td><td>50.00</td><td>64.96</td><td>64.18</td><td>66.44</td><td>2196</td><td>2196</td><td>&#947;-GTP (IU/L)</td><td>&#8722;</td></tr><tr><td> </td><td>2 inputs</td><td>50.00</td><td>67.14</td><td>66.10</td><td>68.53</td><td>2196</td><td>2196</td><td>&#947;-GTP (IU/L)</td><td>WBC (cells/&#956;L)</td></tr></table>
f236b9a1afd10fa2756fef3c6dd6c52ef12a320e0b563aebbe0298811bc49c5e.png
complex
<table><tr><td rowspan="2">Forward</td><td colspan="2">GDS1027</td><td colspan="2">GDS2545</td><td colspan="2">GDS2546</td><td colspan="2">GDS2547</td><td colspan="2">GDS3715</td></tr><tr><td>Orig</td><td>Modi</td><td>Orig</td><td>Modi</td><td>Orig</td><td>Modi</td><td>Orig</td><td>Modi</td><td>Orig</td><td>Modi</td></tr><tr><td>KNN</td><td>0.69</td><td>0.66</td><td>0.64</td><td>0.61</td><td>0.65</td><td>0.63</td><td>0.64</td><td>0.55</td><td>0.84</td><td>0.87</td></tr><tr><td>SVM</td><td>0.83</td><td>0.84</td><td>0.73</td><td>0.75</td><td>0.73</td><td>0.749</td><td>0.74</td><td>0.82</td><td>0.88</td><td>0.91</td></tr><tr><td>Ft number</td><td>11</td><td>14</td><td>10</td><td>15</td><td>8</td><td>10</td><td>9</td><td>16</td><td>8</td><td>13</td></tr></table>
dfa63b08a226d6f14334693c8a59dca9389c73e3046a4c9f9769d288be844e21.png
complex
<table><tr><td></td><td colspan="2">Primary aldosteronism N = 158</td></tr><tr><td>Source</td><td>F statistic</td><td>p-value</td></tr><tr><td>Age</td><td>0.28</td><td>0.598</td></tr><tr><td>Sex</td><td>13.15</td><td>&lt;0.001</td></tr><tr><td>Hypertension duration</td><td>1.98</td><td>0.162</td></tr><tr><td>Mean blood pressure</td><td>5.78</td><td>0.018</td></tr><tr><td>UAldo, tertile</td><td>6.11</td><td>0.003</td></tr><tr><td>UNa, tertile</td><td>7.29</td><td>0.001</td></tr><tr><td>UAldo*UNa</td><td>0.25</td><td>0.907</td></tr></table>
ff887ef95bfdf5eaeccf0dde53dfb97686b4bb39848ec3407c6cefd1fa26f2df.png
simple
<table><tr><td>Plant species</td><td>Origin</td><td>uPA inhibitoryactivity *</td></tr><tr><td><i>Amyris elemifera</i></td><td>Florida, Bahamas, Puerto Rico, West Indies, Central America.</td><td>+</td></tr><tr><td><i>Bidens alba L.</i></td><td>Native to South America. Pan tropical weed</td><td>&#8722;</td></tr><tr><td><i>Cananga odorata</i></td><td>Native to southern Asia and Philippines</td><td>+</td></tr><tr><td><i>Capparis cynophallophora</i></td><td>Florida, Bahamas, Puerto Rico, West Indies, Central America.</td><td>&#8722;</td></tr><tr><td><i>Colubrina elliptica</i></td><td>Puerto Rico, Florida, Bahamas, West Indies, Central Mexico to Venezuela</td><td>&#8722;</td></tr><tr><td><i>Croton lucidus</i></td><td>Native to PR, Bahamas, Greater Antilles, and Grand Cayman.</td><td>+</td></tr><tr><td><i>Erythroxylum areolatum</i></td><td>Bahamas, Greater Antilles, and South America</td><td>+</td></tr><tr><td><i>Exostema caribaeum</i></td><td>Florida, Bahamas, West Indies, Mexico, Central America, NE coast South America</td><td>&#8722;</td></tr><tr><td><i>Guaiacum officinale</i></td><td>Continental Tropical America, PR, West Indies</td><td>&#8722;</td></tr><tr><td><i>Kalanchoe pinnata</i></td><td>Native to Madagascar</td><td>&#8722;</td></tr><tr><td><i>Lantana camara</i></td><td>Pantropical</td><td>+</td></tr><tr><td><i>Plumeria alba L.</i></td><td>Central America and the Caribbean</td><td>&#8722;</td></tr><tr><td><i>Tabebuia heterophylla</i></td><td>Puerto Rico, Hispaniola, Virgin Islands, and Lesser Antilles.</td><td>+</td></tr><tr><td><i>Vanilla claviculata</i></td><td>Puerto Rico and Greater Antilles</td><td>&#8722;</td></tr></table>
e9a665b21b77bdcda8ec93696993a300157ad15373cef850f3584d5a2e0d3731.png
simple
<table><tr><td>GO attribute</td><td>No. of genes in category</td><td>No. of genes bound by Gcn5p (<i>P </i>value)</td><td>No. of genes bound by Sas3p (<i>P </i>value)</td><td>No. of genes bound by both (<i>P </i>value)</td></tr><tr><td>Cytosolic ribosome</td><td>171</td><td>43 (3.6 &#215; 10<sup>-26</sup>)</td><td>54 (3.2 &#215; 10<sup>-29</sup>)</td><td>17 (9.4 &#215; 10<sup>-16</sup>)</td></tr><tr><td>Ribosome</td><td>284</td><td>51 (1.1 &#215; 10<sup>-23</sup>)</td><td>67 (8.6 &#215; 10<sup>-28</sup>)</td><td>21 (6.8 &#215; 10<sup>-16</sup>)</td></tr></table>
84b98dad353c0e5a307dc87cfc7f88846b8cd1bf523ca234c3f501464ae9454c.png
complex
<table><tr><td>Variable</td><td>With dementia (<i>n</i> = 36)</td><td>Without dementia (<i>n</i> = 36)</td><td>Chi-square</td><td><i>p</i>-value</td></tr><tr><td></td><td>n (%)</td><td>n (%)</td><td></td><td></td></tr><tr><td colspan="5">GENDER</td></tr><tr><td>Male</td><td>6 (16.7)</td><td>19 (52.8)</td><td>10.356</td><td>0.001</td></tr><tr><td>Female</td><td>30 (83.3)</td><td>17 (47.2)</td><td></td><td></td></tr><tr><td colspan="5">AGE</td></tr><tr><td>65&#8211;74</td><td>1 (2.8)</td><td>7 (19.4)</td><td>5.063</td><td>0.080</td></tr><tr><td>75&#8211;84</td><td>18 (50)</td><td>15 (41.7)</td><td></td><td></td></tr><tr><td>&gt; 84</td><td>17 (47.2)</td><td>14 (38.9)</td><td></td><td></td></tr><tr><td colspan="5">SCHOOLING</td></tr><tr><td>&lt; primary</td><td>24 (66.7)</td><td>23 (63.9)</td><td>0.061</td><td>0.804</td></tr><tr><td>&#8805;primary</td><td>12 (33.3)</td><td>13 (36.1)</td><td></td><td></td></tr><tr><td colspan="5">MARITAL STATUS</td></tr><tr><td>Single</td><td>5 (13.9)</td><td>8 (22.2)</td><td>1.969</td><td>0.579</td></tr><tr><td>Married</td><td>7 (19.4)</td><td>6 (16.7)</td><td></td><td></td></tr><tr><td>Widowed</td><td>24 (66.7)</td><td>21 (58.3)</td><td></td><td></td></tr><tr><td>Divorced</td><td>0 (0)</td><td>1 (2.8)</td><td></td><td></td></tr><tr><td colspan="5">HOSPITALIZATION TIME</td></tr><tr><td>&lt; 1 year</td><td>20 (55.6)</td><td>21 (58.3)</td><td>0.072</td><td>0.965</td></tr><tr><td>1&#8211;5 years</td><td>11 (30.6)</td><td>10 (27.8)</td><td></td><td></td></tr><tr><td>&gt;5 years</td><td>5 (13.9)</td><td>5 (13.9)</td><td></td><td></td></tr><tr><td colspan="5">AMOUNT RECEIVED BY THE OWNER OF SOCIAL SECURITY</td></tr><tr><td>&lt;&#8364;445</td><td>20 (55.6)</td><td>28 (77.8)</td><td>4.000</td><td>0.046</td></tr><tr><td>&#8805;&#8364;445</td><td>16 (44.4)</td><td>8 (22.2)</td><td></td><td></td></tr><tr><td colspan="5">STATE SEVERITY BIMS</td></tr><tr><td>Intact cognition</td><td>1 (2.8)</td><td>18 (50)</td><td>27.300</td><td>0.000</td></tr><tr><td>Moderate</td><td>4 (11.1)</td><td>8 (22.2)</td><td></td><td></td></tr><tr><td>Severe</td><td>31 (86.1)</td><td>10 (27.8)</td><td></td><td></td></tr></table>
0a7b9554cbcdfae1cd84bb327880b86631b4ec8cba0691ffe6585ced67343f75.png
complex
<table><tr><td>Gene</td><td rowspan="2">#</td><td colspan="2">A</td><td colspan="2">B</td><td colspan="2">C</td><td rowspan="2">Gene description</td><td rowspan="2">Accession numbers</td></tr><tr><td>Symbols</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td><i>hsp90</i>+</td><td>8</td><td>5.03*</td><td>0.79</td><td>0.20*</td><td>0.16</td><td>0.79</td><td>0.15</td><td>Heat shock protein 90. beta</td><td>NM_198210</td></tr><tr><td><i>fas</i>+</td><td>9</td><td>4.09*</td><td>0.27</td><td>0.61*</td><td>0.09</td><td>1.27</td><td>0.16</td><td>Fas (TNF receptor superfamily, member 6)</td><td>XM_685355</td></tr><tr><td><i>il1b</i></td><td>14</td><td>3.71*</td><td>0.47</td><td>0.42*</td><td>0.05</td><td>2.05*</td><td>0.34</td><td>Interleukin 1, beta</td><td>NM_212844</td></tr><tr><td><i>hspb</i>+</td><td>7</td><td>3.51*</td><td>0.33</td><td>0.52*</td><td>0.04</td><td>2.27*</td><td>0.32</td><td>Heat shock protein. alpha-crystalline-related</td><td>NM 001008615</td></tr><tr><td><i>Ifih</i></td><td>7</td><td>2.78*</td><td>0.47</td><td>0.48*</td><td>0.02</td><td>0.78</td><td>0.04</td><td>Novel protein similar to vertebrate interferon</td><td>XM_689032</td></tr><tr><td><i>irf7</i></td><td>8</td><td>2.65*</td><td>0.17</td><td>0.80</td><td>0.05</td><td>1.29</td><td>0.16</td><td>Interferon regulatory factor 7</td><td>NM_200677</td></tr><tr><td><i>faslg</i>+</td><td>11</td><td>2.38*</td><td>0.28</td><td>0.84</td><td>0.05</td><td>0.91</td><td>0.26</td><td>Fas ligand (TNF superfamily, member 6)</td><td>NM_001042701</td></tr><tr><td><i>casp7</i>+</td><td>7</td><td>2.23*</td><td>0.07</td><td>0.55*</td><td>0.04</td><td>1.36</td><td>0.11</td><td>Caspase 7, apoptosis cysteine peptidase</td><td>NM_001020607</td></tr><tr><td><i>jak1</i></td><td>17</td><td>2.21*</td><td>0.14</td><td>0.76</td><td>0.07</td><td>1.25</td><td>0.12</td><td>Janus kinase 1</td><td>NM_131073</td></tr><tr><td><i>stat3</i></td><td>13</td><td>2.17*</td><td>0.24</td><td>0.80</td><td>0.10</td><td>1.18</td><td>0.07</td><td>Signal transduction/activation transcription 3</td><td>XM_002661113</td></tr><tr><td><i>stat1a</i></td><td>23</td><td>1.93*</td><td>0.15</td><td>1.00</td><td>0.18</td><td>1.21</td><td>0.17</td><td>Signal transduction/activation transcription 1a</td><td>NM_131480</td></tr><tr><td><i>Ikbke</i></td><td>9</td><td>1.90*</td><td>0.12</td><td>0.69</td><td>0.03</td><td>1.65</td><td>0.19</td><td>Inhibitor of kappa light polypeptide gene</td><td>NM_001002751</td></tr><tr><td><i>Tnfsf</i></td><td>8</td><td>1.82*</td><td>0.54</td><td>0.73</td><td>0.21</td><td>1.16</td><td>0.39</td><td>Tumor necrosis factor (ligand) superfamily</td><td>NM_001002593</td></tr><tr><td><i>inpp5d</i></td><td>7</td><td>1.75*</td><td>0.11</td><td>0.79</td><td>0.01</td><td>1.09</td><td>0.08</td><td>Inositol polyphosphate-5-phosphatase</td><td>XM_001922972</td></tr><tr><td><i>irf6</i></td><td>8</td><td>0.73</td><td>0.12</td><td>0.90</td><td>0.29</td><td>2.15*</td><td>0.56</td><td>Interferon regulatory factor 6</td><td>NM_200598</td></tr><tr><td><i>Igm</i></td><td>7</td><td>0.03*</td><td>0.01</td><td>0.73</td><td>0.04</td><td>0.51*</td><td>0.02</td><td>Ig heavy chain constant region home design</td><td>AY643753</td></tr></table>
c4acc9644852de4b7bce928028c79932b396d52fe52cf5300dd86356c43d6fc5.png
complex
<table><tr><td rowspan="2">Breed</td><td rowspan="2">n</td><td></td><td colspan="5">Region-1</td><td colspan="5">Region-2</td><td colspan="3">Region-3</td></tr><tr><td></td><td><i>A<sub>1</sub></i></td><td><i>B<sub>1</sub></i></td><td><i>C<sub>1</sub></i></td><td><i>D<sub>1</sub></i></td><td></td><td><i>A<sub>2</sub></i></td><td><i>B<sub>2</sub></i></td><td><i>C<sub>2</sub></i></td><td><i>D<sub>2</sub></i></td><td></td><td><i>A<sub>3</sub></i></td><td><i>B<sub>3</sub></i></td><td><i>C<sub>3</sub></i></td></tr><tr><td>Merino</td><td>68</td><td></td><td>50.0</td><td>48.5</td><td>0.0</td><td>1.5</td><td></td><td>55.2</td><td>5.2</td><td>9.6</td><td>30.2</td><td></td><td>66.9</td><td>11.8</td><td>21.3</td></tr><tr><td>Romney</td><td>71</td><td></td><td>52.8</td><td>41.6</td><td>4.9</td><td>0.7</td><td></td><td>76.8</td><td>0.0</td><td>4.9</td><td>18.3</td><td></td><td>49.3</td><td>1.4</td><td>49.3</td></tr><tr><td>Suffolk</td><td>42</td><td></td><td>53.6</td><td>46.4</td><td>0.0</td><td>0.0</td><td></td><td>75.0</td><td>1.2</td><td>0.0</td><td>23.8</td><td></td><td>35.7</td><td>0.0</td><td>64.3</td></tr><tr><td>Texel</td><td>22</td><td></td><td>56.8</td><td>43.2</td><td>0.0</td><td>0.0</td><td></td><td>100.0</td><td>0.0</td><td>0.0</td><td>0.0</td><td></td><td>65.9</td><td>6.8</td><td>27.3</td></tr><tr><td>Corriedale</td><td>41</td><td></td><td>39.0</td><td>57.3</td><td>0.0</td><td>3.7</td><td></td><td>75.6</td><td>2.4</td><td>6.1</td><td>15.9</td><td></td><td>28.1</td><td>3.7</td><td>68.3</td></tr><tr><td>Perendale</td><td>14</td><td></td><td>57.1</td><td>39.3</td><td>0.0</td><td>3.6</td><td></td><td>89.3</td><td>0.0</td><td>0.0</td><td>10.7</td><td></td><td>42.9</td><td>0.0</td><td>57.1</td></tr><tr><td>Dorper</td><td>39</td><td></td><td>76.9</td><td>23.1</td><td>0.0</td><td>0.0</td><td></td><td>56.4</td><td>1.3</td><td>38.5</td><td>3.9</td><td></td><td>53.9</td><td>5.1</td><td>41.0</td></tr><tr><td>Dorset Down</td><td>19</td><td rowspan="2"></td><td>81.6</td><td>18.4</td><td>0.0</td><td>0.0</td><td></td><td>100.0</td><td>0.0</td><td>0.0</td><td>0.0</td><td></td><td>34.2</td><td>0.0</td><td>65.8</td></tr><tr><td>Overall</td><td>316</td><td>55.7</td><td>42.1</td><td>1.1</td><td>1.1</td><td></td><td>72.78</td><td>1.7</td><td>8.7</td><td>16.8</td><td></td><td>49.1</td><td>4.4</td><td>46.5</td></tr></table>
e55869ae43b5acdf14bd23087a28c3d0f30330b01fd42b52fa288258083c16d6.png
complex
<table><tr><td>Patients demographics</td><td><i>N</i>, % (total 30)</td></tr><tr><td>Age (mean, SD)</td><td>35.6 (9.3)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td> Males</td><td>6 (20.0)</td></tr><tr><td> Females</td><td>24 (80.0)</td></tr><tr><td>Pre-op BMI (mean, SD)</td><td>42.8 (5.8)</td></tr><tr><td>Diabetes</td><td>4 (13.3)</td></tr><tr><td>History of smoking</td><td>4 (13.3)</td></tr><tr><td colspan="2">Type of bariatric surgery</td></tr><tr><td rowspan="2"> Sleeve gastrectomy RYG bypass</td><td>28 (93.3)</td></tr><tr><td>2 (6.7)</td></tr></table>
5e3a28687fad3147e7de19f791a09dd128eea432439be836df49091af0473407.png
complex
<table><tr><td></td><td></td><td colspan="4">Significance<sup>a</sup></td></tr><tr><td>Valence</td><td>Percentage</td><td>Race/Ethnicity</td><td>Gender</td><td>Age</td><td>Education</td></tr><tr><td>Negative</td><td>80%</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Ambivalent or Neutral</td><td>30%</td><td>*</td><td>+</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Positive</td><td>59%</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td>Not discernible</td><td>52%</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td></tr></table>
e5d052a1c9314b3608b289cf1bb02dd93d7a6b632cdd591512f0c23abb5aa7f6.png
complex
<table><tr><td><i>Ingredient:</i></td><td>%</td></tr><tr><td>Corn</td><td>59.36</td></tr><tr><td>SBM, dehulled (48% CP)</td><td>33.70</td></tr><tr><td>Corn Oil</td><td>3.00</td></tr><tr><td>Dicalcium phosphate (Technical grade)</td><td>1.47</td></tr><tr><td>Calcium carbonate (Technical grade)</td><td>1.21</td></tr><tr><td>Salt, iodized</td><td>0.45</td></tr><tr><td>DL-methionine</td><td>0.21</td></tr><tr><td>L-lysine</td><td>0.10</td></tr><tr><td>Vitamin premix<sup>1</sup> (no mineral)</td><td>0.25</td></tr><tr><td>Mineral premix<sup>2</sup> (no Zn)</td><td>0.25</td></tr><tr><td>Total</td><td>100.00</td></tr><tr><td colspan="2"><underline>Calculated (analyzed) nutrients</underline></td></tr><tr><td>ME, kcal/kg</td><td>3,080</td></tr><tr><td>CP, %</td><td>21</td></tr><tr><td>Ca<sup>3</sup>, %</td><td>1.00 (1.3)</td></tr><tr><td>Nonphytate P<sup>3</sup>, %</td><td>0.45 (0.40)</td></tr><tr><td>Lysine, %</td><td>1.24</td></tr><tr><td>Methionine + Cystein, %</td><td>0.90</td></tr><tr><td>Zinc (mg/kg)</td><td>25</td></tr></table>
f525908b7a911db4f0816bb3d63b2e7f09ea8911ae9c516a3d98f0cdec4bfc0d.png
simple
<table><tr><td>Substrate</td><td>Dyad position</td><td>Translational shift</td></tr><tr><td> </td><td> </td><td>(base pairs<sup>a</sup>)</td></tr><tr><td>S1</td><td>74</td><td>-</td></tr><tr><td>S1-CGG19</td><td>72</td><td>&#8722;2</td></tr><tr><td>S1-1AGGa</td><td>74.75</td><td>+0.75</td></tr><tr><td>S1-1AGGb</td><td>77.5</td><td>+3.5</td></tr><tr><td>S1-2AGG</td><td>78</td><td>+4</td></tr></table>
63f97de7dddc0a6c1454a670dd33b273cc1ae5307c14749fb9794daa6f73cb8d.png
complex
<table><tr><td rowspan="2">Gene</td><td rowspan="2">Copy number change (diploid model)</td><td colspan="2">All TCGA</td><td colspan="2">ESCA_SCC TCGA</td><td colspan="2">All TCGA (matched normal)</td><td>Bodymap</td></tr><tr><td>%ile</td><td>kIQR</td><td>%ile</td><td>kIQR</td><td>%ile</td><td>kIQR</td><td>Mean FC</td></tr><tr><td><i>APC</i></td><td>&#8722;1 (DLOH)</td><td>84</td><td>1.1</td><td>70</td><td>0.41</td><td>86</td><td>0.88</td><td>&#8722;1.17</td></tr><tr><td><i>BAP1</i></td><td>&#8722;1 (DLOH)</td><td>1</td><td>&#8722;1.5</td><td>0</td><td>&#8722;1.77</td><td>0</td><td>&#8722;2.33</td><td>&#8722;1.79</td></tr><tr><td><i>BRAF</i></td><td>0</td><td>94</td><td>1.7</td><td>79</td><td>0.73</td><td>100</td><td>2.06</td><td>1.25</td></tr><tr><td><i>CDK4</i></td><td>0</td><td>2</td><td>&#8722;0.96</td><td>4</td><td>&#8722;1.1</td><td>13</td><td>&#8722;0.91</td><td>1.48</td></tr><tr><td><i>CDK6</i></td><td>0</td><td>96</td><td>4.25</td><td>89</td><td>1.08</td><td>100</td><td>9.78</td><td>7.59</td></tr><tr><td><i>CDKN1A</i></td><td>&#8722;1 (DLOH)</td><td>60</td><td>0.2</td><td>56</td><td>0.06</td><td>56</td><td>0.11</td><td>1.44</td></tr><tr><td><i>CDKN2A</i></td><td>&#8722;1 (DLOH)</td><td>60</td><td>0.15</td><td>72</td><td>0.56</td><td>99</td><td>4.35</td><td>4.67</td></tr><tr><td><i>CDKN2B</i></td><td>&#8722;1 (DLOH)</td><td>96</td><td>3.74</td><td>90</td><td>1.43</td><td>91</td><td>1.78</td><td>3.91</td></tr><tr><td><i>CTNNB1</i></td><td>&#8722;1 (DLOH)</td><td>86</td><td>1.06</td><td>97</td><td>2.49</td><td>91</td><td>1.5</td><td>1.73</td></tr><tr><td><i>CYLD</i></td><td>0</td><td>65</td><td>0.28</td><td>56</td><td>0.1</td><td>53</td><td>0.04</td><td>&#8722;1.59</td></tr><tr><td><i>DPH3</i></td><td>0</td><td>95</td><td>1.91</td><td>100</td><td>3.36</td><td>95</td><td>1.3</td><td>&#8722;1.01</td></tr><tr><td><i>E2F1</i></td><td>0</td><td>31</td><td>&#8722;0.3</td><td>9</td><td>&#8722;0.73</td><td>92</td><td>1.5</td><td>1.98</td></tr><tr><td><i>E2F2</i></td><td>0</td><td>46</td><td>&#8722;0.08</td><td>6</td><td>&#8722;0.99</td><td>82</td><td>2.24</td><td>1.45</td></tr><tr><td><i>E2F3</i></td><td>&#8722;1 (DLOH)</td><td>48</td><td>&#8722;0.03</td><td>47</td><td>&#8722;0.05</td><td>91</td><td>1.13</td><td>1.09</td></tr><tr><td><i>EGFR</i></td><td>0</td><td>99</td><td>17.91</td><td>93</td><td>3.62</td><td>100</td><td>29.5</td><td>16.72</td></tr><tr><td><i>ERBB2</i></td><td>0</td><td>22</td><td>&#8722;0.47</td><td>3</td><td>&#8722;0.68</td><td>10</td><td>&#8722;0.79</td><td>1.77</td></tr><tr><td><i>EZH2</i></td><td>0</td><td>42</td><td>&#8722;0.14</td><td>14</td><td>&#8722;0.63</td><td>90</td><td>2.35</td><td>1.57</td></tr><tr><td><i>FZD1</i></td><td>0</td><td>90</td><td>2.28</td><td>92</td><td>2.15</td><td>92</td><td>1.97</td><td>3.21</td></tr><tr><td><i>FZD6</i></td><td>0</td><td>97</td><td>2.78</td><td>53</td><td>0.04</td><td>100</td><td>3.95</td><td>5.25</td></tr><tr><td><i>FZD7</i></td><td>0</td><td>98</td><td>5.58</td><td>93</td><td>1.52</td><td>97</td><td>4.43</td><td>4.18</td></tr><tr><td><i>GSK3B</i></td><td>+2 (ASCNA)</td><td>100</td><td>5.08</td><td>97</td><td>2.22</td><td>100</td><td>8.58</td><td>3.62</td></tr><tr><td><i>HRAS</i></td><td>0</td><td>7</td><td>&#8722;0.69</td><td>0</td><td>&#8722;1.09</td><td>14</td><td>&#8722;0.7</td><td>1.05</td></tr><tr><td><i>JAG1</i></td><td>0</td><td>99</td><td>5.62</td><td>83</td><td>1.02</td><td>100</td><td>8.97</td><td>6.42</td></tr><tr><td><i>KRAS</i></td><td>0</td><td>96</td><td>2.45</td><td>90</td><td>1.24</td><td>100</td><td>4.41</td><td>1.83</td></tr><tr><td><i>MDM2</i></td><td>0</td><td>97</td><td>3.31</td><td>97</td><td>4.19</td><td>99</td><td>5.89</td><td>2.86</td></tr><tr><td><i>MDM4</i></td><td>0</td><td>93</td><td>2.08</td><td>90</td><td>2.07</td><td>100</td><td>3.26</td><td>&#8722;1.07</td></tr><tr><td><i>MUTYH</i></td><td>0</td><td>1</td><td>&#8722;0.97</td><td>2</td><td>&#8722;1.37</td><td>5</td><td>&#8722;0.91</td><td>&#8722;1.14</td></tr><tr><td><i>NOTCH1</i></td><td>0</td><td>96</td><td>3.16</td><td>82</td><td>0.96</td><td>100</td><td>4.81</td><td>5.35</td></tr><tr><td><i>PIK3CB</i></td><td>+2 (ASCNA)</td><td>89</td><td>1.19</td><td>82</td><td>0.98</td><td>87</td><td>1.05</td><td>1.76</td></tr><tr><td><i>PTEN</i></td><td>&#8722;1 (DLOH)</td><td>80</td><td>0.69</td><td>76</td><td>0.64</td><td>66</td><td>0.33</td><td>1.14</td></tr><tr><td><i>RB1</i></td><td>0</td><td>95</td><td>1.82</td><td>64</td><td>0.29</td><td>100</td><td>3.31</td><td>2.26</td></tr><tr><td><i>TP53</i></td><td>0</td><td>64</td><td>0.29</td><td>56</td><td>0.16</td><td>89</td><td>1.19</td><td>1.75</td></tr><tr><td><i>TGFB1</i></td><td>0</td><td>79</td><td>0.73</td><td>18</td><td>&#8722;0.49</td><td>94</td><td>1.75</td><td>1.77</td></tr><tr><td><i>TGFBR1</i></td><td>0</td><td>94</td><td>1.79</td><td>90</td><td>1.45</td><td>97</td><td>2.05</td><td>1.86</td></tr><tr><td><i>TGFBR2</i></td><td>0</td><td>99</td><td>3.84</td><td>100</td><td>6.67</td><td>81</td><td>0.82</td><td>1.15</td></tr><tr><td><i>WNT10A</i></td><td>0</td><td>96</td><td>8.33</td><td>89</td><td>1.54</td><td>100</td><td>14.41</td><td>18.52</td></tr><tr><td><i>WNT5A</i></td><td>&#8722;1 (DLOH)</td><td>83</td><td>1.09</td><td>33</td><td>&#8722;0.13</td><td>91</td><td>2.12</td><td>2.9</td></tr></table>
46df0f81be2b2173d28550eef1fa4a5b63fb3a579c494da6ae4ea5515692a36e.png
simple
<table><tr><td>Gene or Construct</td><td>Accession No:</td><td>Primers</td><td>Template</td><td>Vector</td></tr><tr><td><i>NvStbm </i>(in situ hybridization probe)</td><td>1526895:4</td><td>Forward 5' CGACAAAGCGAACCAATGTTTACTCT 3'Reverse 5' CCGACATCATGTAAGGGTTATACTCA 3'</td><td>Mixed stage <i>N.vectensis </i>cDNA</td><td>pGEM</td></tr><tr><td><i>NvStbm </i>(Full-length)</td><td>1526895:4</td><td>Forward 5'GCCGGAATTCATGCCGCAATATCGTACCAAAGAC 3'Reverse 5' GCCTAGGCCTGACGGAGGTCTCCGAATTTAACTTG 3'</td><td>Mixed stage <i>N.vectensis </i>cDNA</td><td>pCS2<sup>+</sup>GFP</td></tr><tr><td><i>NvFz10</i></td><td>XP_001630630</td><td>Forward 5' AGTACGATCAGTGCGTCCCCCAATG 3'Reverse 5' CCGCCACGACTTGAATGTTTTTGTAG 3'</td><td>Mixed stage <i>N.vectensis </i>cDNA</td><td>pGEM</td></tr><tr><td><i>NvFz5</i></td><td>XP_001634995</td><td>Forward 5' GCGAAGAGATCACCATTCCCATGTGC 3'Reverse 5' ACCCACCAAACAGAGGAAGCCATTC 3'</td><td>Mixed stage <i>N.vectensis </i>cDNA</td><td>pGEM</td></tr><tr><td><i>SpAxin</i></td><td>XP_781992</td><td>Forward 5' GCCGGAATTCATGAGTCTAGAAGTGTATAGGTTC 3'Reverse 5' GCCGAGGCCTGTGATCATCGACAGATTCCACCTG 3'</td><td>Blastula stage <i>S. purpuratus </i>cDNA</td><td>pCS2<sup>+</sup>GFP</td></tr></table>
7d76fe52fef71b5e5fb43d9d102daa027f00532e8c6b57d573ca9ea2efebb926.png
simple
<table><tr><td>Gd-dendrimer generation (G)</td><td>Peak concentration in orthotopic RG-2 gliomas (mM)</td><td>Peak concentration time point (min)</td><td>Peak concentration in ectopic RG-2 gliomas (mM)</td><td>Peak concentration time point (min)</td></tr><tr><td>Gd-G5</td><td>0.147</td><td>167</td><td>0.195</td><td>149</td></tr><tr><td>Gd-G6</td><td>0.106</td><td>200</td><td>0.144</td><td>189</td></tr><tr><td>Gd-G7</td><td>0.064</td><td>75</td><td>0.084</td><td>107</td></tr><tr><td>Gd-G8</td><td>0.049</td><td>77</td><td>0.052</td><td>81</td></tr></table>
1089ca42338b6178c69b353aee135dbb5618420d8aca6726f698b76011144563.png
simple
<table><tr><td></td><td>DVT(n = 9)</td><td>PE(n = 9)</td><td>AF(n = 13)</td><td>Total(n = 31)</td></tr><tr><td>COUNTRY (n)</td><td></td><td></td><td></td><td></td></tr><tr><td>France</td><td>3</td><td>3</td><td>5</td><td>11</td></tr><tr><td>The Netherlands</td><td>3</td><td>3</td><td>4</td><td>10</td></tr><tr><td>The United States</td><td>3</td><td>3</td><td>4</td><td>10</td></tr><tr><td>GENDER (n)</td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>5</td><td>2</td><td>7</td><td>14</td></tr><tr><td>Female</td><td>4</td><td>7</td><td>6</td><td>17</td></tr><tr><td>AGE (years)</td><td></td><td></td><td></td><td></td></tr><tr><td>Range</td><td>21 &#8211; 77</td><td>30 &#8211; 74</td><td>39 &#8211; 79</td><td>21 &#8211; 79</td></tr><tr><td>Mean</td><td>47.4</td><td>51.3</td><td>68.5</td><td>57.4</td></tr><tr><td>LIVING SITUATION (n)</td><td></td><td></td><td></td><td></td></tr><tr><td>Living alone</td><td>3</td><td>.</td><td>5</td><td>8</td></tr><tr><td>Living as a couple</td><td>6</td><td>9</td><td>8</td><td>23</td></tr><tr><td>LEVEL OF EDUCATION (n)</td><td></td><td></td><td></td><td></td></tr><tr><td>Primary school</td><td>1</td><td>.</td><td>3</td><td>4</td></tr><tr><td>High school diploma</td><td>3</td><td>3</td><td>3</td><td>9</td></tr><tr><td>Some college or vocational school</td><td>1</td><td>3</td><td>4</td><td>8</td></tr><tr><td>College or university degree</td><td>3</td><td>2</td><td>1</td><td>6</td></tr><tr><td>Graduate or professional school</td><td>1</td><td>1</td><td>1</td><td>3</td></tr><tr><td>Other, please specify</td><td>.</td><td>.</td><td>1 (grammar school)</td><td>1</td></tr><tr><td>EMPLOYMENT STATUS (n)</td><td></td><td></td><td></td><td></td></tr><tr><td>Full-time paid employment</td><td>4</td><td>1</td><td>1</td><td>6</td></tr><tr><td>Part-time paid employment</td><td>1*</td><td>1*</td><td>1</td><td>3</td></tr><tr><td>Homemaker/housewife</td><td>.</td><td>1</td><td>1</td><td>2</td></tr><tr><td>Retired</td><td>3</td><td>3</td><td>10</td><td>16</td></tr><tr><td>Unemployed</td><td>.</td><td>1</td><td>.</td><td>1</td></tr><tr><td>Not working due to present health status</td><td>.</td><td>2</td><td>.</td><td>2</td></tr><tr><td>Other, please specify</td><td>1 (disabled)</td><td>.</td><td>.</td><td>1</td></tr></table>
cbafa9d94e90229b097de9c5f250bb64a953b05568fd34ab34adc7fdc89e6151.png
complex
<table><tr><td rowspan="2">Models</td><td colspan="2">T2DM</td><td colspan="2">IFG</td></tr><tr><td>OR (95% CI)</td><td><i>P</i> value</td><td>OR* (95% CI)</td><td><i>P</i> value</td></tr><tr><td>let-7b</td><td></td><td></td><td></td><td></td></tr><tr><td>Univariate model</td><td>1.36 (1.24, 1.49)</td><td>&lt;0.001</td><td>1.25 (1.23, 1.38)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 1<sup>a</sup></td><td>1.36 (1.23, 1.49)</td><td>&lt;0.001</td><td>1.22 (1.10, 1.35)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 2<sup>b</sup></td><td>1.35 (1.22, 1.50)</td><td>&lt;0.001</td><td>1.23 (1.10, 1.37)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 3<sup>c</sup></td><td>1.33 (1.10, 1.50)</td><td>&lt;0.001</td><td>1.20 (1.07, 1.35)</td><td>0.002</td></tr><tr><td>miR-142</td><td></td><td></td><td></td><td></td></tr><tr><td>Univariate model</td><td>0.80 (0.74, 0.86)</td><td>&lt;0.001</td><td>0.85 (0.78, 0.92)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 1<sup>a</sup></td><td>0.78 (0.73, 0.85)</td><td>&lt;0.001</td><td>0.84 (0.77, 0.92)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 2<sup>b</sup></td><td>0.80 (0.74, 0.88)</td><td>&lt;0.001</td><td>0.86 (0.79, 0.95)</td><td>0.001</td></tr><tr><td>Multivariate model 3<sup>c</sup></td><td>0.83 (0.75, 0.93)</td><td>&lt;0.001</td><td>0.86 (0.78, 0.94)</td><td>0.002</td></tr><tr><td>miR-144</td><td></td><td></td><td></td><td></td></tr><tr><td>Univariate model</td><td>1.10 (1.06, 1.14)</td><td>&lt;0.001</td><td>1.08 (1.04, 1.12)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 1<sup>a</sup></td><td>1.10 (1.06, 1.14)</td><td>&lt;0.001</td><td>1.12 (1.07, 1.18)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 2<sup>b</sup></td><td>1.09 (1.05, 1.13)</td><td>&lt;0.001</td><td>1.11 (1.05, 1.17)</td><td>&lt;0.001</td></tr><tr><td>Multivariate model 3<sup>c</sup></td><td>1.08 (1.03, 1.13)</td><td>0.004</td><td>1.12 (1.05, 1.18)</td><td>&lt;0.001</td></tr><tr><td>miR-29a</td><td></td><td></td><td></td><td></td></tr><tr><td>Univariate model</td><td>1.09 (1.03, 1.16)</td><td>0.007</td><td>1.09 (1.02, 1.18)</td><td>0.014</td></tr><tr><td>Multivariate model 1<sup>a</sup></td><td>1.09 (1.02, 1.14)</td><td>0.010</td><td>1.09 (1.01, 1.17)</td><td>0.025</td></tr><tr><td>Multivariate model 2<sup>b</sup></td><td>1.08 (1.01, 1.16)</td><td>0.027</td><td>1.09 (1.01, 1.18)</td><td>0.027</td></tr><tr><td>Multivariate model 3<sup>c</sup></td><td>1.10 (1.00, 1.20)</td><td>0.036</td><td>1.10 (1.01, 1.20)</td><td>0.033</td></tr></table>
7a076c023a19df4516573a36539d71fd56437c0f9d8f51295501845cbd2b33e4.png
simple
<table><tr><td>Neurological status</td><td><i>n</i></td><td>Canal compromise (%)</td><td>Loss of vertebral body height (%)</td><td>kyphotic angle (degree)</td></tr><tr><td>A</td><td>11</td><td>52.27 &#177; 9.73</td><td>42.18 &#177; 8.36</td><td>15.27 &#177; 4.00</td></tr><tr><td>B</td><td>16</td><td>50.38 &#177; 8.65</td><td>38.06 &#177; 12.34</td><td>15.75 &#177; 6.87</td></tr><tr><td>C</td><td>16</td><td>52.88 &#177; 7.32</td><td>41.63 &#177; 8.73</td><td>19.69 &#177; 8.11</td></tr><tr><td>D</td><td>10</td><td>48.90 &#177; 6.77</td><td>38.90 &#177; 5.78</td><td>17.70 &#177; 6.83</td></tr><tr><td>Total</td><td>53</td><td>51.25 &#177; 8.09</td><td>40.15 &#177; 9.40</td><td>17.21 &#177; 6.87</td></tr><tr><td> </td><td> </td><td> *<i>P</i> &gt; 0.05</td><td> *<i>P</i> &gt; 0.05</td><td> *<i>P</i> &gt; 0.05</td></tr></table>
cb346131a505ccee1cd462c10df0da476ca19936fb03ea4d27c93c99f13d1f55.png
simple
<table><tr><td></td><td>n</td><td>&#964;<sup>2</sup></td><td>Adjust &#964;<sup>2</sup></td><td>OR</td><td>95% CI</td><td>p-value<sup>$</sup></td><td>Egger's test p-value</td></tr><tr><td>Race</td><td>35</td><td>0.0452</td><td>0.0460</td><td>0.90</td><td>0.72&#8211;1.12</td><td>0.345</td><td>0.011</td></tr><tr><td>Study design</td><td>35</td><td>0.0452</td><td>0.0423</td><td>1.09</td><td>0.90&#8211;1.34</td><td>0.382</td><td>0.039</td></tr><tr><td>Quality score (per 1 score)</td><td>35</td><td>0.0452</td><td>0.0425</td><td>1.08</td><td>0.97&#8211;1.19</td><td>0.152</td><td>0.063</td></tr><tr><td>Kidney function of case</td><td>35</td><td>0.0452</td><td>0.0341</td><td>1.21</td><td>0.95&#8211;1.54</td><td>0.129</td><td>0.108</td></tr><tr><td>Gender (per 100%)</td><td>33</td><td>0.0480</td><td>0.0502</td><td>1.00</td><td>0.70&#8211;1.42</td><td>0.977</td><td>0.087</td></tr><tr><td>Age (per 10 year)</td><td>34</td><td>0.0473</td><td>0.0436</td><td>1.09</td><td>0.98&#8211;1.20</td><td>0.104</td><td>0.093</td></tr><tr><td>BMI (per 5 kg/m<sup>2</sup>)</td><td>11</td><td>0.0393</td><td>0.0488</td><td>0.95</td><td>0.65&#8211;1.38</td><td>0.790</td><td>0.263</td></tr><tr><td>Hypertension (per 100%)</td><td>29</td><td>0.0552</td><td>0.0487</td><td>1.63</td><td>0.80&#8211;3.32</td><td>0.178</td><td>0.064</td></tr><tr><td>DM (per 100%)</td><td>25</td><td>0.0603</td><td>0.0352</td><td>0.69</td><td>0.48&#8211;1.00</td><td>0.051</td><td>0.017</td></tr><tr><td>Smoke (per 100%)</td><td>11</td><td>0.0102</td><td>0.0123</td><td>1.58</td><td>0.34&#8211;7.41</td><td>0.562</td><td>0.355</td></tr></table>
2f872925c2aa1187dc61b32a5aa08b6f4bd173299d12c2559d6b348ab1f4d6b0.png
complex
<table><tr><td rowspan="2">Variables</td><td colspan="2">rs3803304</td><td colspan="2">rs2494732</td></tr><tr><td>CC</td><td>CG+GG</td><td>CC</td><td>CT+TT</td></tr><tr><td colspan="5">Affected breast</td></tr><tr><td>Right</td><td>28 (30.8)</td><td>24 (26.4)</td><td>24 (26.4)</td><td>28 (30.8)</td></tr><tr><td>Left</td><td>26 (28.6)</td><td>13 (14.3)</td><td>17 (18.7)</td><td>22 (24.2)</td></tr><tr><td>OR (95% CI)</td><td colspan="2">0.6 (0.2-1.4)</td><td colspan="2">1.1 (0.5-3.6)</td></tr><tr><td><i>P</i> value</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td></tr><tr><td colspan="5">Tumor stage<sup>a</sup></td></tr><tr><td>T1-T2</td><td>43 (48.9)</td><td>27 (30.7)</td><td>32 (36.4)</td><td>38 (43.2)</td></tr><tr><td>T3-T4</td><td>8 (9.1)</td><td>10 (11.4)</td><td>7 (7.9)</td><td>11 (12.5)</td></tr><tr><td>OR (95% CI)</td><td colspan="2">1.9 (0.7-5.7)</td><td colspan="2">1.3 (0.5-3.8)</td></tr><tr><td><i>P</i> value</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td></tr><tr><td colspan="5">LN status</td></tr><tr><td>+</td><td>29 (31.9)</td><td>18 (19.8)</td><td>22 (24.1)</td><td>25 (27.5)</td></tr><tr><td>-</td><td>25 (27.5)</td><td>19 (20.9)</td><td>19 (20.9)</td><td>25 (27.5)</td></tr><tr><td>OR (95% CI)</td><td colspan="2">1.2 (0.5-2.8)</td><td colspan="2">1.2 (0.5-2.6)</td></tr><tr><td><i>P</i> value</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td></tr><tr><td colspan="5">ER status</td></tr><tr><td>+</td><td>33 (36.3)</td><td>26 (28.6)</td><td>26 (28.6)</td><td>33 (36.3)</td></tr><tr><td>-</td><td>21 (23.1)</td><td>11 (12.1)</td><td>15 (16.5)</td><td>17 (18.7)</td></tr><tr><td>OR (95% CI)</td><td colspan="2">0.7 (0.3-1.6)</td><td colspan="2">0.9 (0.4-2.1)</td></tr><tr><td><i>P</i> value</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td></tr><tr><td colspan="5">PR status</td></tr><tr><td>+</td><td>31 (34.1)</td><td>24 (26.4)</td><td>25 (27.5)</td><td>30 (33.0)</td></tr><tr><td>-</td><td>23 (25.3)</td><td>13 (14.3)</td><td>16 (17.6)</td><td>20 (22.0)</td></tr><tr><td>OR (95% CI)</td><td colspan="2">0.7 (0.3-1.7)</td><td colspan="2">1.0 (0.4-2.4)</td></tr><tr><td><i>P</i> value</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td></tr><tr><td colspan="5">HER2 status</td></tr><tr><td>+</td><td>12 (13.2)</td><td>15 (16.5)</td><td>11 (8.8)</td><td>16 (20.9)</td></tr><tr><td>-</td><td>42 (46.2)</td><td>22 (24.2)</td><td>30 (25.3)</td><td>34 (45.1)</td></tr><tr><td>OR (95% CI)</td><td colspan="2">0.4 (0.2-1.0)</td><td colspan="2">0.8 (0.3-1.9)</td></tr><tr><td><i>P</i> value</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td></tr><tr><td colspan="5">Surgical margins</td></tr><tr><td>+</td><td>33 (36.3)</td><td>28 (30.8)</td><td>25 (27.5)</td><td>36 (39.6)</td></tr><tr><td>-</td><td>21 (23.1)</td><td>9 (9.9)</td><td>16 (17.6)</td><td>14 (15.4)</td></tr><tr><td>OR (95% CI)</td><td colspan="2">0.5 (0.1-1.3)</td><td colspan="2">0.6 (0.3-1.5)</td></tr><tr><td><i>P</i> value</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td><td colspan="2"><i>P</i> &gt; 0.05, <i>Q</i> &gt; 0.05</td></tr></table>
52fd274495b8ccab6e81e21e2ce763604c858751bcb3bd27a71293020f52745e.png
complex
<table><tr><td>Group</td><td></td><td></td><td colspan="2">Very low</td><td colspan="2">Low</td><td colspan="2">Moderate</td><td colspan="2">High</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>All youth</td><td>8.26</td><td>3.84</td><td>304</td><td>13.8</td><td>961</td><td>43.7</td><td>574</td><td>26.1</td><td>361</td><td>16.4</td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Female</td><td>8.20</td><td>3.64</td><td>134</td><td>12.4</td><td>485</td><td>45.0</td><td>290</td><td>26.9</td><td>168</td><td>15.6</td></tr><tr><td> Male</td><td>8.32</td><td>4.04</td><td>170</td><td>15.1</td><td>476</td><td>42.4</td><td>284</td><td>25.3</td><td>193</td><td>17.2</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt;14</td><td>7.04</td><td>3.07</td><td>146</td><td>21.8</td><td>400</td><td>51.5</td><td>183</td><td>23.6</td><td>48</td><td>5.9</td></tr><tr><td> 14&#8211;15</td><td>8.66</td><td>3.78</td><td>84</td><td>14.5</td><td>278</td><td>39.9</td><td>197</td><td>28.3</td><td>138</td><td>19.2</td></tr><tr><td> 16&gt;</td><td>9.17</td><td>4.31</td><td>74</td><td>12.0</td><td>283</td><td>40.0</td><td>194</td><td>26.7</td><td>175</td><td>23.7</td></tr></table>
2189682245f8c4ec2815747a2ca9c86c51834b09961db3041da3cfa604c48d62.png
simple
<table><tr><td>Regions</td><td>L/R</td><td>MNI (X, Y, Z)</td><td>Voxels (mm<sup>3</sup>)</td><td>t-Score</td></tr><tr><td>Thalamus</td><td>R</td><td>14, -30, 10</td><td>28</td><td>2.9962</td></tr><tr><td>Thalamus</td><td>L</td><td>-12, -28, 9</td><td>35</td><td>3.6621</td></tr><tr><td>Posterior cingulate</td><td>R</td><td>-13, -50, 16</td><td>31</td><td>3.5521</td></tr><tr><td>Posterior cingulate</td><td>L</td><td>12, -45, 18</td><td>28</td><td>2.7536</td></tr><tr><td>Angular gyrus</td><td>L</td><td>-56, -47, 39</td><td>35</td><td>3.8926</td></tr><tr><td>Inferior parietal lobule</td><td>L</td><td>-50, -27, 25</td><td>28</td><td>3.6249</td></tr></table>
30f2b9860a4566bc6fa6a60f3bca4d03e22215081c366314574b2c14163ebbd7.png
complex
<table><tr><td colspan="6">GO:BP terms enriched in orthologs differentially expressed exclusively in C. elegans</td></tr><tr><td>GO.ID</td><td>Term</td><td>Annotated</td><td>Significant</td><td>Expected</td><td>p-Value</td></tr><tr><td>GO:0018996</td><td>molting cycle; collagen and cuticulin-based cuticle.</td><td>157</td><td>17</td><td>4.19</td><td>5.70E-07</td></tr><tr><td>GO:0040011</td><td>locomotion</td><td>789</td><td>34</td><td>21.07</td><td>0.0019</td></tr><tr><td>GO:0040018</td><td>positive regulation of multicellular organism growth</td><td>167</td><td>11</td><td>4.46</td><td>0.0046</td></tr><tr><td>GO:0006560</td><td>proline metabolic process</td><td>5</td><td>2</td><td>0.13</td><td>0.0067</td></tr><tr><td>GO:0010171</td><td>body morphogenesis</td><td>322</td><td>16</td><td>8.6</td><td>0.0106</td></tr><tr><td>GO:0009084</td><td>glutamine family amino acid biosynthesis</td><td>8</td><td>2</td><td>0.21</td><td>0.0178</td></tr><tr><td>GO:0006694</td><td>steroid biosynthetic process</td><td>10</td><td>2</td><td>0.27</td><td>0.0277</td></tr><tr><td>GO:0055114</td><td>oxidation-reduction process</td><td>219</td><td>11</td><td>5.85</td><td>0.0306</td></tr><tr><td>GO:0006508</td><td>proteolysis</td><td>197</td><td>10</td><td>5.26</td><td>0.0362</td></tr><tr><td>GO:0018991</td><td>oviposition</td><td>145</td><td>8</td><td>3.87</td><td>0.0387</td></tr><tr><td colspan="6">GO:MF terms enriched in orthologs differentially expressed exclusively in C. elegans</td></tr><tr><td>GO.ID</td><td>Term</td><td>Annotated</td><td>Significant</td><td>Expected</td><td>p-Value</td></tr><tr><td>GO:0042302</td><td>structural constituent of cuticle</td><td>21</td><td>10</td><td>0.53</td><td>1.60E-11</td></tr><tr><td>GO:0004222</td><td>metalloendopeptidase activity</td><td>50</td><td>6</td><td>1.25</td><td>0.0014</td></tr><tr><td>GO:0016776</td><td>phosphotransferase activity; phosphate group as acceptor</td><td>5</td><td>2</td><td>0.13</td><td>0.0059</td></tr><tr><td>GO:0016903</td><td>oxidoreductase activity; acting on the aldehyde or oxo group of donors</td><td>8</td><td>2</td><td>0.2</td><td>0.0157</td></tr><tr><td>GO:0003854</td><td>3-beta-hydroxy-delta5-steroid dehydrogenase activity</td><td>8</td><td>2</td><td>0.2</td><td>0.0157</td></tr><tr><td>GO:0019205</td><td>nucleobase; nucleoside; nucleotide kinase activity</td><td>8</td><td>2</td><td>0.2</td><td>0.0157</td></tr><tr><td>GO:0020037</td><td>heme binding</td><td>51</td><td>4</td><td>1.28</td><td>0.0374</td></tr><tr><td>GO:0004601</td><td>peroxidase activity</td><td>14</td><td>2</td><td>0.35</td><td>0.0464</td></tr></table>
f6a078efa133f295f172b1cb58be555df7394b0da5b0fcb4864f28c670b8645c.png
complex
<table><tr><td></td><td colspan="2">Discharge status</td><td></td><td colspan="2">Discharge status</td><td></td></tr><tr><td></td><td>Early</td><td>Standard</td><td>aIRR (95% CI)</td><td>Early</td><td>Standard</td><td>aIRR (95% CI)</td></tr><tr><td></td><td colspan="3">Induction I</td><td colspan="3">Induction II</td></tr><tr><td>Antibiotics</td><td>1698.0</td><td>1404.4</td><td>1.30 (1.13, 1.50)*</td><td>1620.5</td><td>996.5</td><td>1.60 (1.46, 1.76)*</td></tr><tr><td>Antifungals</td><td>848.5</td><td>889.5</td><td>0.91 (0.74, 1.12)</td><td>814.8</td><td>857.4</td><td>0.97 (0.89, 1.07)</td></tr><tr><td>Antivirals</td><td>70.7</td><td>145.6</td><td>0.59 (0.21, 1.62)</td><td>114.8</td><td>151.2</td><td>0.67 (0.39, 1.13)</td></tr><tr><td>Vasopressors</td><td>27.6</td><td>5.2</td><td>8.07 (3.50, 18.6)*</td><td>32.7</td><td>6.8</td><td>4.54 (2.08, 9.89)*</td></tr><tr><td>Blood Products</td><td>298.8</td><td>246.5</td><td>1.29 (1.09, 1.54)*</td><td>238.7</td><td>221.5</td><td>1.06 (0.94, 1.19)</td></tr><tr><td> Platelets</td><td>206.1</td><td>179.5</td><td>1.32 (1.05, 1.66)*</td><td>150.2</td><td>144.5</td><td>1.03 (0.88, 1.21)</td></tr><tr><td> Packed RBC</td><td>135.2</td><td>105.7</td><td>1.30 (1.06, 1.59)*</td><td>144.9</td><td>106.8</td><td>1.20 (1.06, 1.36)*</td></tr><tr><td> FFP</td><td>6.8</td><td>4.9</td><td>1.41 (0.44, 4.56)</td><td>12.4</td><td>3.3</td><td>3.03 (1.23, 7.48)*</td></tr><tr><td>Parenteral Nutrition</td><td>111.4</td><td>169.8</td><td>1.00 (0.50, 2.01)</td><td>86.2</td><td>84.8</td><td>1.28 (0.76, 2.14)</td></tr><tr><td>Oxygen therapy</td><td>40.9</td><td>13.3</td><td>5.14 (1.96, 13.5)*</td><td>32.2</td><td>8.7</td><td>3.63 (1.79, 7.36)*</td></tr><tr><td></td><td colspan="3">Intensification I</td><td colspan="3">Intensification II</td></tr><tr><td>Antibiotics</td><td>1589.9</td><td>1030.4</td><td>1.52 (1.39, 1.67)*</td><td>1862.1</td><td>1357.5</td><td>1.36 (1.25, 1.49)*</td></tr><tr><td>Antifungals</td><td>775.3</td><td>853.1</td><td>0.93 (0.84, 1.03)</td><td>882.9</td><td>915.9</td><td>0.96 (0.87, 1.07)</td></tr><tr><td>Antivirals</td><td>116.2</td><td>170.1</td><td>0.70 (0.41, 1.19)</td><td>109.0</td><td>165.4</td><td>0.62 (0.32, 1.21)</td></tr><tr><td>Vasopressors</td><td>40.6</td><td>9.2</td><td>5.67 (2.63, 12.2)*</td><td>45.7</td><td>14.0</td><td>3.56 (1.65, 7.66)*</td></tr><tr><td>Blood products</td><td>259.3</td><td>228.7</td><td>1.17 (0.99, 1.38)</td><td>383.1</td><td>319.6</td><td>1.25 (1.12, 1.40)*</td></tr><tr><td> Platelets</td><td>168.3</td><td>154.5</td><td>1.21 (0.96, 1.52)</td><td>287.0</td><td>244.2</td><td>1.26 (1.09, 1.46)*</td></tr><tr><td> Packed RBC</td><td>151.4</td><td>109.6</td><td>1.42 (1.18, 1.72)*</td><td>171.5</td><td>133.8</td><td>1.32 (1.11, 1.56)*</td></tr><tr><td> FFP</td><td>5.6</td><td>2.2</td><td>4.31 (1.61, 11.5)*</td><td>8.6</td><td>5.5</td><td>1.72 (0.56, 5.25)*</td></tr><tr><td>Parenteral Nutrition</td><td>73.7</td><td>99.4</td><td>1.22 (0.75, 1.98)</td><td>109.0</td><td>88.3</td><td>1.23 (0.82, 1.85)</td></tr><tr><td>Oxygen Therapy</td><td>40.0</td><td>18.3</td><td>2.22 (1.10, 4.51)*</td><td>46.3</td><td>16.2</td><td>2.85 (1.39, 5.83)*</td></tr></table>
54b08c7e5d603b39b09f51a47509eaee3492cc4aa5510a3404253687eaef0ed7.png
complex
<table><tr><td></td><td colspan="3">OS Univariate analysis</td><td colspan="3">OS Multivariate analysis</td></tr><tr><td>Characteristics</td><td>95.0% CIs</td><td>HR</td><td><i>P</i> value</td><td>95.0% CIs</td><td>HR</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt;55</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>&#8805;55</td><td>0.99 to 2.69</td><td>1.63</td><td>0.056 <sup>a</sup></td><td>0.97 to 2.90</td><td>1.68</td><td>0.063 <sup>b</sup></td></tr><tr><td>Gender</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Female</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>Male</td><td>0.86 to 2.62</td><td>1.50</td><td>0.152 <sup>a</sup></td><td>0.64 to 2.72</td><td>1.32</td><td>0.461 <sup>b</sup></td></tr><tr><td>Smoking history</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Never smoking</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>Current or ever Smoking</td><td>0.85 to 2.28</td><td>1.39</td><td>0.194 <sup>a</sup></td><td>0.62 to 2.29</td><td>1.19</td><td>0.599 <sup>b</sup></td></tr><tr><td>Differentiation</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Well</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>Moderate</td><td>0.52 to 9.04</td><td>2.17</td><td>0.289 <sup>a</sup></td><td>0.34 to 6.66</td><td>1.50</td><td>0.598 <sup>b</sup></td></tr><tr><td>Poor</td><td>0.89 to 16.17</td><td>3.80</td><td>0.071 <sup>a</sup></td><td>0.54 to 11.32</td><td>2.46</td><td>0.247 <sup>b</sup></td></tr><tr><td>pTNM stage, continuous</td><td>1.01 to 1.32</td><td>1.15</td><td>0.038 <sup>a</sup></td><td>1.06 to 1.41</td><td>1.22</td><td>0.005 <sup>b</sup></td></tr><tr><td>pT status</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T1</td><td></td><td>1.0 (ref.)</td><td></td><td>-</td><td>-</td><td>-</td></tr><tr><td>T2</td><td>0.56 to 2.39</td><td>1.16</td><td>0.691 <sup>a</sup></td><td>-</td><td>-</td><td>-</td></tr><tr><td>T3+ T4</td><td>0.83 to 4.43</td><td>1.92</td><td>0.129 <sup>a</sup></td><td>-</td><td>-</td><td>-</td></tr><tr><td>pN status</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>N0+ N1</td><td></td><td>1.0 (ref.)</td><td></td><td>-</td><td>-</td><td>-</td></tr><tr><td>N2+ N3</td><td>0.60 to 1.63</td><td>0.99</td><td>0.980 <sup>a</sup></td><td>-</td><td>-</td><td>-</td></tr><tr><td>pM status</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>M0</td><td></td><td>1.0 (ref.)</td><td></td><td>-</td><td>-</td><td>-</td></tr><tr><td>M1</td><td>0.83 to 2.68</td><td>1.49</td><td>0.184 <sup>a</sup></td><td>-</td><td>-</td><td>-</td></tr><tr><td>Adjuvant chemotherapy</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>No</td><td>0.89 to 2.52</td><td>1.50</td><td>0.129 <sup>a</sup></td><td>1.08 to 3.48</td><td>1.94</td><td>0.027 <sup>b</sup></td></tr><tr><td>EGFR mutation status</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Positive</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>Negative</td><td>0.39 to 1.57</td><td>0.79</td><td>0.494 <sup>a</sup></td><td>0.33 to 1.64</td><td>0.73</td><td>0.452 <sup>b</sup></td></tr><tr><td>Not performed</td><td>0.63 to 2.00</td><td>1.12</td><td>0.695 <sup>a</sup></td><td>0.37 to 1.42</td><td>0.73</td><td>0.350 <sup>b</sup></td></tr><tr><td>Anti-EGFR drug treatment</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>No</td><td>0.44 to 1.20</td><td>0.73</td><td>0.214 <sup>a</sup></td><td>0.46 to 1.41</td><td>0.81</td><td>0.450 <sup>b</sup></td></tr><tr><td>Serum CEA</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Normal (&#8804;5 ng/ml)</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>Elevated (&gt;5ng/ml)</td><td>0.84 to 2.27</td><td>1.38</td><td>0.204 <sup>a</sup></td><td>0.63 to 1.88</td><td>1.09</td><td>0.771 <sup>b</sup></td></tr><tr><td>Plakoglobin expression</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>IRS 0-3</td><td></td><td>1.0 (ref.)</td><td></td><td></td><td>1.0 (ref.)</td><td></td></tr><tr><td>IRS 4-12</td><td>1.01 to 2.86</td><td>1.70</td><td>0.046 <sup>a</sup></td><td>1.12 to 3.37</td><td>1.94</td><td>0.019 <sup>b</sup></td></tr></table>
247c3f8c72cdd0b685c411eb392ffa01a6ede6604edf477233d558d0353a4273.png
complex
<table><tr><td>Parameter</td><td>Treatment</td><td>Baseline</td><td colspan="2">Pulmonary hypertension</td></tr><tr><td></td><td></td><td></td><td>Pre-inhalation</td><td>5 minutes after inhalation</td></tr><tr><td>Mw (mWatt&#183;s/ml)</td><td>Iloprost</td><td>8.29 &#177; 1.66</td><td>10.67 &#177; 2.45*</td><td>8.08 &#177; 2.22</td></tr><tr><td></td><td>Control</td><td>7.54 &#177; 1.06</td><td>9.01 &#177; 1.27*</td><td>9.24 &#177; 2.69</td></tr><tr><td>Emax (mmHg/ml)</td><td>Iloprost</td><td>1.10 &#177; 0.46</td><td>1.51 &#177; 0.74</td><td>1.20 &#177; 0.66</td></tr><tr><td></td><td>Control</td><td>1.13 &#177; 0.62</td><td>1.29 &#177; 0.75</td><td>1.64 &#177; 0.95</td></tr><tr><td>LVEF (%)</td><td>Iloprost</td><td>61 &#177; 5</td><td>63 &#177; 12</td><td>59 &#177; 13</td></tr><tr><td></td><td>Control</td><td>57 &#177; 9</td><td>53 &#177; 7</td><td>50 &#177; 5</td></tr><tr><td>&#964;/RR (ms)</td><td>Iloprost</td><td>0.06 &#177; 0.02</td><td>0.08 &#177; 0.02</td><td>0.07 &#177; 0.01</td></tr><tr><td></td><td>Control</td><td>0.07 &#177; 0.01</td><td>0.07 &#177; 0.01</td><td>0.08 &#177; 0.02</td></tr><tr><td>&#946; (ml<sup>-1</sup>)</td><td>Iloprost</td><td>0.11 &#177; 0.03</td><td>0.11 &#177; 0.06</td><td>0.04 &#177; 0.03*</td></tr><tr><td></td><td>Control</td><td>0.11 &#177; 0.04</td><td>0.13 &#177; 0.09</td><td>0.09 &#177; 0.05</td></tr><tr><td>C (ml/mmHg)</td><td>Iloprost</td><td>0.72 &#177; 0.23</td><td>0.60 &#177; 0.20</td><td>0.64 &#177; 0.27</td></tr><tr><td></td><td>Control</td><td>0.88 &#177; 0.27</td><td>0.71 &#177; 0.25*</td><td>0.66 &#177; 0.21*</td></tr><tr><td>Ea (mmHg/ml)</td><td>Iloprost</td><td>1.87 &#177; 0.51</td><td>1.68 &#177; 0.44</td><td>1.67 &#177; 0.50</td></tr><tr><td></td><td>Control</td><td>1.80 &#177; 0.46</td><td>1.93 &#177; 0.55</td><td>1.95 &#177; 0.56</td></tr><tr><td>Emax/Ea</td><td>Iloprost</td><td>0.60 &#177; 0.24</td><td>0.92 &#177; 0.50</td><td>0.69 &#177; 0.30</td></tr><tr><td></td><td>Control</td><td>0.62 &#177; 0.24</td><td>0.67 &#177; 0.31</td><td>0.86 &#177; 0.48</td></tr></table>
22e5f49dc08c2cd0e0cc7d2df4483e547d99a34f2fc0ee9c570d8387fe0c67d0.png
complex
<table><tr><td rowspan="2">Characteristics</td><td colspan="6">Patients</td></tr><tr><td>8010</td><td>8011</td><td>8013</td><td>8030</td><td>8031</td><td>8032</td></tr><tr><td>Age (years)</td><td>50</td><td>47</td><td>59</td><td>69</td><td>56</td><td>49</td></tr><tr><td>Lymphocytosis(&#215;10<sup>9</sup>/L)</td><td>6,4</td><td>2,5</td><td>3,9</td><td>2,8</td><td>4,4</td><td>2,4</td></tr><tr><td>Lymphocytosis(% total leukocytosis)</td><td>58,4</td><td>32,1</td><td>36,5</td><td>42,5</td><td>56,6</td><td>48,7</td></tr><tr><td>B cells/<i>&#956;</i>L</td><td>5250</td><td>1550</td><td>910</td><td>1200</td><td>2240</td><td>760</td></tr><tr><td>Serum IgM(g/L)</td><td>12,1</td><td>7,8</td><td>3,8</td><td>9,6</td><td>9,5</td><td>7,3</td></tr><tr><td>Number of <i>BCL-2/Ig</i> rearrangements<sup>a</sup></td><td>3 </td><td>5 </td><td>3 </td><td>7 </td><td>5 </td><td>5 </td></tr><tr><td>HLA</td><td>A 2, 9 B 14, 44Dr 2, 5</td><td>A 9, 30 B 13, 14Dr 5, 13</td><td>A 9, 39 B 14, 35Dr 5, 13</td><td>A 1, 3 B 7, 57Dr 7, 14</td><td>ND</td><td>A 11, 29 B 35, 44Dr 7, 14</td></tr><tr><td>Cigarette smoking<sup>b</sup></td><td>Yes </td><td>Stopped &#215; 7 years</td><td>Yes </td><td>Stopped &#215; 3 years</td><td>Yes </td><td>Stopped &#215; 5 years</td></tr></table>
215d4cc468699a799e1506c792ae8ab3cf60abb9a623d71038a5466a3a500ba8.png
complex
<table><tr><td></td><td colspan="2">Men</td><td colspan="2">Women</td></tr><tr><td></td><td>TG</td><td>TC:HDL cholesterol</td><td>TG</td><td>TC:HDL cholesterol</td></tr><tr><td>WC<sup>a</sup></td><td>r = 0.14<i>P </i>= 0.007</td><td>r = 0.20<i>P </i>&lt; 0.001</td><td>r = 0.12<i>P </i>= 0.0008</td><td>r = 0.09<i>P </i>= 0.01</td></tr><tr><td>BMI<sup>b</sup></td><td>r = -0.024<i>P </i>= 0.66</td><td>r = 0.0004<i>P </i>= 0.99</td><td>r = 0.01<i>P </i>= 0.78</td><td>r = 0.07<i>P </i>= 0.04</td></tr></table>
f8b6769e34e3b81a6508e9ef60a6bf5f55339473d3ebd66b58e4e05de1e303ea.png
complex
<table><tr><td></td><td colspan="2">Univariate analysis</td></tr><tr><td>Factor</td><td>Hazard Ratio</td><td>p value</td></tr><tr><td>Chloroquine treatment</td><td>3.28 (1.41-7.63)</td><td>0.006</td></tr><tr><td>Female</td><td>0.93 (0.46-1.91)</td><td>0.85</td></tr><tr><td>Age (years)</td><td>0.96 (0.92-1.00)</td><td>0.03</td></tr><tr><td>Recruitment site(Jalalabad as reference)</td><td></td><td></td></tr><tr><td>Taloqan</td><td>0.79 (0.26-2.43)</td><td>0.68</td></tr><tr><td>Maimana</td><td>3.06 (1.42-6.61)</td><td>0.004</td></tr><tr><td>Parasitaemia</td><td>0.86 (0.32-2.29)</td><td>0.76</td></tr><tr><td>Presence of gametocytes</td><td>1.13 (0.46-2.77)</td><td>0.784</td></tr><tr><td>Haemoglobin at admission (g/dl)</td><td>0.49 (0.37-0.65)</td><td>&lt;0.001</td></tr></table>
81422acb3510777246e62b20cfeeaf5d0042425a55b4ba633d188b1d8fe0dafd.png
complex
<table><tr><td rowspan="2">Adverse event, n (%)</td><td colspan="3">DA-naive</td><td colspan="3">DA-exposed</td></tr><tr><td>Placebo (n = 195)</td><td>GEn 600 mg (n = 133)</td><td>GEn 1200 mg (n = 217)</td><td>Placebo (n = 50)</td><td>GEn 600 mg (n = 30)</td><td>GEn 1200 mg (n = 52)</td></tr><tr><td>Any event</td><td>149 (76)</td><td>105 (79)</td><td>187 (86)</td><td>34 (68)</td><td>27 (90)</td><td>40 (77)</td></tr><tr><td>Somnolence</td><td>12 (6)</td><td>25 (19)</td><td>54 (25)</td><td>0</td><td>7 (23)</td><td>7 (14)</td></tr><tr><td>Dizziness</td><td>9 (5)</td><td>20 (15)</td><td>44 (20)</td><td>2 (4)</td><td>2 (7)</td><td>15 (29)</td></tr><tr><td>Headache</td><td>22 (11)</td><td>12 (9)</td><td>36 (17)</td><td>5 (10)</td><td>7 (23)</td><td>4 (8)</td></tr><tr><td>Nasopharyngitis</td><td>10 (5)</td><td>13 (10)</td><td>17 (8)</td><td>6 (12)</td><td>1 (3)</td><td>4 (8)</td></tr><tr><td>Nausea</td><td>8 (4)</td><td>5 (4)</td><td>15 (7)</td><td>4 (8)</td><td>4 (13)</td><td>4 (8)</td></tr><tr><td>Fatigue</td><td>10 (5)</td><td>5 (4)</td><td>15 (7)</td><td>1 (2)</td><td>3 (10)</td><td>3 (6)</td></tr><tr><td>Diarrhea</td><td>10 (5)</td><td>3 (2)</td><td>7 (3)</td><td>2 (4)</td><td>3 (10)</td><td>3 (6)</td></tr><tr><td>Upper respiratory tract infection</td><td>7 (4)</td><td>6 (5)</td><td>5 (2)</td><td>2 (4)</td><td>3 (10)</td><td>1 (2)</td></tr><tr><td>Dry mouth</td><td>4 (2)</td><td>4 (3)</td><td>11 (5)</td><td>1 (2)</td><td>1 (3)</td><td>1 (2)</td></tr><tr><td>Constipation</td><td>6 (3)</td><td>0</td><td>7 (3)</td><td>2 (4)</td><td>3 (10)</td><td>3 (6)</td></tr><tr><td>Insomnia</td><td>6 (3)</td><td>7 (5)</td><td>4 (2)</td><td>1 (2)</td><td>1 (3)</td><td>2 (4)</td></tr><tr><td>Irritability</td><td>3 (2)</td><td>2 (2)</td><td>8 (4)</td><td>0</td><td>4 (13)</td><td>3 (6)</td></tr><tr><td>Back pain</td><td>6 (3)</td><td>4 (3)</td><td>6 (3)</td><td>1 (2)</td><td>2 (7)</td><td>1 (2)</td></tr><tr><td>Sinusitis</td><td>5 (3)</td><td>2 (2)</td><td>6 (3)</td><td>1 (2)</td><td>3 (10)</td><td>1 (2)</td></tr><tr><td>Increased weight</td><td>3 (2)</td><td>2 (2)</td><td>7 (3)</td><td>2 (4)</td><td>2 (7)</td><td>2 (4)</td></tr></table>
3dd74d17b4d07bf839396e3932b2a4b3c77a0f43d9952dfc5a93e531727dc6e3.png
simple
<table><tr><td></td><td>All patients (n = 92)</td><td>No postoperative delirium (n = 48)</td><td>Postoperative delirium (n = 44)</td><td><i>P</i></td></tr><tr><td>Male, n (%)</td><td>66 (60.6)</td><td>35 (72.9)</td><td>31 (70.4)</td><td>0.082</td></tr><tr><td>Body mass index (BMI)</td><td>27.1 &#177; 3.9</td><td>27.1 &#177; 3.3</td><td>27.2 &#177; 4.5</td><td>0.91</td></tr><tr><td>Mean age, (years)</td><td>67.5 &#177; 8.9</td><td>64.5 &#177; 9</td><td>70.8 &#177; 7.8</td><td>0.001</td></tr><tr><td>Alcohol abuse, n (%)</td><td>10 (10.9)</td><td>3 (6.2)</td><td>7 (15.9)</td><td>0.14</td></tr><tr><td>Smoking, n (%)</td><td>23 (25)</td><td>7 (14.6)</td><td>16 (36.3)</td><td>0.016</td></tr><tr><td>Diabetes, n (%)</td><td>21 (22.8)</td><td>10 (20.8)</td><td>11 (25)</td><td>0.63</td></tr><tr><td>Arterial hypertension, n (%)</td><td>89 (96.7)</td><td>46 (95.8)</td><td>43 (97.7)</td><td>0.34</td></tr><tr><td>Chronic obstructive lung disease, n (%)</td><td>20 (21.7)</td><td>7 (14.6)</td><td>13 (29.5)</td><td>0.09</td></tr><tr><td>Renal insufficiency, n (%)</td><td>13 (14.1)</td><td>5 (10.4)</td><td>8 (18.2)</td><td>0.25</td></tr><tr><td>Impaired left ventricular function, EF n (%): normal (&#8805;55%)</td><td>58 (63)</td><td>30 (62.5)</td><td>28 (65.1)</td><td>0.7</td></tr><tr><td>Mild (45-54%)</td><td>16 (17.4)</td><td>10 (20.8)</td><td>5 (11.6)</td><td></td></tr><tr><td>Moderate (36-44%)</td><td>8 (8.7)</td><td>3 (6.3)</td><td>4 (9.3)</td><td></td></tr><tr><td>Severe (&#8804;35%)</td><td>11 (12.5)</td><td>5 (10.4)</td><td>6 (14)</td><td></td></tr><tr><td>History of stroke, n (%)</td><td>7 (7.6)</td><td>3 (6.3)</td><td>4 (9.1)</td><td>0.48</td></tr><tr><td>Atrial fibrillation preoperative, n (%)</td><td>13 (14.1)</td><td>6 (12.5)</td><td>7 (16.7)</td><td>0.22</td></tr><tr><td>Long-term glucocorticoid medication, n (%)</td><td>5 (5.4)</td><td>0 (0.0)</td><td>5 (11.4)</td><td>0.056</td></tr><tr><td>Albumin g/l</td><td>43.5 &#177; 3.4</td><td>44.4 &#177; 3.1</td><td>42.3 &#177; 3.4</td><td>0.003</td></tr><tr><td>Hemoglobin g/dl</td><td>13.2 &#177; 1.6</td><td>13.7 &#177; 1.5</td><td>12.7 &#177; 1.6</td><td>0.005</td></tr><tr><td>Urea mg/dl</td><td>37.9 &#177; 19.0</td><td>36.1 &#177; 13.9</td><td>40.2 &#177; 23.5</td><td>0.33</td></tr><tr><td>Mean number of transfused packs of RBC</td><td>3.0 &#177; 2.3</td><td>2.2 &#177; 1.8</td><td>3.8 &#177; 2.6</td><td>0.001</td></tr><tr><td>Type of heart surgery (CABG/open heart surgery &#177; CABG)</td><td>47/45</td><td>26/22</td><td>21/23</td><td>0.54</td></tr><tr><td>Mean extracorporeal circulation time (min.)</td><td>112 &#177; 41.5</td><td>108 &#177; 41.4</td><td>115 &#177; 42</td><td>0.37</td></tr><tr><td>Postoperative intubation time (hrs) median (IQR [range])</td><td>13 (10-18 [4-91])</td><td>11 (9-14 [5&#8211;29])</td><td>18 (14-23[4-91])</td><td>&lt;0.001</td></tr><tr><td>Time (days) spent in intensive and intermediate care unit, median (IQR [range])</td><td>5 (3-6 [2&#8211;17])</td><td>4 (3-5 [2&#8211;15])</td><td>6 (5-8 [2&#8211;17])</td><td>&lt;0.001</td></tr><tr><td>Time (hrs) spent in intensive care unit, median (IQR [range])</td><td>23 (20-47 [11-289])</td><td>21 (19-24 [12-77])</td><td>46 (23-78[11-289])</td><td>&lt;0.001</td></tr><tr><td>Benzodiazepine intake during the night of the sleep study (yes/no)</td><td>22 (25.6)</td><td>12 (27.9)</td><td>10 (25.6)</td><td>0.82</td></tr></table>
6971cc0d72589da7f85bd2947799986fc7618ee84b43ff503074bc5ee8b48abc.png
complex
<table><tr><td rowspan="2">MBL</td><td colspan="4">IC<sub>50</sub> (&#956;M)</td></tr><tr><td>CBS</td><td>Bi(NAC)<sub>3</sub></td><td>Bi(NIT)<sub>3</sub></td><td>Bi(PCM)<sub>2</sub></td></tr><tr><td>NDM-1</td><td>2.81 &#177; 0.34</td><td>1.65 &#177; 0.60</td><td>0.70 &#177; 0.13</td><td>2.80 &#177; 0.11</td></tr><tr><td>VIM-2</td><td>3.55 &#177; 0.78</td><td>2.65 &#177; 0.57</td><td>1.20 &#177; 0.13</td><td>3.71 &#177; 1.19</td></tr><tr><td>IMP-4</td><td>0.70 &#177; 0.08</td><td>2.80 &#177; 0.79</td><td>0.99 &#177; 0.19</td><td>1.00 &#177; 0.37</td></tr></table>
c6da246a810a930d65ba5134892dd9573c85ef7bf0237502c01639d3e1d06005.png
simple
<table><tr><td>Case #</td><td>TI #1 (min)</td><td>TI #2 (min)</td><td>TI#3 (min)</td><td>TI#4 (min)</td><td>TI#5 (min)</td></tr><tr><td>1</td><td>5</td><td>3</td><td>2</td><td>41</td><td>51</td></tr><tr><td>2</td><td>5</td><td>3</td><td>2</td><td>41</td><td>51</td></tr><tr><td>3</td><td>3</td><td>2</td><td>2</td><td>42</td><td>49</td></tr><tr><td>4</td><td>1</td><td>2</td><td>7</td><td>44</td><td>54</td></tr><tr><td>5</td><td>1</td><td>1</td><td>3</td><td>41</td><td>46</td></tr><tr><td>6</td><td>1</td><td>3</td><td>3</td><td>41</td><td>48</td></tr><tr><td>7</td><td>2</td><td>2</td><td>2</td><td>40</td><td>46</td></tr><tr><td>8</td><td>2</td><td>2</td><td>3</td><td>39</td><td>46</td></tr><tr><td>9</td><td>2</td><td>3</td><td>3</td><td>52</td><td>60</td></tr><tr><td>10</td><td>1</td><td>2</td><td>2</td><td>44</td><td>49</td></tr></table>
f513a407cf590ebc179c6448ebdd442c2bfb0163c8be85e8af125b37695cc648.png
simple
<table><tr><td>Classifier</td><td>SRCCA<i><sub>TT</sub></i></td><td>SRCCA<i><sub>WRST</sub></i></td><td>SRCCA<i><sub>WLT</sub></i></td></tr><tr><td>PCA</td><td>1.7 &#215; 10<sup>-13</sup></td><td>4.7 &#215; 10<sup>-12</sup></td><td>1.4 &#215; 10<sup>-10</sup></td></tr><tr><td>PLS</td><td>1.3 &#215; 10<sup>-5</sup></td><td>8.5 &#215; 10<sup>-3</sup></td><td>1.6 &#215; 10<sup>-4</sup></td></tr><tr><td>CCA</td><td>6.8 &#215; 10<sup>-7</sup></td><td>5.4 &#215; 10<sup>-6</sup></td><td>2.1 &#215; 10<sup>-7</sup></td></tr><tr><td>RCCA</td><td>3.4 &#215; 10<sup>-9</sup></td><td>1.8 &#215; 10<sup>-9</sup></td><td>3.6 &#215; 10<sup>-16</sup></td></tr></table>
50efab6a3a2a1b2218b7e708d66d8014e4d88527187d6863160de5113837bf6f.png
simple
<table><tr><td></td><td>Studies, n</td><td>SRR (95% CI)</td><td>I<sup>2</sup>(%)</td><td>P<sub>heterogeneity</sub></td><td>P<sub>difference</sub></td></tr><tr><td>All</td><td>14</td><td>2.06 (1.50&#8211;2.85)</td><td>96.7</td><td>&lt;0.001</td><td></td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td>0.399</td></tr><tr><td>Male</td><td>6</td><td>2.04(1.11 &#8211;3.74</td><td>98.3</td><td>&lt;0.001</td><td></td></tr><tr><td>Female</td><td>3</td><td>2.67(1.27 &#8211;5.59)</td><td>93.3</td><td>&lt;0.001</td><td></td></tr><tr><td>Locations</td><td></td><td></td><td></td><td></td><td>0.029</td></tr><tr><td>Europe</td><td>4</td><td>2.40(1.81&#8211; 3.18)</td><td>49.3</td><td>0.116</td><td></td></tr><tr><td>USA</td><td>8</td><td>1.65(1.32&#8211; 2.05)</td><td>84.0</td><td>&lt;0.001</td><td></td></tr><tr><td>Asia</td><td>2</td><td>2.99(1.18&#8211; 7.60)</td><td>98.7</td><td>&lt;0.001</td><td></td></tr><tr><td>Smoking status</td><td></td><td></td><td></td><td></td><td>0.289</td></tr><tr><td>Never</td><td>3</td><td>2.32 (1.42&#8211;3.77)</td><td>0</td><td>0.833</td><td></td></tr><tr><td>Ever</td><td>3</td><td>1.60 (1.28-2.01)</td><td>76.0</td><td>&lt;0.001</td><td></td></tr><tr><td>Diagnosis of COPD</td><td></td><td></td><td></td><td></td><td>0.201</td></tr><tr><td>Physiological diagnosis</td><td>6</td><td>2.02(1.69 &#8211;2.41)</td><td>0</td><td>0.931</td><td></td></tr><tr><td>Disease registry</td><td>3</td><td>2.75(0.87 &#8211;8.73)</td><td>99.4</td><td>&lt;0.001</td><td></td></tr><tr><td>Self-report</td><td>5</td><td>1.75(1.40 &#8211;2.19)</td><td>80.2</td><td>&lt;0.001</td><td></td></tr><tr><td>COPD severity</td><td></td><td></td><td></td><td></td><td>0.016</td></tr><tr><td>Mild</td><td>4</td><td>1.46 (1.20&#8211;1.76)</td><td>0</td><td>0.876</td><td></td></tr><tr><td>Moderate</td><td>3</td><td>2.05(1.67&#8211;2.52)</td><td>8.1</td><td>0.337</td><td></td></tr><tr><td>Severe</td><td>3</td><td>2.44(1.73&#8211;3.45)</td><td>0</td><td>0.438</td><td></td></tr><tr><td>Follow-up, years</td><td></td><td></td><td></td><td></td><td>0.453</td></tr><tr><td>&#8804;5</td><td>7</td><td>1.87 (1.36&#8211;2.59)</td><td>89.3</td><td>&lt;0.001</td><td></td></tr><tr><td>&gt;5</td><td>7</td><td>2.23(1.41&#8211;3.53)</td><td>96.3</td><td>&lt;0.001</td><td></td></tr><tr><td>Type of outcome</td><td></td><td></td><td></td><td></td><td>0.948</td></tr><tr><td>Incidence</td><td>10</td><td>2.06 (1.34&#8211;3.16)</td><td>97.6</td><td>&lt;0.001</td><td></td></tr><tr><td>Mortality</td><td>4</td><td>1.95 (1.71&#8211;2.23)</td><td>0</td><td>0.775</td><td></td></tr></table>
7333349e6314e84f3ca89199ad7b7f44dc306a5b203ba624a0b2ec860315ebfb.png
complex
<table><tr><td>Diseases</td><td>Genetic variations of TRAFs</td><td>References</td></tr><tr><td colspan="3">B cell malignancies</td></tr><tr><td>Multiple myeloma</td><td>Deletions or inactivating mutations of TRAF3, TRAF2</td><td>[294-296]</td></tr><tr><td> </td><td>SNPs of TRAF3</td><td>[297]</td></tr><tr><td>Splenic marginal zone lymphoma</td><td>Deletions or inactivating mutations of TRAF3</td><td>[298,299]</td></tr><tr><td>B cell chronic lymphocytic leukemia</td><td>Deletions or inactivating mutations of TRAF3</td><td>[298]</td></tr><tr><td>Mantle cell lymphoma</td><td>Deletions or inactivating mutations of TRAF3</td><td>[298]</td></tr><tr><td>Waldenstro&#776;m&#8217;s macroglobulinemia</td><td>Deletions or inactivating mutations of TRAF3</td><td>[300]</td></tr><tr><td>Hodgkin lymphoma</td><td>Deletion of TRAF3</td><td>[301]</td></tr><tr><td>Diffuse large B-cell lymphoma</td><td>Inactivating mutations of TRAF2, TRAF5</td><td>[302]</td></tr><tr><td>Non-Hodgkin lymphoma</td><td>SNPs of TRAF1</td><td>[303]</td></tr><tr><td colspan="3">Carcinomas</td></tr><tr><td>Breast cancers</td><td>Amplification of TRAF4</td><td>[304]</td></tr><tr><td>Lung cancers</td><td>Amplification of TRAF4, TRAF6</td><td>[304,305]</td></tr><tr><td>Osteosarcoma</td><td>Amplification of TRAF6</td><td>[306]</td></tr><tr><td colspan="3">Autoimmune diseases</td></tr><tr><td>Systemic lupus erythematosus</td><td>SNPs of TRAF6, TRAF1/C5</td><td>[22,307,308]</td></tr><tr><td>Rheumatoid arthritis</td><td>SNPs of TRAF5, TRAF6, TRAF1/C5</td><td>[22,309-311]</td></tr><tr><td colspan="3">Immunodeficiencies</td></tr><tr><td>HSV-1 encephalitis</td><td>Inactivating mutation of TRAF3</td><td>[312]</td></tr><tr><td colspan="3">Other</td></tr><tr><td>Hypohidrotic ectodermal dysplasia</td><td>Inactivating mutation of TRAF6</td><td>[313]</td></tr></table>
bd5800c12f0be6e13e0f880550b2a98c084f0e61c5086f4986f88884da754feb.png
complex
<table><tr><td></td><td colspan="2">Mismatch distribution</td><td colspan="2">Neutrality tests</td></tr><tr><td></td><td>SSD</td><td>R</td><td>Tajima's D</td><td>Fu's F</td></tr><tr><td>Northern</td><td>0.0230 (0.137)</td><td>0.0453 (0.072)</td><td>0.0730 (0.607)</td><td>0.415 (0.614)</td></tr><tr><td>Central</td><td>0.127 (0.012)</td><td>0.240 (0.000)</td><td>0.929 (0.851)</td><td>7.498 (0.955)</td></tr><tr><td>Southern</td><td>0.0923 (0.375)</td><td>0.223 (0.070)</td><td>&#8722;0.251 (0.447)</td><td>1.713 (0.822)</td></tr><tr><td>Overall</td><td>0.017 (0.087)</td><td>0.032 (0.000)</td><td>1.101 (0.894)</td><td>6.699 (0.896)</td></tr></table>
e4d6843fed0d415f1afb1c81bf5323cd7ace8ba61e1c3dfb89a7cf2414a84ef4.png
simple
<table><tr><td><i>Approach</i></td><td>Pombe</td><td>Kinase</td><td>Chromosome</td><td>ESP</td><td>RNA</td></tr><tr><td>Filling with zeros</td><td>1.01</td><td>1.00</td><td>1.01</td><td>1.00</td><td>1.00</td></tr><tr><td>uKNN (K = 5)</td><td>0.78</td><td>0.90</td><td>0.79</td><td>0.83</td><td>0.83</td></tr><tr><td>BPCA(K = 300)</td><td>0.74</td><td>0.89</td><td>0.85</td><td>0.80</td><td>0.82</td></tr><tr><td>wNN (K = 50)</td><td>0.71</td><td>0.85</td><td>0.75</td><td>0.79</td><td>0.78</td></tr><tr><td>LLS (K = 20)</td><td>0.68</td><td>0.85</td><td>0.73</td><td>0.76</td><td>0.77</td></tr></table>
5ae09ebc52a2916060a7a4bf5b15f2ca0899bdacb18b1b2ea70a07276158dbfe.png
simple
<table><tr><td></td><td></td><td># spots (percent of total)</td><td># genes (percent of total)</td></tr><tr><td>all</td><td>SIG<sup>1</sup></td><td>4273 (51.6)</td><td>6708 (52.2)</td></tr><tr><td></td><td>NON-SIG<sup>2</sup></td><td>4000 (48.4)</td><td>6141 (47.8)</td></tr><tr><td></td><td>Total</td><td>8273 (100)</td><td>12849 (100)</td></tr><tr><td>large gene families<sup>3</sup></td><td>SIG</td><td>739 (50.1)</td><td>1010 (51.5)</td></tr><tr><td></td><td>NON-SIG</td><td>735 (49.9)</td><td>950 (48.5)</td></tr><tr><td></td><td>Total</td><td>1474 (100)</td><td>1960 (100)</td></tr><tr><td>minus large gene families</td><td>SIG</td><td>3534 (52.0)</td><td>5698 (52.3)</td></tr><tr><td></td><td>NON-SIG</td><td>3265 (48.0)</td><td>5191 (47.7)</td></tr><tr><td></td><td>Total</td><td>6799 (100)</td><td>10889 (100)</td></tr></table>
35a6490f13012302601ca2038d403cd811295400851af5d6a5e682f3a67c194a.png
complex
<table><tr><td> </td><td> </td><td colspan="3">Age group</td><td> </td></tr><tr><td> </td><td>Total</td><td>Young adult</td><td>Adult</td><td>Elderly</td><td><i>P</i></td></tr><tr><td colspan="6">Anorectal angle (o)</td></tr><tr><td>At rest</td><td>102 &#177; 24</td><td>114 &#177; 28</td><td>94 &#177; 21</td><td>103 &#177; 19</td><td>0.09</td></tr><tr><td>Contraction</td><td>83 &#177; 21</td><td>91 &#177; 13</td><td>77 &#177; 25</td><td>86 &#177; 19</td><td>0.20</td></tr><tr><td>Valsalva maneuver</td><td>97 &#177; 24</td><td>100 &#177; 28</td><td>91 &#177; 22</td><td>105 &#177; 21</td><td>0.21</td></tr><tr><td>Evacuation</td><td>122 &#177; 22</td><td>119 &#177; 24</td><td>118 &#177; 22</td><td>133 &#177; 15</td><td>0.09</td></tr><tr><td colspan="6">Perineal descent (cm)</td></tr><tr><td>At rest (length)</td><td>4.0 &#177; 1.9</td><td>3.2 &#177; 1.1</td><td>4.2 &#177; 1.6</td><td>4.3 &#177; 3.3</td><td>0.41</td></tr><tr><td>Contraction(length)</td><td>3.0 &#177; 2.1</td><td>2.2 &#177; 1.9</td><td>3.3 &#177; 2.0</td><td>3.5 &#177; 2.7</td><td>0.37</td></tr><tr><td>Valsalva maneuver(length)</td><td>5.5 &#177; 2.4</td><td>5.8 &#177; 3.1</td><td>5.1 &#177; 1.9</td><td>5.7 &#177; 2.6</td><td>0.71</td></tr><tr><td>Evacuation(length)</td><td>7.7 &#177; 2.0</td><td>8.4 &#177; 1.1</td><td>7.4 &#177; 2.3</td><td>7.5 &#177; 2.3</td><td>0.45</td></tr><tr><td colspan="6">Puborectalis muscle (cm)</td></tr><tr><td>At rest</td><td>20 &#177; 5</td><td>20 &#177; 5</td><td>20.9 &#177; 3.7</td><td>19.8 &#177; 5.8</td><td>0.79</td></tr><tr><td>Contraction</td><td>19 &#177; 5</td><td>19 &#177; 6</td><td>20.4 &#177; 4.1</td><td>19.6 &#177; 5.8</td><td>0.77</td></tr><tr><td>Valsalva maneuver</td><td>21 &#177; 4</td><td>21 &#177; 3</td><td>20.9 &#177; 3.9</td><td>21.1 &#177; 4.1</td><td>0.99</td></tr><tr><td>Evacuation</td><td>20 &#177; 5</td><td>19 &#177; 6</td><td>21.1 &#177; 3.6</td><td>19.3 &#177; 5.4</td><td>0.56</td></tr><tr><td colspan="6">Length of the anal canal (cm)</td></tr><tr><td>At rest</td><td>4.6 &#177; 1.3</td><td>4.5 &#177; 1.2</td><td>4.7 &#177; 1.0</td><td>4.5 &#177; 1.8</td><td>0.89</td></tr><tr><td>Contraction</td><td>6.1 &#177; 1.6</td><td>6.1 &#177; 2.0</td><td>6.2 &#177; 1.6</td><td>5.8 &#177; 1.3</td><td>0.81</td></tr><tr><td>Valsalva maneuver</td><td>3.7 &#177; 1.6</td><td>3.2 &#177; 1.9</td><td>3.9 &#177; 1.6</td><td>3.8 &#177; 1.2</td><td>0.94</td></tr><tr><td>Evacuation</td><td>2.4 &#177; 1.2</td><td>2.6 &#177; 1.4</td><td>2.6 &#177; 1.4</td><td>2.5 &#177; 1.0</td><td>0.97</td></tr><tr><td colspan="6">Opening of the anal canal (cm)</td></tr><tr><td>At rest</td><td>0.9 &#177; 0.4</td><td>0.9 &#177; 0.3</td><td>1.0 &#177; 0.3</td><td>0.9 &#177; 0.5</td><td>0.72</td></tr><tr><td>Contraction</td><td>0.7 &#177; 0.3</td><td>0.7 &#177; 0.3</td><td>0.8 &#177; 0.2</td><td>0.7 &#177; 0.4</td><td>0.57</td></tr><tr><td>Valsalva maneuver</td><td>0.9 &#177; 0.5</td><td>0.8 &#177; 0.2</td><td>1.0 &#177; 0.5</td><td>1.1 &#177; 0.6</td><td>0.35</td></tr><tr><td>Evacuation</td><td>1.4 &#177; 0.4</td><td>1.4 &#177; 0.4</td><td>1.3 &#177; 0.4</td><td>1.3 &#177; 0.3</td><td>0.76</td></tr><tr><td>Emptying of the rectal ampulla (%)</td><td>70 &#177; 20</td><td>54 &#177; 25</td><td>79 &#177; 12</td><td>74 &#177; 11</td><td>0.001</td></tr></table>
072026e4d3bf9b0ee96cebcd51a8637311058b7d9b652cc58f0d8d4a0e63fde6.png
simple
<table><tr><td>Category</td><td>Variable name</td><td>Variable definition</td></tr><tr><td>Political Domain</td><td>Embassies</td><td>Absolute number of in-country embassies and high commissions</td></tr><tr><td></td><td>Organizations</td><td>Absolute number of memberships in international organizations</td></tr><tr><td></td><td>Military</td><td>Trade in conventional arms as a share of military spending</td></tr><tr><td>Economic domain</td><td>Trade</td><td>Imports + exports of goods and services as a share of GDP</td></tr><tr><td></td><td>FDI</td><td>Gross foreign direct stocks as a share of GDP</td></tr><tr><td></td><td>Capital</td><td>Gross private capital flows as a share of GDP</td></tr><tr><td>Social &amp; Cultural Domain</td><td>Migrants</td><td>Those who changes their country of usual residence per 100 inhabitant</td></tr><tr><td></td><td>Tourism</td><td>International arrivals + departures per 100 inhabitants</td></tr><tr><td>Technological Domain</td><td>Phone</td><td>Incoming + outgoing international telephone traffic in minutes per capita</td></tr><tr><td></td><td>Internet</td><td>Internet users as a share of population</td></tr><tr><td>Ecological Domain</td><td>Eco footprint</td><td>Ecological deficit in global ha</td></tr></table>
775f304e63d28ee3995ccba3ab80a2e546edeb58ff94069b25e128ef370ab347.png
complex
<table><tr><td></td><td></td><td colspan="2">recomWell IgG assay</td><td colspan="2">Axiom assay</td></tr><tr><td></td><td></td><td>Seroprevalence</td><td>95 % CI</td><td>Seroprevalence</td><td>95 % CI</td></tr><tr><td>Age groups</td><td>20&#8211;29</td><td>0 % (0/7)</td><td></td><td>14 % (1/7)</td><td>0-43*</td></tr><tr><td></td><td>30&#8211;39</td><td>0 % (0/9)</td><td></td><td>0 % (0/9)</td><td></td></tr><tr><td></td><td>40&#8211;49</td><td>16 % (4/25)</td><td>1.1&#8211;31</td><td>24 % (6/25)</td><td>7&#8211;41</td></tr><tr><td></td><td>50&#8211;59</td><td>20 % (7/35)</td><td>6.4&#8211;34</td><td>43 % (15/35)</td><td>26&#8211;60</td></tr><tr><td></td><td>60&#8211;69</td><td>19 % (7/36)</td><td>3.2&#8211;33</td><td>47 % (17/36)</td><td>31&#8211;64</td></tr><tr><td></td><td>70&#8211;79</td><td>67 % (8/12)</td><td>39&#8211;95</td><td>67 % (8/12)</td><td>39&#8211;95</td></tr><tr><td></td><td>80&#8211;89</td><td>0 % (0/2)</td><td></td><td>50 % (1/2)</td><td>0&#8211;100*</td></tr><tr><td></td><td>Total</td><td>21 % (26/126)</td><td>13&#8211;28</td><td>38 % (48/126)</td><td>29&#8211;47</td></tr><tr><td>Sex</td><td>male</td><td>20 % (24/118)</td><td>13&#8211;28</td><td>39 % (46/118)</td><td>30&#8211;48</td></tr><tr><td></td><td>female</td><td>25 % (2/8)</td><td>0&#8211;57*</td><td>25 % (2/8)</td><td>0&#8211;57*</td></tr><tr><td>Hunting area</td><td>East (E)</td><td>26 % (9/34)</td><td>11&#8211;42</td><td>52 % (17/34)</td><td>34&#8211;69</td></tr><tr><td></td><td>Northwest (NW)</td><td>14 % (9/65)</td><td>5&#8211;22</td><td>31 % (20/65)</td><td>19&#8211;42</td></tr><tr><td></td><td>Southwest (SW)</td><td>30 % (8/27)</td><td>12&#8211;47</td><td>41 % (11/27)</td><td>22&#8211;60</td></tr></table>
6fb79f013754eb653d9b529ad2f4730dc68fe71406df7a8d6539b47cd2db7471.png
complex
<table><tr><td></td><td>PfNapL</td><td>PfNapS</td><td>Vps75</td><td>yNAP-1</td><td>hSET</td></tr><tr><td colspan="2">Effect binding</td><td></td><td></td><td></td><td></td></tr><tr><td>1</td><td>I136</td><td>N112</td><td>S95</td><td>-</td><td>F115</td></tr><tr><td>2</td><td>I147</td><td>K120</td><td>S104</td><td>K230</td><td>R123</td></tr><tr><td colspan="2">No effect on binding to PfNapL</td><td>PfNapS</td><td>Vps75</td><td>yNAP-1</td><td>hSET</td></tr><tr><td>1*</td><td>D192</td><td>E161</td><td>Q150</td><td>D278</td><td>S162</td></tr><tr><td>2</td><td>H227</td><td>E187</td><td>G181</td><td>N314</td><td>T191</td></tr><tr><td>3*</td><td>T230</td><td>T191</td><td>R184</td><td>D317</td><td>T194</td></tr><tr><td>4</td><td>Y259</td><td>P198</td><td>D198</td><td>Y342</td><td>D202</td></tr><tr><td>5*</td><td>E260</td><td>D199</td><td>S199</td><td>S343</td><td>E203</td></tr><tr><td>6*</td><td>K266</td><td>R205</td><td>S205</td><td>K349</td><td>K209</td></tr><tr><td>7</td><td>D223</td><td>W183</td><td>K177</td><td>E320</td><td>Disordered</td></tr></table>
2dca3b378a761ed7db53f67427426be8501eb4a28021ef2fe0f8baf096d9418b.png
complex
<table><tr><td rowspan="2">Microglia (load (%))</td><td colspan="3">No dementia</td><td colspan="3">Dementia with Alzheimer&#8217;s pathology</td></tr><tr><td><i>&#946;</i></td><td>95 % CI (<i>&#946;</i>)</td><td><i>P</i></td><td><i>&#946;</i></td><td>95 % CI (<i>&#946;</i>)</td><td><i>P</i></td></tr><tr><td>Iba1</td><td>0.37</td><td>(0.29; 0.45)</td><td>&lt;0.001</td><td>&#8722;0.13</td><td>(&#8722;0.32; 0.05)</td><td>0.154</td></tr><tr><td>CD68</td><td>&#8722;<i>1.54</i></td><td>(&#8722;<i>2.96</i>;&#8722;<i>0.13</i>)</td><td><i>0.033</i></td><td>&#8722;<i>12.17</i></td><td>(&#8722;<i>15.13</i>; &#8722;<i>9.21</i>)</td><td>&lt;<i>0.001</i></td></tr><tr><td>HLA-DR</td><td>0.18</td><td>(&#8722;0.04; 0.41)</td><td>0.116</td><td>&#8722;<i>1.11</i></td><td>(&#8722;<i>1.59</i>; &#8722;<i>0.64</i>)</td><td>&lt;<i>0.001</i></td></tr><tr><td>MSR-A</td><td>&#8722;0.69</td><td>(&#8722;1.38; 0.00)</td><td>0.051</td><td>&#8722;<i>4.94</i></td><td>(&#8722;<i>6.82</i>; &#8722;<i>3.07</i>)</td><td>&lt;<i>0.001</i></td></tr><tr><td>CD64</td><td>0.27</td><td>(&#8722;0.03; 0.58)</td><td>0.076</td><td>1.08</td><td>(0.15; 2.02)</td><td>0.023</td></tr></table>
af91d1bfec0de2dad5b5386a9fe122eee667b794d06a0a2df97b46dceb52004b.png
simple
<table><tr><td></td><td>Region</td><td>Time consumed (hours)</td></tr><tr><td></td><td>Local group</td><td>12.00-19.20 (12.48 &#177; 2.40)</td></tr><tr><td>Group 1</td><td>Within-Sichuan group</td><td>24.00-84.00 (47.76 &#177; 18.72)</td></tr><tr><td></td><td>Outside-Sichuan group</td><td>48.00-108 (64.08 &#177; 13.92)</td></tr><tr><td>Group 2</td><td></td><td>0.03-0.08 (0.04 &#177; 0.03)</td></tr></table>
298318076874f6089703c9feebb526738b12729131dcd99376dbd5e1d746933f.png
simple
<table><tr><td>Species</td><td>Peptide</td><td>Ensembl gene ID</td><td>Genome assembly</td><td>Comment</td></tr><tr><td>Coelacanth</td><td>NPY</td><td>ENSLACG00000001891</td><td>LatCha1</td><td></td></tr><tr><td>Human</td><td>NPY</td><td>ENSG00000131096</td><td>GRCh37</td><td></td></tr><tr><td>Coelacanth</td><td>PYY</td><td>ENSLACG00000015096</td><td>LatCha1</td><td></td></tr><tr><td>Human</td><td>PYY</td><td>ENSG00000131096</td><td>GRCh37</td><td></td></tr><tr><td>Coelacanth</td><td>Pancreatic polypeptide</td><td>Not annotated in database (JH126680.1:1,154,715&#8211;1,154,819)</td><td></td><td></td></tr><tr><td>Human</td><td>Pancreatic polypeptide</td><td>ENSG00000108849</td><td>GRCh37</td><td></td></tr></table>
52b049b71c4f6edd967f61d07c2530b94eb4b47baa4bcbe6899dd1cfcadf8f64.png
complex
<table><tr><td>Database</td><td>Type</td><td>Species</td><td>Method</td><td>Entries</td></tr><tr><td>Unipep</td><td><i>N</i>-Glycosylated proteins and peptides</td><td><i>Homo sapiens</i></td><td>Hydrazide chemistry &amp; Solid Phase Extraction, in-silico triptic digestion of IPI proteins, and prediction of NXS/T glycosylation site with proteotypic potential</td><td>2265</td></tr><tr><td>Glycofly</td><td><i>N</i>-Glycosylated proteins and peptides</td><td><i>Drosophila melanogaster</i></td><td>Hydrazide chemistry and Solid Phase Extraction</td><td>740</td></tr><tr><td>Glycofish</td><td><i>N</i>-Glycosylated proteins and peptides</td><td><i>Danio Rerio</i></td><td>Hydrazide chemistry and Solid Phase Extraction</td><td>269</td></tr><tr><td>GlycoSuiteDB</td><td>O-linked and N-linked Glycoproteins and glycans</td><td> </td><td>Published glycoproteins with different methods</td><td>9436</td></tr><tr><td rowspan="2">GlycoProtDB</td><td rowspan="2">N2 and mouse tissues <i>N</i>-Glycoproteins</td><td><i>Caenorhabditis elegans</i></td><td rowspan="2">Lectin Concavilin A Chromatography</td><td rowspan="2">1465</td></tr><tr><td><i>Mus Musculus</i></td></tr><tr><td rowspan="2"><i>O</i>-GlycBase NetOGlyc</td><td rowspan="2"><i>O</i> and C-Glycosylated proteins</td><td rowspan="2">Combination of references</td><td rowspan="2">Data curation from literature and coupling ZFN gene targeting, SimpleCell and Lectin Chromatography</td><td>2413</td></tr><tr><td>3000</td></tr><tr><td rowspan="5">dbOGAP</td><td rowspan="5"><i>O</i>-GlcNAcylated proteins</td><td><i>Homo Sapiens</i></td><td rowspan="5">Curation from literature and SVM based prediction</td><td rowspan="5">798 (exp) 300 (pred)</td></tr><tr><td><i>Mus Musculus</i></td></tr><tr><td><i>Rattus Norvegicus</i></td></tr><tr><td><i>Drosophila Melanogaster</i></td></tr><tr><td><i>Xenopus Laevis</i></td></tr></table>
cd85ad1e553b3f5355de18c49235689a2e4dc427b19bcff5ba61a7dac9076059.png
complex
<table><tr><td rowspan="2">Is it possible to reduce the chance of getting the HIV virus by doing the following?</td><td colspan="2">Yes (<i>n</i> = 171; Male)</td><td colspan="2">Yes (<i>n</i> = 231; Female)</td></tr><tr><td><i>n</i></td><td>%</td><td><i>n</i></td><td>%</td></tr><tr><td>Always using a condom</td><td>161</td><td>94</td><td>222</td><td>96</td></tr><tr><td>Having one uninfected sexual partner</td><td>150</td><td>87</td><td>184</td><td>79</td></tr><tr><td>Clinical male circumcision</td><td>138</td><td>80</td><td>180</td><td>77</td></tr><tr><td>Abstinence</td><td>145</td><td>84</td><td>210</td><td>90</td></tr></table>
0917b1d011573b502b71e78f065782c70d829205aab14172532a009f1b50ddb1.png
complex
<table><tr><td rowspan="2"></td><td>Non-participation</td><td>Model 1 <sup>b</sup></td><td>Model 2 <sup>c</sup></td></tr><tr><td>/ total n (%)</td><td>aOR (95% CI)</td><td>aOR (95% CI)</td></tr><tr><td colspan="4">Total KCL</td></tr><tr><td> &lt;7</td><td>725/1138 (63.7)</td><td>reference</td><td></td></tr><tr><td> &#8805;7</td><td>467/595 (78.5)</td><td>1.14 (0.87, 1.49)</td><td></td></tr><tr><td> Unknown</td><td>667/883 (75.5)</td><td>1.21 (0.95, 1.53)</td><td></td></tr><tr><td colspan="4">IADL</td></tr><tr><td> &lt;3</td><td>1404/2098 (67.0)</td><td>reference</td><td>reference</td></tr><tr><td> &#8805;3</td><td>310/341 (90.9)</td><td>2.42 (1.60, 3.64)<sup>**</sup></td><td>2.28 (1.50, 3.46)<sup>**</sup></td></tr><tr><td> Unknown</td><td>145/177 (81.9)</td><td>1.79 (1.11, 2.89)<sup>*</sup></td><td>1.63 (0.99, 2.67)</td></tr><tr><td colspan="4">Physical function/strength</td></tr><tr><td> &lt;3</td><td>1075/1614 (66.6)</td><td>reference</td><td>reference</td></tr><tr><td> &#8805;3</td><td>555/694 (80.0)</td><td>1.36 (1.07, 1.73)<sup>*</sup></td><td>1.28 (1.00, 1.65)<sup>*</sup></td></tr><tr><td> Unknown</td><td>229/308 (74.4)</td><td>1.11 (0.81, 1.52)</td><td>0.92 (0.65, 1.30)</td></tr><tr><td colspan="4">Malnutrition</td></tr><tr><td> &lt;2</td><td>1466/2114 (69.4)</td><td>reference</td><td>reference</td></tr><tr><td> 2</td><td>38/52 (73.1)</td><td>0.76 (0.39, 1.46)</td><td>0.78 (0.40, 1.53)</td></tr><tr><td> Unknown</td><td>355/450 (78.9)</td><td>1.32 (1.00, 1.74)<sup>*</sup></td><td>1.25 (0.93, 1.67)</td></tr><tr><td colspan="4">Oral function</td></tr><tr><td> &lt;2</td><td>1311/1887 (69.5)</td><td>reference</td><td>reference</td></tr><tr><td> &#8805;2</td><td>433/587 (73.8)</td><td>0.85 (0.68, 1.08)</td><td>0.80 (0.63, 1.03)</td></tr><tr><td> Unknown</td><td>115/142 (81.0)</td><td>1.33 (0.83, 2.13)</td><td>1.16 (0.69, 1.94)</td></tr><tr><td colspan="4">Socialization</td></tr><tr><td> &lt;1</td><td>995/1507 (66.0)</td><td>reference</td><td>reference</td></tr><tr><td> &#8805;1</td><td>788/1013 (77.8)</td><td>1.23 (1.00, 1.51)</td><td>1.17 (0.94, 1.46)</td></tr><tr><td> Unknown</td><td>76/96 (79.2)</td><td>1.47 (0.84, 2.58)</td><td>1.42 (0.78, 2.59)</td></tr><tr><td colspan="4">Memory</td></tr><tr><td> &lt;1</td><td>1095/1602 (68.4)</td><td>reference</td><td>reference</td></tr><tr><td> &#8805;1</td><td>668/888 (75.2)</td><td>0.98 (0.80, 1.20)</td><td>0.92 (0.75, 1.14)</td></tr><tr><td> Unknown</td><td>96/126 (76.2)</td><td>1.06 (0.66, 1.70)</td><td>0.85 (0.51, 1.42)</td></tr><tr><td colspan="4">Mood</td></tr><tr><td> &lt;2</td><td>1008/1508 (66.8)</td><td>reference</td><td>reference</td></tr><tr><td> &#8805;2</td><td>557/736 (75.7)</td><td>1.06 (0.84, 1.33)</td><td>0.99 (0.78, 1.26)</td></tr><tr><td> Unknown</td><td>294/372 (79.0)</td><td>1.29 (0.92, 1.81)</td><td>1.15 (0.81, 1.64)</td></tr></table>
c1997d38202afa4eb47b41f38bc121b304ef2c7660f2e74b31bee3d027dfdf16.png
complex
<table><tr><td></td><td colspan="6">Dominant model &#8211; infection outcome</td></tr><tr><td><i>APOL1</i> haplotype</td><td colspan="2"><i>T.b.g</i> Disease</td><td colspan="2"><i>T.b.g</i> Carriage</td><td colspan="2">Association analysis<sup>*</sup><i>T.b.g</i> Disease/Carriage</td></tr><tr><td></td><td>Number</td><td>%</td><td>Number</td><td>%</td><td>OR [95% CI]</td><td><i>P</i></td></tr><tr><td>G1 Haplotype<sup>&#8224;,&#8225; </sup>rs73885319 (A&gt;G) + rs60910145 (T&gt;G)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>G1</td><td>36</td><td>23.4</td><td>25</td><td>48.1</td><td>0.33 [0.17 to 0.64]</td><td>0.0012</td></tr><tr><td>Non-G1</td><td>118</td><td>76.6</td><td>27</td><td>51.9</td><td></td><td></td></tr><tr><td>Total</td><td>154</td><td>100.0</td><td>52</td><td>100.0</td><td></td><td></td></tr><tr><td>G2 Haplotype<sup>&#8225; </sup>rs71785313 (TTATAA&gt;del6)</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>G2</td><td>50</td><td>31.6</td><td>4</td><td>7.3</td><td>5.87 [2.16 to 20.01]</td><td>0.0001</td></tr><tr><td>Non-G2</td><td>108</td><td>68.4</td><td>51</td><td>92.7</td><td></td><td></td></tr><tr><td>Total</td><td>158</td><td>100.0</td><td>55</td><td>100.0</td><td></td><td></td></tr></table>
121fab410ab8acfc61b1e488b98d42bad526c0f5171520a76a893c5d7eee90b0.png
complex
<table><tr><td rowspan="2">Variables</td><td rowspan="2">No. of studies</td><td> </td><td>Ala/Ala vs Val/Val</td><td> </td><td> </td><td>Ala/Ala vs Ala/Val</td><td> </td><td> </td><td>Ala/Val vs Val/Val</td><td> </td></tr><tr><td>OR (95% CI)</td><td>P<sub>h</sub></td><td>P</td><td>OR (95% CI)</td><td>P<sub>h</sub></td><td>P</td><td>OR (95% CI)</td><td>P<sub>h</sub></td><td>P</td></tr><tr><td>Total</td><td>51</td><td>0.870(0.789 0.958)</td><td>0.001</td><td>0.005</td><td>0.969(0.923 1.016)</td><td>0.206</td><td>0.191</td><td>0.895(0.821 0.976)</td><td>0.021</td><td>0.012</td></tr><tr><td>Asian</td><td>19</td><td>0.787(0.645 0.961)</td><td>0.017</td><td>0.019</td><td>0.929(0.843 1.023)</td><td>0.212</td><td>0.132</td><td>0.865(0.753 0.993)</td><td>0.300</td><td>0.039</td></tr><tr><td>Caucasian</td><td>25</td><td>0.869(0.741 1.020)</td><td>0.040</td><td>0.319</td><td>1.004(0.921 1.095)</td><td>0.137</td><td>0.926</td><td>0.910(0.778 1.064)</td><td>0.031</td><td>0.238</td></tr><tr><td>Mixed</td><td>7</td><td>0.925(0.793 1.079)</td><td>0.050</td><td>0.087</td><td>0.958(0.898 1.022)</td><td>0.946</td><td>0.191</td><td>0.912(0.778 1.068)</td><td>0.050</td><td>0.253</td></tr><tr><td rowspan="2">Variables</td><td rowspan="2">No. of studies</td><td colspan="3">Ala/Val + Ala/Val vs Val/Va (dominant)</td><td colspan="3">Ala/Ala vs Ala/Val + Val/Va (recessive)</td><td colspan="3">Ala allele vs Val allele</td></tr><tr><td>OR (95% CI)</td><td>P<sub>h</sub></td><td>P</td><td>OR (95% CI)</td><td>P<sub>h</sub></td><td>P</td><td>OR (95% CI)</td><td>P<sub>h</sub></td><td>P</td></tr><tr><td>Total</td><td>51</td><td>0.882(0.808 0.963)</td><td>0.004</td><td>0.005</td><td>0.944(0.898 0.993)</td><td>0.055</td><td>0.026</td><td>0.935(0.887 0.986)</td><td>0.000</td><td>0.013</td></tr><tr><td>Asian</td><td>19</td><td>0.826(0.703 0.972)</td><td>0.075</td><td>0.021</td><td>0.890(0.799 0.991)</td><td>0.043</td><td>0.034</td><td>0.877(0.801 0.960)</td><td>0.003</td><td>0.008</td></tr><tr><td>Caucasian</td><td>25</td><td>0.916(0.790 1.063)</td><td>0.030</td><td>0.247</td><td>0.985(0.908 1.069)</td><td>0.141</td><td>0.720</td><td>0.883(0.805 0.968)</td><td>0.052</td><td>0.359</td></tr><tr><td>Mixed</td><td>7</td><td>0.888(0.758 1.041)</td><td>0.029</td><td>0.144</td><td>0.946(0.890 1.006)</td><td>0.773</td><td>0.076</td><td>0.957(0.838 1.094)</td><td>0.000</td><td>0.523</td></tr></table>
a16d3cdfafb996926c9b23869f2fb4ed70b74378b8a04873281f8c31c8245d70.png
complex
<table><tr><td>Brain regions</td><td colspan="3">MNI coordinate</td><td>BA</td><td>Clustersize</td><td><i>T</i>-score</td></tr><tr><td></td><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td></td></tr><tr><td colspan="5">F&#8211;NF</td></tr><tr><td> Medial&#8901;Superior frontal gyrus</td><td>3</td><td>33</td><td>48</td><td>8</td><td>17</td><td>5.23</td></tr><tr><td> Lt. middle temporal gyrus</td><td>&#8722;66</td><td>&#8722;39</td><td>&#8722;6</td><td>21</td><td>28</td><td>5.21</td></tr><tr><td> Lt. middle temporal gyrus</td><td>&#8722;63</td><td>&#8722;36</td><td>3</td><td>22</td><td></td><td>4.58</td></tr><tr><td> Lt. inferior frontal gyrus/insula</td><td>&#8722;39</td><td>15</td><td>9</td><td>45/13</td><td>17</td><td>4.81</td></tr><tr><td></td><td>&#8722;30</td><td>24</td><td>6</td><td>45</td><td></td><td>4.64</td></tr><tr><td> Lt. medial frontal gyrus</td><td>&#8722;3</td><td>36</td><td>48</td><td>8</td><td>12</td><td>4.60</td></tr><tr><td colspan="5">NF&#8211;F</td></tr><tr><td> No significant activation</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5">E&#8211;I</td></tr><tr><td> No significant activation</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="5">I&#8211;E</td></tr><tr><td> Rt. inferior parietal lobule</td><td>42</td><td>&#8722;54</td><td>48</td><td>40</td><td>10</td><td>5.02</td></tr><tr><td> Rt. superior parietal lobule</td><td>36</td><td>&#8722;57</td><td>54</td><td>7</td><td></td><td>3.87</td></tr><tr><td colspan="5">(I_F&#8211;I_NF)&#8211;(E_F&#8211;E_NF)</td></tr><tr><td> Rt. superior parietal lobule</td><td>27</td><td>&#8722;57</td><td>45</td><td>7</td><td>33</td><td>4.74</td></tr><tr><td> Rt. precuneus</td><td>24</td><td>&#8722;72</td><td>51</td><td>7</td><td></td><td>3.37</td></tr><tr><td> Lt. fusiform gyrus</td><td>&#8722;48</td><td>&#8722;57</td><td>&#8722;15</td><td>37</td><td>10</td><td>4.22</td></tr><tr><td> Rt. middle frontal gyrus</td><td>48</td><td>33</td><td>18</td><td>46</td><td>10</td><td>3.70</td></tr><tr><td colspan="5">(E_F&#8211;E_NF)&#8211;(I_F&#8211;I_NF)</td></tr><tr><td> No significant activation</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table>